Untitled record

Full description Background of the invention

The present invention relates to a rapid-acting insulin formulation.

Since the beginning of the year 1980, diabetic patients have benefited from human insulin in their treatment. Increase the balled product

<p dir="rtl">5 In particular, this is particularly important, since this immune system is arranged using two insulins that indicate an abnormality of non-human insulin, specifically_aThis is pig insulin, since you removed this. What are these?</p>

Subcutaneously-injected human insulin has a hypoglycemic effect after only 60 minutes, which means that diabetics treated with human insulin should be injected 30 minutes before taking the drug.

<p dir="rtl">10 Select the previous example to solve this problem to improve the information. Please provide them with a message that will provide them with a response message. This will remind them of the user's permission to respond to the anomaly. This will provide them with a specific response document for the user. The physiological state of a healthy person. If the secretion of endogenous insulin in a healthy individual decreases, then the penis increases in this case. This goal is achieved when you eat food, so you will avoid eating with those who eat the meal.</p>

<p dir="rtl">15 Nowadays, it is accepted that the provision of bulk trays is sufficient_aThis is in order for the patient to receive the best possible health care.</p>

This is why the geometry of the minaret responds to the ears of the minaret. The aforementioned insulin is absorbed more quickly in one or more insulins than in the body compared to that time. This compound is not used insulins lispro 20 (Lilly®, Humalog), insulins lispro 20 (Lilly®, Humalog), insulins lispro, Novo, Novolog® (aspart) and glulisine.

٥٦٣٩

-٣-

(Sanofi Aventis, Apidra®) are stable insulin solutions that provide a faster response to diabetes compared to human insulin. Therefore, the treatment of insulin with the aforementioned method can be done by injecting insulin only 15 minutes before a meal.

The principle of rapid insulin release is to form a hexagonal compound with a concentration of 100 IU/ml5 to ensure the stability of insulin in the product._aThis is because of this hexagonal compound, which is constantly being used by the skin, so that the same response can be obtained.

A quick.

Insulting in the tidings, in its commercial form, does not make the one who makes it possible to obtain a pretext to respond to the remembrance of the slander.

With regard to movement, in relation to the physiological response that must be generated at the beginning of the meal (Ziyad

<p dir="rtl">10 Thus, at the general concentration (100), the zinc radical and the excipients are taken from the phenol or m-cresol molecules, they combine to form two hexagonal compounds, while they form In pictures The monomer and the dimer._aThis is for gathering and then slandering^YTo, hurl,</p>

<p dir="rtl">15 What makes this happen? Therefore, this is the reason for this, then this is the collected roots of this memory, this is the anomaly of every immune system._aOh Ali Al-Marri.</p>

Tf^،The hexagonal compounds L-dimer and monomer L-dimer work to intensify their effect for approximately

Brange J., et al., Advanced Drug (20 minutes before comparison with insulin and insulin). Delivery Review, 35, 1999, 307-335

<p dir="rtl">20 In addition to pleasure, this movement does not negate pleasure, and there is a real need for a formula that uses a more effective means of stimulation in order to approach the movement of secretion of the endogenous insulin stimulant in people. Cheers .</p>

Propose a Biodel model to describe this problem using the Inszdolin-by-Inszdolin formula.

Ethylene diamine tetra-acetic acid (EDTA)

٥٦٣٩

-٤-

citric acid as described in the American Bar Code 200839365.^YSince then, the chemical compound of insulin has been implemented since then, as the process of destabilizing the hexameric compound of insulin, and thus reducing the time required if the effect occurs.

<p dir="rtl">5 This is the case, so this is the case, this is the case._aThis is the hexameric form of insulin, which is the only stable radical capable of this parity as long as it meets the stability mentioned in the medicine tablets.</p>

General description of the invention

The international standard for seed production is prepared in accordance with the International Institutes for Seed Control No. 122385/2010

<p dir="rtl">10 This is what is known, meaning_aThis is the case, and this is the same as this</p>

Insulin, which can be deleted from the various problems mentioned above, may be added to two insulins with this substitution that includes a carboxyl group.

This is the problem that leads to chronic and chronic use or even the use of food, such that the person taking it to the ear of the person then using this food should make the molar mass and volume as small as possible in order to facilitate its clearance.

This is the most important thing in the world.

122385/2010 A 1 and the American dedicated, so I made it 094902/2012 A 1, so he made it._aOh, and you make such a delicious meal_aThis is the maximum interaction potential possible with a component with two extreme peaks. These two can be ashamed of the lack of privacy in terms of interpretation,

<p dir="rtl">20 The word "juzā" is similar to that of the smallest and the sharpest^YGive a better way than to appoint a muezzin who is the one who authorizes these chains, so that you can make a slaughter.</p>

Specializing in this topic.

In addition to Tl, the part that has a main chain is fixed^Ydd g_aThis is generally easier to control in the context of administration, distribution, or administration.

٥٦٣٩

-٥-

This is the metabolism, which is specifically defined as the elimination of warning (ADME) in these experiments, which generally means a widespread and disturbing signal at the mass scale.

On the contrary, it is not concluded that the erased part^Ydd g_aThis and the smaller molecule can suffer from a deficiency in nutrients, such as this, which makes up these two effective peaks. Khasoo_aThis is the case with the size of this product. Reduce this size by 5. This is because it does not have the same size as the polymers. This is what I remember

polysaccharide Since there is a loss of the effect of the polymer, as shown in the comparative figure in parts of the experiments; In particular, we test the decomposition of insulin at the point of electrophoresis and test the interaction with a typical protein with albumin.

Therefore, from these encouraging results, we model a highly atomized atom capable of atomizing 10 insulin using an anionic compound that has been replaced by an anionic compound.

Therefore, the use of this compound, the insulin compound, was not affected, and therefore the stability of the country was not affected, according to what has been confirmed, i.e._aI am lost with a sweet drunkenness, and I am devoid of Indholin Al-Bashdhar, and I forgot Indholin, with the help of my taste. Increase the pleasures of my mind, and I am pleased with this and the roots of Morkbih. They will inform me of this replacement according to_aThis is for taking. This makes it possible, in particular, to prepare human insulin or a non-insulin formula,

It has been able, after notifications, to dispense atomized insulin in one or two segments since then, and the dose has decreased more quickly when compared to Al-Manar commercial insulin products.

Brief explanation of the drawings

Figure 1: D-glucose (dehydrated glucose) as a function of the dose after injection (minutes). Show 20 curve statement._aIn the illuminated box for B8, and glucose per minute = 30 ± 11 minutes, it was plotted

The curve is a statement_aOh Palm No, Al-Manar, No, B2, and glucose time per minute = 44 ± 14 minutes

٥٦٣٩

-٦-

Figure 2: DInsulin (exactly) as a result of this moment (exactly). Explain the curve statement._aIn the bright square for B8, the maximum time for insulin = 11 ± 6 minutes.

The curve is a statement_aOh Palm No, Al-Manar, No, B2, maximum insulin time = 18 ± 8 minutes

Figure 3: D'glucose (released substance) as a function of the quantity of fluid at the moment of injection (minute). Statement of the curve._aThat's it

<p dir="rtl">5 With this square, the alarm clock is 10, and the glucose rate is 13 minutes = 33 ± 13 minutes.</p>

statement_aOh Palm No, Al-Manar, No, B2, and glucose time per minute = 44 ± 14 minutes

Figure 4: D Insulin (picomolar) as a function of dose dose by number of injections (minutes). Show the curve plot._aThen

In the lighted box for B10, the maximum time for insulin = 15 ± 9 minutes, the curve was drawn as a statement._aHey

Palm L A Al Manar L B2, maximum insulin time = 18 ± 8 minutes

<p dir="rtl">10 Figure 5: D'glucose (released substance) as a function of the quantity of fluid at the moment of injection (minute). Statement of the curve._aThat's it</p>

With this square, the previous time was 7, and the previous hourly minute = 41 ± 16 minutes._aOh palm for A Manar for L for B2, and glucose time per minute = 50 ± 14 minutes

Figure 6: D Insulin (picomolar) as a function of dose dose by number of injections (minutes). Show the curve plot._aIn the lighted box for B2, the maximum time for insulin = 21 ± 10 minutes, the curve was drawn as a statement._aHey

<p dir="rtl">15 Palm No. Al-Manar No. 2, maximum insulin time = 20 ± 9 minutes</p>

Figure 7: D'glucose (released substance) as a function of the quantity of fluid at the moment of injection (minute). Statement of the curve._aThat's it

With the square of this time, this time is 3, and the glucose rate in this time = 61 ± 31 minutes this time, the current curve is a statement._aOh Palm No, Al-Manar, No, B1, and glucose per minute = 44 ± 13 minutes

Figure 8: D Insulin (picomolar) as a function of dose dose by number of injections (minutes). Show the curve plot._aThen

<p dir="rtl">20 In the illuminated square for LB3, the maximum time for insulin = 36 ± 33 minutes, the curve was drawn as a statement._aHey</p>

Palm L A Al Manar L B1, maximum insulin time = 28 ± 13 minutes

٥٦٣٩

-٧-

Figure 9: D'glucose (the excreted substance) as a function of the quantity of fluid at the moment of injection (minute)._aThat's it

With this square, the previous time was 39, and the previous hourly minute = 46 ± 9 minutes._aOh Palm No, Al-Manar, No, B1, and glucose time per minute = 53 ± 24 minutes

Figure 10: D Insulin (picomolar) as a function of time after injection (minutes). The curve was plotted._aHey

<p dir="rtl">5 In the illuminated square for LBP 39, the maximum time for insulin = 20 ± 7 minutes, the curve was drawn as follows:_aHey</p>

Palm L A Al Manar L B1, maximum insulin time = 22 ± 10 minutes

Figure 11 describes on the X axis, from left to right:

Humalog Himalo

<p dir="rtl">9 .3 + Humalog mM Star citrate</p>

<p dir="rtl">10 6 + Humalog mM EDTA</p>

<p dir="rtl">6 + Humalog mM 9.3+ EDTA mM Star</p>

<p dir="rtl">7.3 + Humalog mg/ml Compound 1</p>

<p dir="rtl">7.3 + Humalog mg/mL Compound 1 + 9.3 mM Star</p>

<p dir="rtl">7.3 + Humalog mg/ml Complex 1 + 20 mg/ml Polyanionic Complex 1</p>

15 On the Y axis is the CD signal at 251 nm (degrees.cm2.dmol-1).

Figure 12 describes on the X axis, from left to right:

Recombinant human insulin (rhINS)

<p dir="rtl">9.3 + rhINS mM Star</p>

<p dir="rtl">6 + rhINS millimolar EDTA</p>

20 6+ rhINS mM 9.3+ EDTA mM Star

٥٦٣٩

-٨-

<p dir="rtl">7.3 + rhINS mg/ml compound 1</p>

<p dir="rtl">7.3 + rhINS mg/mL compound 1 + 9.3 mM Star</p>

<p dir="rtl">7.3 + rhINS mg/ml compound 1 + 20 mg/ml polyanionic compound 1</p>

On the Y axis is the CD signal at 275 nm (degrees.cm2.dmol-1).

<p dir="rtl">5 Figure 13: D'glucose (mM) as a function of time after injection (minutes). Show the curve plot._aThen</p>

With this square, the alarm clock is 11, and the glucose rate is 10 minutes = 32 ± 10 minutes, the curve graph is a statement._aOh Palm No, Al-Manar, No, B2, and glucose per minute = 41 ± 21 minutes

Figure 14: D Insulin (picomolar) as a function of time after injection (minutes). The curve was plotted._aHey

In the illuminated square for LB11, the maximum time for insulin = 13 ± 5 minutes, the curve was drawn as a statement._aHey

<p dir="rtl">10 Palm L A Al Manar L B2, maximum insulin time = 22 ± 13 minutes</p>

Figure 15: D'glucose (mM) as a function of time after injection (minutes). Show the curve plot._aThen

In the illuminated square of LB 102, and the glucose per minute = 47 ± 30 minutes, the curve graph is a statement_aOh Palm No, Al-Manar, No, B1, and glucose per minute = 47 ± 15 minutes

Figure 16: D Insulin (picomolar) as a function of time after injection (minutes). The curve was plotted._aHey

<p dir="rtl">15 With the square of this warning t for the second with 38, the maximum and the maximum for the second = 22 ± 21 minutes for the second, the maximum and the maximum for the second day_aOh Palm No, Al-Manar, No, B1, maximum insulin time = 19 ± 12 minutes</p>

Figure 17: D'glucose (mM) as a function of time after injection (minutes). Show the curve plot._aThe square of this alarm clock is 53, and the hourly alarm clock is 63 ± 36 minutes, so the alarm clock is a statement_aOh Palm No, Al-Manar, No, B1, and glucose per minute = 53 ± 19 minutes

<p dir="rtl">20 Figure 18: D Insulin (picomolar) as a function of time after injection (minutes). The curve was plotted._aHey</p>

With the square of this alarm t for the second b 53, the maximum and the maximum for the two alarms = 19 ± 12 minutes for the second, the maximum and final curve statement_aOh Palm No, Al-Manar, No, B1, maximum insulin time = 19 ± 6 minutes

٥٦٣٩

-٩-

Figure 19 describes on the X axis:

A: Lispro insulin (100 IU/ml)

B: Insulin lispro + 7.3 mg/ml for compound 2

: Insulin lispro + 7.3 mg/ml of compound 2 + star citrate at 9.3 mM

5 D: Insulin lispro + 7.3 mg/ml for compound 1

This is: insulin lispro + 7.3 mg/ml of compound 1 + STAR at 9.3 mM.

F: Insulin lispro + 7.3 mg/ml for compound 3

G: Insulin lispro + 7.3 mg/ml for compound 3 + STAR at 9.3 mM.

H: Insulin lispro + 7.3 mg/ml for compound 4

10 : Insulin lispro + 7.3 mg/ml for compound 4 + STAR at 9.3 mM

: Insulin lispro + 7.3 mg/ml for compound 5

: Insulin lispro + 7.3 mg/ml for compound 5 + Star at 9.3 mM

L: Insulin lispro + 7.3 mg/ml for compound 6

M: Insulin lispro + 7.3 mg/ml for compound 6 + Star at 9.3 mM

15

N: Insulin lispro + 7.3 mg/ml for compound 7

Q: Insulin lispro + 7.3 mg/ml for compound 7 + STAR at 9.3 mM

P: Insulin lispro + 7.3 mg/ml for compound 8

F: Insulin lispro + 7.3 mg/ml for compound 8 + STAR at 9.3 mM

P: Insulin lispro + 7.3 mg/ml for compound 9

٥٦٣٩

-١٠-

Q: Insulin lispro + 7.3 mg/ml for compound 9 + Star at 9.3 mM

R: Insulin lispro + 7.3 mg/ml for compound 10

SH: Insulin lispro + 7.3 mg/ml for compound 10 + Star at 9.3 mM.

: Insulin lispro + 7.3 mg/ml for compound 11

5 J: Insulin lispro + 7.3 mg/ml of compound 11 + Star at 9.3 mM.

On the Y axis, the color of the circle increases at 251 nm (degrees.cm2.dmol-1).

Figure 20: Described on the X axis:

A: Human insulin (100 IU/ml)

B: Human insulin + 7.3 mg/ml for compound 2

10

15

: Human insulin + 7.3 mg/ml for compound 2 + STAR at 9.3 mM

D: Human insulin + 7.3 mg/ml for compound 1

This is: human insulin + 7.3 mg/ml for compound 1 + STAR at 9.3 mM.

F: Human insulin + 7.3 mg/ml for compound 3

G: Human insulin + 7.3 mg/ml for compound 3 + STAR at 9.3 mM.

H: Human insulin + 7.3 mg/ml for compound 4

: Human insulin + 7.3 mg/ml for compound 4 + STAR at 9.3 mM

: Human insulin + 7.3 mg/ml for compound 5

: Human insulin + 7.3 mg/ml for compound 5 + STAR at 9.3 mM

L: Human insulin + 7.3 mg/ml for compound 6

٥٦٣٩

-١١-

M: Human insulin + 7.3 mg/ml for compound 6 + Star at 9.3 mM.

N: Human insulin + 7.3 mg/ml for compound 7

Q: Human insulin + 7.3 mg/ml for compound 7 + STAR at 9.3 mM

P: Human insulin + 7.3 mg/ml for compound 8

5 F: Human insulin + 7.3 mg/ml for compound 8 + STAR at 9.3 mM

P: Human insulin + 7.3 mg/ml for compound 9

Q: Human insulin + 7.3 mg/ml for compound 9 + Star at 9.3 mM.

R: Human insulin + 7.3 mg/ml for compound 10

SH: Human insulin + 7.3 mg/ml for compound 10 + Star at 9.3 mM.

<p dir="rtl">10 : Human insulin + 7.3 mg/ml for compound 11</p>

J: Human insulin + 7.3 mg/ml for compound 11 + Star at 9.3 mM.

On the Y axis, the color of the circle increases at 275 nm (degrees.cm2.dmol-1).

Detailed description:

They use the following combinations: 15 points, 15 points, 15 points, 15 points, 15 points, 15 points, 15 points, 15 points, 15 points The anion is the same as the anion -non

.polymeric polyanionic

The phrase “Saccharide is a simple saccharide that is formed from a separate number of saccharides.” Between 1 and 8 (1 ≥ 8 ≤ u) of identical or different disaccharide units, connected by a glycoside link Whether the same or different, it is done

<p dir="rtl">20 Choose one of the polysaccharides from the group that consists of the hexose compound, which has a single radical or a single open radical, which includes the compound compound that contains a single carboxyl radical.</p>

٥٦٣٩

-١٢-

A carboxyl group that has a partial substitution; a carboxyl group that does not have a substitution forms a salt.

In one form, insulin has a hexagonal shape.

In one form, the insulin is human insulin.

<p dir="rtl">5 The expression "absolutely" means two insulins obtained by synthesis or recombination, the peptide sequence of which is the sequence of human insulin, including allelic and homologous allele forms.</p>

This is the case with these examples.

<p dir="rtl">10 Described in the European Pharmacopoeia and the US Pharmacopoeia.</p>

In one form, insulin is an insulin analog.

The term “nother insulin” means a genetic recombination of insulin for which the primary sequence has at least one modification to the human insulin primary sequence.

If you have taken these examples, you may take a warning from those who have authorized the group that you take from those who have not yet taken these examples. 15 Humalog® (insulin lispro), insulin reports Novolog® (insulin lispro,

Novorapid® and Apidra® insulin glulisine.

In one form, insulin lispro is insulin lispro (Humalog).

Novolog®,

Novorapid®

<p dir="rtl">20 In one form, the insulin precursor is insulin glulisine (Apidra®).</p>

In one model, the substituted anionic compound is selected from substituted anionic compounds, in isolated forms or in radicals, which consist of a formal series that can be formed by a separate number u.

٥٦٣٩

-١٣-

The polysaccharide is composed of two identical or different polysaccharides, connected by identical or different glycoside bonds. The two polysaccharides mentioned are chosen from the group that consists of hexose compounds, in cyclic or open forms. Reduced, characterized by the substitution of y:

a) The set of at least one substitution has the general form I:

<p dir="rtl">5 -[m ]AA[-a ]R1 Formula I</p>

<p dir="rtl">• The set of substituted methods is identical or different when there are two roots of the set of substituted methods.</p>

At least, it includes:

<p dir="rtl">• In the moiety [AA] is a building block of amino acid.</p>

<p dir="rtl">• The slit -R1- is:</p>

<p dir="rtl">10 - So, I want you to have a word for the trustworthy person - [AA].</p>

direct_a In the main chain with G and Y,

<p dir="rtl">- Or a chain based on carbon, C2 carbon, to C15, and from m = 1, with a choice of substitution and/or inclusion of an atom, and select the smallest homogeneous atom (O), a standard of sulfur (S), and a specification. Load acid function and select the dirtiest one</p>

<p dir="rtl">15 Before the reaction with the amino acid, the aforementioned chain forms the structural definition of the amino acid - [AA] and an amide function, and is connected to the main chain by a function F resulting from a reaction between a hydroxyl and a hydroxyl function carried by the main chain and a function. Or a replacement set carried by the slot-producing material -R1-,</p>

<p dir="rtl">• F Abddhdhdhdhạr Adhadhdhaḍn and Yafdhadhdhatha Mukhathadhdhatharah Mudhadhdhaan and Yafzadhadharah ether, and Yafzadhadharat ester and carbamadhadhadha</p>

, carbamate 20

<p dir="rtl">• G represents the carbamate function,</p>

<p dir="rtl">• m is a variable equal to 1 or 2,</p>

٥٦٣٩

-١٤-

<p dir="rtl">• The degree of replacement and deletion of the sazdhakarid, j, then this - [m ]AA[-a ]R1 tkzdon Akbdhadhr Fazdhala Mudhann Sazdhafar</p>

and less than or equal to 6, zero &gt; 6 ≤ j

<p dir="rtl">b) And, choice_aOh, one or more R sums of substitution -1'R,</p>

<p dir="rtl">• The substituent group -1'R has its base chain as a carbonyl C2 to C15, which is thus substituted.</p>

<p dir="rtl">5 An atomization and/or anomaly that includes a homogeneous atom, an atomized atom, atomized O, an atomized atom, and S, and at least one ionized atom in the form of a salt cation, an alkali metal cation,</p>

This simple document contains two models attached to the main series and a section 'F'. -1'R,

<p dir="rtl">10 • F' is a term for an ester, an ester or a carbama.</p>

<p dir="rtl">• The degree of substitution of two disaccharide units, i, in -1'R, is between 0 and 6-j, 0 ≥ j-6 ≤ i,</p>

^And

<p dir="rtl">• F and F' are the same or different,</p>

<p dir="rtl">• F and G are the same or different,</p>

,6 ≤ j+i • 15

<p dir="rtl">• -1'R is the same as or different from -R1-,</p>

<p dir="rtl">• This and this are taken in the following example, and the information provided for the information is taken by the group’s teachers, instead of -1’R</p>

Pictures of alkali metal cation salts,

<p dir="rtl">• You may take a note of this particular glycoprotein, which may be the same or different, since you may</p>

20 The group that consists of a glycosidic ligand is a glycosidic ligand of extremities (1, 1), (1, 2), (1, 3), (1, 4) or (1, 6), in the geometric form alpha or beta.

٥٦٣٩

-١٥-

In the case of one of the models, you can choose the anionic minaret that can be replaced by this, so if you have an isolated root, or you have an instantaneous root, then you can choose the anionic minaret with this substitution, so you can use the anionic minaret to replace it. A discrete term u varies between i and 8 (8 ≤ u ≤ i) from One single or different polysaccharide, linked by a bond

Similar or different glycoside molecules, one of the polysaccharides is selected from the two hexose compounds, in 5 cyclic forms or in reduced open forms, characterized by two

A) It has a random replacement with:

At least one substitution set has the general formula I:

<p dir="rtl">-[m ]AA[-a ]R1 Formula I</p>

<p dir="rtl">• The set of substituted methods is identical or different when there are two roots of the set of substituted methods.</p>

<p dir="rtl">10 At least, it includes:</p>

<p dir="rtl">• Ya’a Dhu al-Shadhaq - [AA]- and he chose us as a result of Al-Hamd Amindhi, and he chose Al-Hamd Al-Amindhi Al-Mazdathur.</p>

Of the group consisting of phenylalanine, alpha-4,3-methylphenylalanine, dihydroxyphenylalanine, tyrosine, alpha-methyltyrosine O, alpha-methyltyrosine-methyltyrosine

<p dir="rtl">15 O-methyltyrosine, alpha-phenylglycine, 4-hydroxyphenylglycine and 3,5-da-hydroxyphenylglycine. Dihydroxyphenylglycine, and alkali metal cation salts thereof, of which the aforementioned derivative has taken L or D radicals. , [AA]- is connected to the main chain of the parts via a connection circuit - R1 - or connected directly_a In the main chain with G and Y,</p>

<p dir="rtl">20 direct_a In the main chain with G and Y,</p>

<p dir="rtl">• -R1- is:</p>

<p dir="rtl">- Either the square of G, and from m a = zero,</p>

٥٦٣٩

-١٦-

<p dir="rtl">- Or a carbon-based chain from C2 to C15, and from M 1 = a, which has a selective substitution and/or fragmentation, including a homologous form, O, a sound form, and a S, and/or fragmentation. This includes all the above-mentioned series</p>

The structure of the amino acid - [AA] is an amide bond and is attached to the main polysaccharide chain by ear.

<p dir="rtl">5 A window F is the product of a two-hydroxy compound, a window carried by a normal chain unit, and a window carried by the material producing that R1.</p>

<p dir="rtl">• F is a compound, ester or carbama,</p>

<p dir="rtl">• G represents the word “karbama”,</p>

<p dir="rtl">• m equals 1 or 2,</p>

10 The degree of this replacement, j, then this - [m ]AA[-a ]R1_a Mudhazan zadhafar and Aqaddhamil Mudhazan or Taszathaaw 6, zero &gt; 6 ≤ j,

And, choose_aHey,

<p dir="rtl">&lt; One or more R sums of substitution -1'R</p>

<p dir="rtl">• -1'R is a chain based on carbons C2 to C15, which has a selective substitution and/or includes</p>

<p dir="rtl">15 ạlṭ ṭr wa ḥadḥd ẓal al-adhḥl yātḥr homophone (mdhl O, iḍar mḍn and S) and tamdhāl and yafḍah Ḥamḍ wa dhadhd</p>

At least in the form of a profile of the alkaloid metal cation, the aforementioned chain is connected to the main acetate chain, which is connected to the 'F' chain, and is connected to the 'F' chain, which is carried by the main chain and a function carried by The material produced is y-1'R ,

<p dir="rtl">• F' is a term for an ester, an ester or a carbama.</p>

<p dir="rtl">20 The degree of substitution, i, in -1'R, is between zero and -j-6, zero ≥ j-6 ≤ i, and</p>

<p dir="rtl">• -1'R- is the same as or different from -R1,</p>

<p dir="rtl">• F and F' are the same or different,</p>

٥٦٣٩

-١٧-

<p dir="rtl">• F' and G are the same or different,</p>

<p dir="rtl">• Takht and F of the free salt-forming salts of alkali metal cation salts,</p>

<p dir="rtl">b) The balled glycoside residues, which may be identical or different, are selected from the group consisting of glycoside residues of type (1,1), (1,2), (1,3), (1,4) or (1, 6), in Fig</p>

<p dir="rtl">5 geometric alpha or beta,</p>

<p>6 ≤ j+ i)</p>

In one form, m equals 1.

In one form, -R1 and -1'R, which can be identical or different, form the seeds of a carbon-based chain from C2 to C8.

<p dir="rtl">10 In one form, -R1 and -1'R, which can be identical or different, represent a carbon-based chain from C2 to C4.</p>

i and j are the symbols of this statistic for substituting and the average of these sums is substituting for this single polysaccharide. Since each disaccharide unit carries a different reactivity, it is possible to replace this compound with this anionic compound, which can be replaced by this compound.

<p dir="rtl">15 Different_aFrom one disaccharide unit to another in the same polyanionic compound.</p>

In one model, 0.3≥ i.

In one model, 0.4≥ i.

In one form, 3 ≥ i.

In one model, 2.5≥ i.

<p dir="rtl">20 In one model, 0.3 ≥ j.</p>

In one model, 0.4≥ j.

٥٦٣٩

-١٨-

In one model, 2 ≤ j.

In one model, 1.8 ≤ j.

In a model, i and j have a value of zero &gt; 6 ≤ j + i.

In one form, zero &gt; 5 ≤ j + i.

5 In one form, zero &gt; 4 ≤ j + i.

In one form, zero &gt; 3 ≤ j + i.

In one form, zero &gt; 2.5 ≤ j + i.

In one form, zero &gt; 2 ≤ j + i.

In one model, 0.5 ≥ 3 ≤ j + i.

10 In one model, 0.5 ≥ 2.5 ≤ j + i.

In one model, 0.5 ≥ 2 ≤ j + i.

In one model, 0.6 ≥ 3.5 ≤ j + i.

In one model, 0.8 ≥ 2.5 ≤ j + i.

In one model, 0.7 ≥ 2.5 ≤ j + i.

15 In one model, 0.7 ≥ 2 ≤ j + i.

In one model, 1 ≥ 2.5 ≤ j + i.

In one form, 1 ≥ 2 ≤ j + i.

In one model, -R1 and -1'R are connected to the rational series by an ether bond.

.bond

٥٦٣٩

-١٩-

In one embodiment, when -RI- is a carbon-based chain, it is connected directly to the main chain by an ether bond.

In one embodiment, when -RI- is a carbon-based chain, it optionally includes a heteroatom selected from the group consisting of 0, 0 and C.

5 In one embodiment, -RI- forms an amide bond with the AA residue, and is connected directly to the main chain via an ether function.

In one embodiment, thc-51 with the amino acid residue AA is an amide bond, connected directly to the main chain by a carbamate function.

In one embodiment, [R-] forms an amide bond with the amino acid residue AA, and is connected directly to the main chain via an ester function F.

In one embodiment, -Rl- and -R'l are selected from slots of the form II and |||

C|B =R1

Formula AA

Hb b

Formula AAA,

they

In them:

015 0 and P, which can be the same or different, are greater than or equal to 1 and less than or

Equals 12, and

<p dir="rtl">0 -,-],-p and -], which can be identical or different, are chosen from</p>

The group consisting of a hydrogen atom, a cyclic alkyl to C6, saturated or unsaturated, linear, or branched, benzyl, alkyl aryl to C7 alkylaryl.

» 2 010 and optionally includes heterogeneous atoms selected from the group consisting of 0, standard

٥٦٣٩

-٢٠-

Of and/or 5 or selected functionalities from the group consisting of functionalities of carboxylic acid, amine, alcohol and thiol.

In one embodiment, -RI-, before bonding to -AA -, is -.COOH-CH2

In one embodiment, the substituent anionic compounds according to the invention have the -['R moiety 5 being -C00H-CH2.

In one embodiment, -RI-, prior to enantioselective attachment to -AA-, is derived from citric acid

citric acid

In one embodiment, -81, prior to enantioselective attachment to -AA, is derived from malic acid

.malic acid

<p dir="rtl">0 1 In one embodiment, -R'l is derived from citric acid.</p>

In one embodiment, -R1 is derived from malic acid.

In one embodiment, -RI-, prior to binding to -AA-, is selected from the following sets, wherein the binding site is represented by F:

١٥

O

<img file="SA5639B1_D0001.tif" />

(

OH

O

In one embodiment, -R'l is selected from the following sets, in which

The binding site is represented by F:

Ο

<img file="SA5639B1_D0002.tif" />

OH

5Η

Ο

٥٦٣٩

-٢١-

Or any of these alkali metal cations were chosen from the group consisting of Na+ and K+.

These examples include phenylalanine and alkaline metal cation salts, including D, L, or racemic salts.

<p dir="rtl">5 In one form, the [AA] moiety is a structural unit of alpha-methylphenylalanine, and thus it is a cation, so this form of an alkaloid is thus taken as a D, L or acetyl radical.</p>

M Laqqa.

These examples include the moiety - [AA]. Therefore, we have taken the form of 3, 4-dihydroxyphenylalanine, and for the alkaloid metal cation salts, the form L, D, or 10 is taken as the alkaloid form.

In one form, the [AA] radical is a structural unit of tyrosine and of alkali metal cation salts, which are formed in the form D, L, or acetate.

These examples include the fragment - [AA] with this permission, and they remind us of this type - alpha methyltyrosine - and for alkaline metal cation salts, some of which are formed in the form of D, L or acetate.

<p dir="rtl">15 These examples include: [AA] - [AA] - [AA] - [AA] - [AA] - O methyltyrosine, and for alkaline metal cation salts, which are formed in the form D, L. Or Arsimia m Malaga.</p>

This is the most important example, the fragment - [AA].

4-Hydroxy-hydroxy-[AA]

<p dir="rtl">20 Hydroxyphenylglycine is therefore a cation, so this alkaloid is taken as a D, L, or acetate form.</p>

M Laqqa.

٥٦٣٩

-٢٢-

This is the example, the fragment - [AA] is the same as this, and this is the same as the 3.5-dihydroxyphenylglycine, and the alkali metal cation salts of this are taken as D, L or acetylated.

So, this is the most beautiful of the examples, they are the ones who are shadhaq - [AA] Abdhadhaar Adhazan, and the rest of us are Yadhadhun, for Al-Hadhdhah, Ameendhadhī, so this, the roots of Khadhadhī

<p dir="rtl">5 Arsimi.</p>

So those with the best examples, they lie Al-Shadhaq - [AA] Abdhar Azan and Hadhad Banna Yahtha by Al-Hamddh Amindhi Fdha Dhuzur Aizumdhaar

Isolated isomers of the specific configuration D.

So those with the best examples, they lie Al-Shadhaq - [AA] Abdhar Azan and Hadhad Banna Yahtha by Al-Hamddh Amindhi Fdha Dhuzur Aizumdhaar

Isolated from the L formation.

10 In a model, u is between 1 and 5.

<p dir="rtl">In a formula, u is between 3 and 5.</p>

<p dir="rtl">In one of the numbers, 8=u.</p>

<p dir="rtl">In one of the numerals, 7=u.</p>

<p dir="rtl">In one of the numbers, 6=u.</p>

<p dir="rtl">15 In one form, 5 = u.</p>

<p dir="rtl">In one of the patterns, 4=u.</p>

<p dir="rtl">In one of the patterns, 3=u.</p>

<p dir="rtl">In one form, 2=u.</p>

<p dir="rtl">In one of the models, 1=u.</p>

<p dir="rtl">20 In one model, the two hexose compounds are chosen from the group consisting of mannose and glucose, fructose, sorbose, and tagatose.</p>

٥٦٣٩

-٢٣-

psicose, galactose, allose, altrose, talose, idose, gulose, fucose, fucule ose, rhamnose, mannitol, sorbitol, and galactitol (dulcitol

.)dulcitol

<p dir="rtl">5 In one plant, the glycoside bonds are of the type (1, 4) or (1, 6).</p>

In one model, the anionic compound to be substituted is selected from anionic compounds consisting of a main saccharide chain formed from a discrete number of saccharides (u = 2) of one or two different saccharide units, such as hexoses, linked by a special methyl glycoside. (1,1).

<p dir="rtl">10 In one model, the anionic compound to be substituted is selected from anionic compounds consisting of a main disaccharide chain formed by a separate number u = 2, then different disaccharides selected from hexose compounds and connected by 1,1(1) glycoside bonds The main polysaccharide chain is chosen from the group consisting of trehalose and sucrose.</p>

In one model, the anionic compound with which it is substituted is chosen from the anionic compounds that make up 15 simple notes, a description of which can be formed using a separate number, 2 = 2 notes, and then the following notes are given or

A selection of different hexose compounds connected by glycoside bonds of the type (1, 2).

In a model, the anionic compound with which it is substituted is chosen from the anionic compounds that are made

Note that this document is a separate document. 2 = u Note that this memory has been updated or is different. Note that this document has been installed. This document has been linked to another document. This document has been deleted. Trims (1, 2), a series of 20, the main polysaccharide forming kojibiose.

In a model, the anionic compound with which it is substituted is chosen from the anionic compounds that are made

A separate series of medicinal substances is mentioned in this article. A separate medicinal number is 2 = u. A separate or different medicinal substance is selected from hexose compounds connected by a glycoside linkage of the type (3, 1 f).

٥٦٣٩

-٢٤-

In one model, the anionic compound with which it is substituted is selected from the anionic compounds that make up a simple hexose chain, which can be formed using a separate number 2 = 2, and a similar or different type of hexose compound is chosen from the hexose compounds linked by a glycoside bond. n prominence)1 (3), the main polysaccharide chain is selected from the group consisting of nigeriose and laminaripose.

. laminaribiose 5

In a model, the anionic compound with which it is substituted is chosen from the anionic compounds that are made

A separate series of medicinals is mentioned in this article. A separate medicinal number is 2 = u. A separate or different medicinal chain is selected from hexose compounds connected by a glycoside linkage of the type (1, 4).

In one model, the anionic compound with which it is substituted is chosen from the anionic compounds that make up 10 simple notes, a description of which can be formed using a separate number, 2 = 2 notes, and then the following notes are given or

A selection of different hexose compounds linked by glycosidic ligands of the same type (1, 4). A simple memory chain is chosen, and the nutritional value of the food group is carried out using the same name: maltose, to extract lac. tose and cellobiose.

In one model, the anionic compound with which it is substituted is chosen from the anionic compounds that make up 15 simple notes, a description of which can be formed using a separate number, 2 = 2 notes, and then the following notes are given or

A selection of different hexose compounds connected by a glycoside linkage of the type (1, 6).

In a model, the anionic compound with which it is substituted is chosen from the anionic compounds that are made

A separate series of glycosides is mentioned in this article. A separate number of 2 = u is mentioned in a similar or different memory. Selected from hexose compounds connected by a glycosidic bond with the same name (1, 6), 20 additional series can be chosen. What are the actions taken by the school office? isomaltose,

Melibiose and gentiobiose.

In one model, the anionic compound with which it is substituted is chosen from the anionic compounds that make up a simple reference series, which can be formed using a separate number, 2 = u, and a simple summary of this document is given or

٥٦٣٩

-٢٥-

This is a unique compound called hexachloride, which is linked to a unique glycosylated compound (1, 6). The main polysaccharide chain formed is isomaltose.

In a model, the anionic compound with which it is substituted is chosen from the anionic compounds that are made

Create a separate number of notes, 2 = u, select a message, and delete it from this

<p dir="rtl">5 One is in cyclic form and the other is in reduced open form.</p>

In a model, the anionic compound with which it is substituted is chosen from the anionic compounds that are made

Create a separate number of notes, 2 = u, select a message, and delete it from this

Thus, this is a concise radical and the axis is an abbreviated open radical. You can choose the simplest form of the natural medicinal card that is formed from the group that consists of maltitol and isomaltitol.

<p dir="rtl">10 If these models are used, the center will replace any of the following models according to_aThis is to take into account the details of this document, which are the original documents, which are mentioned in a separate version. 3 ≥ 8 ≤ u.</p>

When the model is selected, the local oscillator is replaced by this model according to_aTo take this into account, take a look at the different related polysaccharides, the main polysaccharide chain of which is formed from a separate number 15 3 ≥ 8 ≤ u. Hxdzdz

Connected by identical or different glycoside bonds.

When the model is selected, the local oscillator is replaced by this model according to_aTo take this into account, take the same number of different related polysaccharides, the main disaccharide chain of which is formed from a separate number 3 ≥ 8 ≤ At least 20 delicious glycosides of one type (1, 2).

When the model is selected, the local oscillator is replaced by this model according to_aTo take this into account, take the same number of different related polysaccharides, the main disaccharide chain of which is formed from a separate number 3 ≥ 8 ≤ At least one glycoside of the same type as: 1, 3(.

٥٦٣٩

-٢٦-

When the model is selected, the local oscillator is replaced by this model according to_aTo take this into account, take the same number of different related polysaccharides, the main disaccharide chain of which is formed from a separate number 3 ≥ 8 ≤ At least one glycoside of the same type as: 1, 4(.

<p dir="rtl">5 When the model is selected, the local oscillator is replaced by this model according to_aTo take this into account, take the same number of different related polysaccharides, the main disaccharide chain of which is formed from a separate number 3 ≥ 8 ≤ At least one glycoside of the same type as: 1, 6(.</p>

If these models are used, the center will replace any of the following models according to_aTo take this as an example, the main 10-saccharide series is formed from a discrete number u = 3 of the same or different disaccharide units.

In one model, the anionic compound that undergoes substitution is characterized by..._aThe invention includes a disaccharide unit, such that the latter is taken from the group consisting of such a hexose compound, so that is, at least one saccharide is selected from the group consisting of such hexose compounds in open forms.

When the model is selected, the local oscillator is replaced by this model according to_aThis is for taking away, ra’a, bdhathan, ladha, mudhaan, and hadhadha 15. The polysaccharides are mutabqa.

If the model is selected, the center oscillator will be replaced by this model according to_aThis means that the polysaccharides are identical.

If the model is the most accurate, the anionic oscillator will be dissatisfied with this replacement according to_aThis is to take the quickest choice and select the remaining adhesives from this hexose compound, so two of these are formed in the radicals of a hexose compound and selected from this in the radicals of 20 open, reduced, and connected by means of glycoside bonds of the type (1, 4).

If the model is the most accurate, the anionic oscillator will be dissatisfied with this replacement according to_aThis is to take the highest possible choice and select the remaining adhesives from this hexose compound. Two of these are formed by the radicals of a hexadecane, and the two of these are formed by the radicals of a hexadecane, and the two of these are formed by a reduced open radical, connected by means of a glycoside bond of the type (1, 6).

٥٦٣٩

-٢٧-

When the model is selected, the local oscillator is replaced by this model according to_aTo take this into account, the different homogeneous polysaccharides are selected from two hexose compounds, and the concentrated hexose disulfide is connected by a glycosidic ligand of the type (1, 2) and by a glycosidic ligand of the type (1, 4).

When the model is selected, the local oscillator is replaced by this model according to_aThis is for taking, take care of your mind, and take the most delicious taste

<p dir="rtl">5 One of the different conjugated polysaccharides is chosen from two hexose compounds and the concentrated hexose disulfide is connected by a glycosidic bond of the type (1, 3) and by a glycoside link of the type (1, 4).</p>

When the model is selected, the local oscillator is replaced by this model according to_aTo take this into account, the different remaining polysaccharides are selected from hexose compounds, and the concentrated hexose disulfide is connected by a glycosidic ligand of type (1, 2) and by glycosidic ligands of type (1, 6).

<p dir="rtl">10 When the model is selected, the local oscillator is replaced by this model according to_aTo take this into account, the two different remaining polysaccharides are selected from the two hexose compounds, and the concentrated hexose disulfide is</p>

Connected by a glycoside linkage of type (1, 2) and by a glycoside linkage of type (1, 3).

When the model is selected, the local oscillator is replaced by this model according to_aThis is for taking, take care of your mind, and take the most delicious taste

One of the different conjugated polysaccharides is chosen from two hexose compounds and the concentrated hexose dimer is

<p dir="rtl">15 Connected by a glycoside bond of type (1, 4) and by a glycoside link of type (1, 6).</p>

If these models are used, the center will replace any of the following models according to_aThis is to take into account the memory of the main memory series, which is about erlose.

In one model, the anionic compound that undergoes substitution is characterized by..._aFor the invention, two identical or different polysaccharide units are a hexose unit selected from the group that makes up a methane.

20 mannose and glucose.

If these models are used, the center will replace any of the following models according to_aTo take this into consideration, the main memory series is about Malto Tarius.

٥٦٣٩

-٢٨-

If these models are used, the center will replace any of the following models according to_aTo take this into consideration, take a look at the smart home series called maltotriose iso.

If these models are used, the center will replace any of the following models according to_aTo take this as an example, a series of basic polysaccharides is formed from a discrete number of identical or different polysaccharides.

<p dir="rtl">5 When these models are selected, the oscillator is replaced by any other models that are replaced according to_aThus, the four cards will be identical.</p>

When the model is selected, the local oscillator is replaced by this model according to_aThis means that the four polysaccharides are methylated.

In one model, the anionic compound that undergoes substitution is characterized by..._aTo choose two or more polysaccharides, they will be 10 mannose and mannose.

.glucose

If these models are used, the center will replace any of the following models according to_aThis is to take into account the main memory series, which is about Maltotarose.

When the model is selected, the local oscillator is replaced by this model according to_aThis is for taking, take care of your mind, and take the most delicious taste

<p dir="rtl">15 One of the different related polysaccharides is chosen from two hexose compounds, and two of the hexose compounds are connected by a glycosidic bond of the type (1, 2), and the other compounds are connected to each other by a glycosidic bond of the type (1, 6).</p>

When the model is selected, the local oscillator is replaced by this model according to_a20 glycosides of the type (1, 6).

If these models are used, the center will replace any of the following models according to_aTo take this as a summary, the main polysaccharide series is formed from a discrete number of identical or different polysaccharides = 5.

٥٦٣٩

-٢٩-

When these models are selected, the oscillator is replaced by any other models that are replaced according to_aThis is to take, take care of this, and take advantage of it

The five are remaining.

When these models are selected, the oscillator is replaced by any other models that are replaced according to_aThis is to take, take care of this, and take advantage of it

The five are hexose units selected from the group consisting of mannose and glucose.

<p dir="rtl">5 When the model is selected, the local oscillator is replaced by this model according to_aThis is to be taken into account, and this is the most important, and this is the most delicious, and this is the most delicious, and this is the most delicious, and this is the choice of this, and this is the compound of this type, and it is connected to this, and this is the compound of this type, a glycoside (1, 4).</p>

If these models are used, the center will replace any of the following models according to_aTo wit, take note of the main memory series, which is maltotetraose.

<p dir="rtl">10 If these models are used, the center will replace any of the following models according to_aTo take this as an example, a series of basic polysaccharides is formed from a discrete number of identical or different polysaccharides.</p>

In one model, the anionic compound that undergoes substitution is characterized by..._aWhen one of the six polysaccharides is separated, one of the six polysaccharides is left behind.

When the model is selected, the local oscillator is replaced by this model according to_aThis is to be taken into account, and this is the most important thing. 15 And this is the memory of these various delicious substances. This is the choice of this compound, this is a compound, and it is connected with a compound of a delicious glycoside of the type (1, 4).

In one model, the anionic compound that undergoes substitution is characterized by..._aTo invent, the six identical or different disaccharide units are hexose units selected from the group consisting of methane and glucose.

<p dir="rtl">20 If these models are used, the center will replace any of the following models according to_aThis is to take into account the main memory series, which is maltohexaose.</p>

٥٦٣٩

-٣٠-

If these models are used, the center will replace any of the following models according to_aThis is for taking, take advantage of this series

The core is formed from a discrete number of identical or different polysaccharides.

When these models are selected, the oscillator is replaced by any other models that are replaced according to_aThis is to take, take care of this, and take advantage of it

The seven remain.

<p dir="rtl">5 When the model is selected, the local oscillator is replaced by this model according to_aThis is to be taken into account, and this is the most important, and this is the most delicious, and this is the most delicious, and this is the most delicious, and this is the choice of this, and this is the compound of this type, and it is connected to this, and this is the compound of this type, a glycoside (1, 4).</p>

When these models are selected, the oscillator is replaced by any other models that are replaced according to_aThus, the seven glycerides are a hexose unit chosen from the group consisting of mannose and glucose.

<p dir="rtl">10 If these models are used, the center will replace any of the following models according to_aTo wit, take a look at the main memory series, which is maltoheptaose.</p>

If these models are used, the center will replace any of the following models according to_aTo take this as an example, a series of basic polysaccharides is formed from a discrete number of identical or different polysaccharides (u = 8).

When these models are selected, the oscillator is replaced by any other models that are replaced according to_aThis is to take, take care of this, and take advantage of it

15 The Germans are identical.

When the model is selected, the local oscillator is replaced by this model according to_aThis is for taking, take care of your mind, and take the most delicious taste

In addition to these various delicious compounds, you can choose this compound, which is connected to a different delicious glycoside of the type (1, 4).

When these models are selected, the oscillator is replaced by any other models that are replaced according to_aThis is to take, take care of this, and take advantage of it

<p dir="rtl">20 The mannose is a hexose unit selected from the group consisting of mannose and glucose.</p>

If these models are used, the center will replace any of the following models according to_aTo take this into consideration, the main memory card is maltooctaose.

٥٦٣٩

-٣١-

In one form, the anionic compound with the substitution includes a discrete number of disaccharide units

It is a sales vehicle.

In one form, the anionic compound with the substitution includes a discrete number of disaccharide units

It is a synthetic compound.

<p dir="rtl">5 If the models are the best, the local oscillator will be replaced accordingly._aTo take this into account, it is suggested that this is achieved by the enzymatic hydrolysis of polysaccharide metabolized_aOn purification.</p>

If the models are the best, the local oscillator will be replaced accordingly._aTo take this into account, this can be achieved by chemical decomposition of the polysaccharide._aOn purification.

If the models are the best, the local oscillator will be replaced accordingly._a10 Chemistry_aYes, by covalent coupling of the substances produced with a lower molecular weight.

If these models are used, the center will replace any of the following models according to_aTo wit, take note of the main memory series, which is about sophorose.

If these models are used, the center will replace any of the following models according to_aTo take this as an example, take a look at this simple memory series and the main name is sucrose.

<p dir="rtl">15 If these models are used, the center will replace any of the following models according to_aTo wit, take note of this series of main notes: lactulose.</p>

If these models are used, the center will replace any of the following models according to_aTo wit, take a look at this series of simple reminders, the main name of which is maltulose.

If these models are used, the center will replace any of the following models according to_aThis is to take into account, take note of this series of notes 20 The main one is Leucrose.

If these models are used, the center will replace any of the following models according to_aTo take this into consideration, take note of this series of main notes on rutinose.

٥٦٣٩

-٣٢-

If these models are used, the center will replace any of the following models according to_aTo take this into consideration, take a look at the main memory series, which is isomaltulose.

If these models are used, the center will replace any of the following models according to_aFor example, take a look at this series of main notes: Fucosyllactose.

<p dir="rtl">5 If these models are used, the center will replace any of the following models according to_aTo take this into consideration, the main memory series is about gentianose.</p>

If these models are used, the center will replace any of the following models according to_aTo take this as a summary, the main memory series is about raffinose.

If these models are used, the center will replace any of the following models according to_aThis is to be taken from the memory of this series of memories 10 The main one is about melezitose.

If these models are used, the center will replace any of the following models according to_aThis is to take into account the main memory series, which is about Panose.

If these models are used, the center will replace any of the following models according to_aThis is to take into account the main memory series, which is about kestose.

<p dir="rtl">15 If these models are used, the center will replace any of the following models according to_aTo take this into consideration, remember the main memory series, which is stachyose.</p>

In one form, a polyanionic compound is a polyanionic compound atomized with a polymer

(non-polymeric polyanionic (NPP) whose affinity for zinc is less than the affinity of insulin for zinc, and its dissociation rate is less than 20 or equal to 10- 1.5.

This is the most important thing in the world^،The same for the various anionic compounds, the same for the various polyanionic compounds, the same for this ion.

Calcium is measured by external amplifiers using an electrode.

٥٦٣٩

-٣٣-

Toledo-Mettler (calcium ions) and a reference electrode. All measurements were made in 150 mM NaCl at this pH of 7.

Calcium; The calcium ions arranged in the polyionic compound are not a potential electrode.

You can take the multimeter oscillator from the minaret of the group, which you can take from the minaret of this group.

<p dir="rtl">5 With polycarboxylic acids, sodium salts, Na+, potassium, Ca2+, or Magnesium, including.</p>

These examples include citric acid, tartaric acid, Na+, K+, Ca2+, or 10 Mg2+.

In the following examples, the multi-ion anion oscillator is taken into account. This group uses the oscillator of a polyphosphoric anion and the salts Ca2+, K+, Na+ or Mg2+ thereof.

In one form, the urinary phosphorus acid is made up of triphosphate, including sodium, Na+, potassium, K+, calcium, Ca2+, or magnesium, Mg2+.

<p dir="rtl">15 In one form, the polyanionic compound is a sulfuric acid and a mixture of Na+, Ca2+, K+, or Mg2+.</p>

In one form, the polyanionic compound is a mixture of +K+, Na, +Ca2 or +Mg2.

In one form, the polyanionic compound consists of triphosphoric acid 20 and the salts Ca2+, K+, Na, or Mg2+ thereof.

These examples represent the multi-dimensional oscillator on this occasion, and they represent a series of basic memories that were formed from a separate number of memories. The memories obtained from this place are the sum of a number of separate memories. The total trehalose, trehalose, maltose, trehalose

٥٦٣٩

-٣٤-

lactose, sucrose, cellobiose, isomaltose, maltitol and isomaltitol.

In one form, a polyanionic compound consisting of a main disaccharide chain is formed from a discrete number of disaccharide units obtained from a compound consisting of a main disaccharide chain formed from

<p dir="rtl">5 Maltotriose Hence, maltopentaose, maltohexaose, maltoheptaose, maltooctaose and isomaltotriose.</p>

In one model, the polyanionic compound that consists of a formal saccharide series is formed from 10 separate numbers, and the saccharide extracted from the group that consists of a carboxylate chain is formed from the same number.

This is why carboxymethylmaltotriose, carboxymethylmaltotriose This also includes carboxymethylmaltotetraose, carboxymethylmaltotetraose. carboxymethylmaltopentaose, carboxymethylmaltopentaose This is the case carboxymethylmaltohexa ose, carboxylate 15 carboxymethylmaltoheptaose, carboxymethylmaltoheptaose This is the reason why this is the case. Okay, okay?

carboxymethylmaltooctaose and carboxymethylmaltooctaose This is the date of this year.

.carboxymethylisomaltotriose

This is the most important example, and this is a copy (this is mentioned and this is in the example carried by this model).

Anion/the number of moles of anionic compound (greater than or equal to 3.

<p dir="rtl">20 So, this model is given by the model of the anionic oscillator/the number of moles of the anionic compound) which is greater than or equal to 4.</p>

This is the number of the models, and this is the number of this model carried by the model of the current oscillator. Dhuni (Akbdhadhr Mazhan or Tsawa 5.

٥٦٣٩

-٣٥-

This is the number of the models, and this is the number of this model carried by the model of the current oscillator. Dhuni (Akbdhadhr Mudhazan or Tasa) 8.

In one model, the mole ratios of the substituted anionic compound/insulin range from 0.6 to 75.

<p dir="rtl">5 In one form, mole ratios range from 0.7 to 50.</p>

In one model, mole ratios range from 1.4 to 35.

In one model, mole ratios range from 1.9 to 30.

In one model, mole ratios range from 2.3 to 30.

In one model, the mole ratio of the substituted anionic compound/insulin is 8.

10 In one model, the mole ratio of the substituted anionic compound/insulin is 12.

In one model, the mole ratio of the substituted anionic compound/insulin is 16.

In one model, the mass ratios of the substituted anionic compound/insulin range from 0.5 to 10.

In one model, mass ratios range between 0.6 and 7.

In one model, the mass ratios range between 1, 2 and 5.

15 In one model, the mass ratios range between 1, 6 and 4.

In one growth, the mass ratios range between 2 and 4.

In one model, the mass ratio of the anionic compound to be substituted is 2/insulin.

In one model, the mass ratio of the anionic compound to be substituted/insulin is 3.

In one model, the mass ratio of the anionic compound to be substituted/insulin is 4.

٥٦٣٩

-٣٦-

In one model, the mass ratio of the anionic compound to be substituted/insulin is 6.

In one form, the concentration of the substituted anionic compound ranges between 1.8 and 36 mg/ml.

In one plant, the concentration of the substituted anionic compound ranges between 1.8 and 36.5 mg/ml.

In one form, the concentration of the substituted anionic compound ranges between 2.1 and 25 mg/ml.

<p dir="rtl">5 In one plant, the concentration of the substituted anionic compound ranges between 4.2 and 18 mg/ml.</p>

In one form, the concentration of the substituted anionic compound ranges between 5.6 and 15 mg/ml.

In one form, the concentration of the substituted anionic compound ranges between 7 and 15 mg/ml.

In one form, the concentration of the anionic compound to be substituted ranges from 7.3 mg/ml.

In one model, the concentration of the anionic compound being substituted is 10.5 mg/ml.

<p dir="rtl">10 In one model, the concentration of the anionic compound being substituted is 14.6 mg/ml.</p>

In one form, the concentration of the substituted anionic compound ranges from 21.9 mg/ml.

In one form, the concentration of the polyanionic compound is between 2 and 150 mM.

In one form, the concentration of the polyanionic compound is between 2 and 100 mM.

In one form, the concentration of the polyanionic compound is between 2 and 75 mM.

<p dir="rtl">15 In one form, the concentration of the polyanionic compound is between 2 and 50 mM.</p>

In one form, the concentration of the polyanionic compound is between 2 and 30 mM.

In one form, the concentration of the polyanionic compound is between 2 and 20 mM.

In one form, the concentration of the polyanionic compound is between 2 and 10 mM.

In one form, the concentration of the polyanionic compound is between 5 and 150 mM.

٥٦٣٩

-٣٧-

In one form, the concentration of the polyanionic compound is between 5 and 100 mM.

In one form, the concentration of the polyanionic compound is between 5 and 75 mM.

In one form, the concentration of the polyanionic compound is between 5 and 50 mM.

In one form, the concentration of the polyanionic compound is between 5 and 30 mM.

<p dir="rtl">5 In one form, the concentration of the polyanionic compound is between 5 and 20 mM.</p>

In one form, the concentration of the polyanionic compound is between 5 and 10 mM.

In one form, the concentration of the polyanionic compound is between 0.5 and 30 mg/ml.

In one form, the concentration of the polyanionic compound is between 0.5 and 25 mg/ml.

In one form, the concentration of the polyanionic compound is between 0.5 and 10 mg/ml.

<p dir="rtl">10 In one form, the concentration of the polyanionic compound is between 0.5 and 8 mg/ml.</p>

In one form, the concentration of the polyanionic compound is between 1 and 30 mg/ml.

In one form, the concentration of the polyanionic compound is between 1.5 and 25 mg/ml.

In one form, the concentration of the polyanionic compound is between 2 and 25 mg/ml.

In one form, the concentration of the polyanionic compound is between 2 and 10 mg/ml.

<p dir="rtl">15 In one form, the concentration of the polyanionic compound is between 2 and 8 mg/ml.</p>

In one form, the compound is now replaced by sodium maltotriosemethylcarboxylate. Boxylate with sodium phenylalaninate 1.0 = j, 0.65 = i, 3 ​​= u, sodium phenylalaninate.

In one case, the center is now replacing 20 sodium carboxylate with^YDL sodium phenylalanina, j = 0.65, i = 1.0, u = 3.

٥٦٣٩

-٣٨-

In one instance, the center is now replacing sodium carboxylate with^YDL sodium phenylalanina, 2,1 = j, 0.46 = i,3 = u.

In one instance, the center is now replacing sodium carboxylate with^YDL sodium phenylalanina, j = 0.65, i = 0.35, u = 3.

<p dir="rtl">5 These examples include sodium maltotriosemethylcarboxylate.</p>

In one form, the polyanionic compound is sodium citrate.

In one of the examples, they say that the polyanionic compound is the same as the triphosphate, so the acid radical is the same, or the alkaline radical is the same, so is the sodium radical or the potassium radical is

.potassium 10

In one form, the polyanionic compound is a tartrate, an acidic radical.

Or in basic forms in the form of sodium salt or potassium salt.

It is related to taking care of any_aThis formula includes a pharmaceutical formula for both sexes, which includes a formula according to_aThis means that insulin takes hexagonal forms.

<p dir="rtl">15 In the following examples, the pharmaceutical formula that is given is two injection concentrations of 240 and 3000 micromolar (40 to 500 IU/ml).</p>

600

and 3000 microM (100 to 500 IU/ml).

600

20 and 2400 microM (100 to 400 IU/ml).

600

and 1800 microM (100 to 300 IU/ml).

٥٦٣٩

-٣٩-

In the following examples, the pharmaceutical formula used is given at two concentrations of 600 and 1200 micromolar (100 to 200 IU/ml).

In the following model, the pharmaceutical formula requires an insulin concentration of 600 micromolar (100 IU/ml).

<p dir="rtl">5 In one example, it relates to a pharmaceutical formulation that contains an insulin concentration of 1200 microM (200 IU/ml).</p>

In one example, it relates to a pharmaceutical formulation that contains an insulin concentration of 1800 microM (300 IU/ml).

In one example, it relates to a pharmaceutical formulation that contains an insulin concentration of 2400 mM (400 IU/ml).

In one example, it relates to a pharmaceutical formulation that contains an insulin concentration of 3000 microM (500 IU/ml).

The invention relates to the use of an anionic encoder, such as, by this substitution, the said encoder is a radical polysaccharide chain formed from a discrete number u, which ranges between 1 and 8 (1 ≥ 8 ≤ u), hereinafter:

<p dir="rtl">15 Extracted or various other disaccharides, extracted from a special or different form of glycosylated ligand, one of the polysaccharides formed from the group that consists of a hexose compound, is taken from a cyclic radical or from a reduced open radical, The aforementioned compound includes a carboxy tail and is used to replace this part. In this article, this carboxylate is an appendix of the nutritional value of this document, replacing a specific component of the table to prepare a detailed pharmaceutical formula, one at a time, with an excerpt from a concentrated oscillation. The anion is exaggerated, the anion is exaggerated, the anion is exacerbated.</p>

<p dir="rtl">20 Therefore, this atom has the largest atom compared to the composition of a radical free of a substituted anionic compound, and choosing_aO anionic compound.</p>

This is the most important example, the fastest taking is done by using an oscillator, and this is the shortest using this replacement. carboxytail

٥٦٣٩

-٤٠-

This application uses this method to replace the component of the auditor, to prepare a formal model for a separate auditor, with multiple signals, that makes the auditor's auditor, with a number of permissions, a fragmented function. And soft

With a fragment, then this is the same, and for the last of the mentioned, then this is the same, with a greater excuse, compared to the composition of this, this is the same, with a mixed verse, and they will replace me with this, and choose_aO anionic compound.

<p dir="rtl">5 This is the most important example, the fastest taking is done by using an oscillator, and this is the shortest using this replacement. carboxytail</p>

A non-substituent salt-forming formula, to prepare a formula of nerinsulin, by purchasing a compound

Multi-ionics, which make it possible, after modifications, to facilitate the passage of insulin into the blood and, to remind you, this information is more quickly compared to a similar structure of a concentrated oscillator, so they can replace it with this method, and choose_aIt contains 10 anionic compounds.

In one form, the insulin is human insulin.

The expression “human insulin” means insulin obtained by recombination or genetic recombination, the peptide sequence of which is a human insulin sequence, including allele and homolog forms.

These examples include the following examples: 15 described in the European Pharmacopoeia and the US Pharmacopoeia.

In one form, insulin is a non-insulin.

The term “nother insulin” means a genetic recombination of insulin for which the primary sequence has at least one modification to the human insulin primary sequence.

These examples include 20 (Humalog®), 20 (Novolog®, Novorapid®), 20 (Novolog®) and 20 (Novolog®) tablets. These are the ones who are the ones who are the ones

(Apidra®).

In one form, the insulin insulin is insulin lispro (Humalog®).

٥٦٣٩

-٤١-

Novolog®,

Novorapid®

In one form, the insulin precursor is insulin glulisine (Apidra®).

In one embodiment, the use is characterized by the selection of the anionic compound with the substitution from 5-substituted anionic compounds, in isolated forms or in cell forms, which constitute a formal saccharide chain whose formation is then separated by such terms 1 and 8 (1 ≥ 8 ≤ u) The aforementioned or different glycosylated compounds, linked by a previously mentioned or different glycose bond, are a hexose compound, in cyclic or reduced open forms, characterized by a double substitution with:

a) The set of at least one substitution has the general form I:

10 -[m ]AA[-a ]R1 Formula I

<p dir="rtl">• The set of substituted methods is identical or different when there are two roots of the set of substituted methods.</p>

At least, it includes:

<p dir="rtl">• In the part - [AA] is a structural unit for the amino acid,</p>

<p dir="rtl">• The slit -R1- is:</p>

<p dir="rtl">15 - So, Arrab Dhidha and Mazhan Dhim a = Zadhafar and Takadun Al-Wahdhadh Al-Banna Yadha for Al-Hudhadh Al-Amindha -[AA]- Mutazdhali</p>

direct_a In the main chain with G and Y,

<p dir="rtl">- Or this basic sequence, such as a note C2 to this C15, and a note of note 1 = a, hereby replacing a note and/or including a note and specifying that. The most disgusting, the most disgusting, the most shameful, the most shameful, the most disgusting, the most shameful The aforementioned structure is described in Exhibit 20 of the Security Council - [AA] - and this document, and is connected to the main series using a document and the F template is the result of an additional permission with these two hydroxy and a portable window that is carried out using the main series document and is implemented Or a delicious collection Replacement devices carried by the material producing the crack -R1-,</p>

٥٦٣٩

-٤٢-

<p dir="rtl">• F is an expression chosen from F, Ester and Carbama,</p>

<p dir="rtl">• G represents the word “karbama”,</p>

<p dir="rtl">• m equals 1 or 2,</p>

<p dir="rtl">• The degree of replacement and deletion of the sazdhakarid, j, then this - [m ]AA[-a ]R1 tkzdon Akbdhadhr Fazdhala Mudhann Sazdhafar</p>

<p dir="rtl">5 and less than or equal to 6, zero &gt; 6 ≤ j</p>

<p dir="rtl">b) And, choice_aOh, one or more R sums of substitution -1'R,</p>

<p dir="rtl">• The substituent group -1'R has its base chain as a carbonyl C2 to C15, which is thus substituted.</p>

This is the root of the cation of this alkaloid, the mentioned series is like this. One

<p dir="rtl">10 Connected to the main series by a formula and a formula 'F'.</p>

Using the main method and an implementation or replacement tool set implemented using the access tool implemented for that group

substitution -1'R,

F•' is an ester, ester or carbama.

<p dir="rtl">• The degree of substitution of two disaccharides, i, in -1'R, is between 0 and -j-6, zero &gt; j-6 ≤ i.</p>

15 And

<p dir="rtl">• F and F' are the same or different,</p>

<p dir="rtl">• F and G are the same or different,</p>

,6 ≤ j+i •

<p dir="rtl">• -1'R is the same as or different from -R1-,</p>

<p dir="rtl">20 • The free loads of the mass are taken by the group by substituting -1'R into</p>

Pictures of alkali metal cation salts,

٥٦٣٩

-٤٣-

<p dir="rtl">• You may take a note of this particular glycoprotein, which may be the same or different, since you may</p>

The group whose glycosidic ligands are composed of glycosidic ligands (1, 1), (1, 2), (1, 3), (1, 4) or (1, 6), in alpha or beta geometric form.

This is one of the examples, the use is used by taking a compound atom that gives me this substitution, this is an isolated radical, or this is a 5-cell form, of a substituted anionic compound consisting of a main disaccharide chain formed from a discrete number u that ranges between i and 8 (8 ≤ u ≤ i) From identical or different polysaccharide units, linked by identical or different glycoside bonds, the polysaccharide unit is selected, consisting of two hexose compounds, in cyclic or reduced open forms, characterized by this

A) It has a random replacement with:

<p dir="rtl">10 At least one substitution set has the general formula I:</p>

<p dir="rtl">- [m ]AA[-a ]R1 Formula I</p>

<p dir="rtl">• The set of substituted methods is identical or different when there are two roots of the set of substituted methods.</p>

At least, it includes:

<p dir="rtl">• Ya’a Dhu al-Shadhaq - [AA]- and he chose us as a result of Al-Hamd Amindhi, and he chose Al-Hamd Al-Amindhi Al-Mazdathur.</p>

<p dir="rtl">15 From the group that you take from the source of the two, then the same - the same means that the two, 3,4- dahydroxyeth</p>

phenylalanthene, tyrosin, alpha-phenylglycine, O-methyltyrosin, alpha-phenylglycine, 4-hydroxyphenylglycine and 3,5-da-hydroxyphenylglycine, and alkali metal cation salts

Among them, the folded derivative lies in the two flavors labeled L or AA[-, D[-, which are connected to the original series of the molecule by means of a connection sequence -R1- or are connected directly_a In the main chain with G and Y,

<p dir="rtl">20 • -R1- is:</p>

<p dir="rtl">- Either the square of G, and from m a = zero,</p>

٥٦٣٩

-٤٤-

<p dir="rtl">- Or a basic summary such as C2 to C15, and a note to 1 = a. This means replacing the note and/or including the note, and deleting the same number. Ḍḍẓ Ḍḍẓ ᴀᴀᴛᴀᴀ The aforementioned chain of amino acids - [AA] - is an amide ligand, and is connected to the main polysaccharide chain by an F function.</p>

<p dir="rtl">5 Resulting from a reaction between a hydroxyl, a function carried by the main chain, and a function carried by the substance producing it, R1.</p>

<p dir="rtl">• F is a compound, ester or carbama,</p>

<p dir="rtl">• G represents the word “karbama”,</p>

<p dir="rtl">• m equals 1 or 2,</p>

<p dir="rtl">10 The degree of this replacement, j, then this - [m ]AA[-a ]R1_a Mudhazan zadhafar and Aqaddhamil Mudhazan or Taszathaaw 6, zero &gt; 6 ≤ j,</p>

And, choose_aHey,

<p dir="rtl">&lt; One or more R sums of substitution -1'R</p>

<p dir="rtl">• 1'R is the origin of a series based on C2 and C15, thus substituting a choice and/or</p>

<p dir="rtl">15 It contains at least one non-homogeneous syllable (such as O, Idhaar Muthanna and S) and the meaning of the word “Hamad” and “Hamad”</p>

And specify the root of the cation profile of this alkaloid. The aforementioned chain is attached to the main polysaccharide chain via a chain 'F' resulting from a reaction between two hydroxyl compounds, a chain carried by the main chain chain and a function carried by the substance producing it - 1'R. ,

<p dir="rtl">• F' is a term for an ester, an ester or a carbama.</p>

20 The degree of substitution, i, in -1'R, is between zero and j-6, zero &gt; j-6 ≤ i, and

<p dir="rtl">• -1'R- is the same as or different from -R1,</p>

<p dir="rtl">• F and F' are the same or different,</p>

٥٦٣٩

-٤٥-

<p dir="rtl">• F' and G are the same or different,</p>

<p dir="rtl">• Takht and F of the free salt-forming salts of alkali metal cation salts,</p>

<p dir="rtl">B) You may take a note of this glycosylation, which may be the same, which may be the case if you have taken a note of this or a different word, then</p>

The group that consists of a methion of glycosidic oligomers has a methion of (1, 1), (1, 2), (1, 3), (1, 4) or (1, 5 6), in the geometric form alpha or beta,

<p>6 ≤ j+ i)</p>

In one form, m equals 1.

In one form, -R1 and -1'R, which may be identical or different, are the seeds of a carbon-based chain C1 to C8.

<p dir="rtl">10 In one form, -R1 and -1'R, which may be identical or different, are the seeds of a carbon-based chain C1 to C4.</p>

In one form, -R1 and -1'R, which may be identical or different, are the seeds of a carbon-based chain C1 to C2.

It is known to those skilled in the art that the intensification of the insulin effect depends on the concentration of insulin. 15 Effect dimerization values ​​were only documented at a concentration of 100 IU/ml.

The "normal" effect of insulin in a person's body, which reaches a concentration of 600 microM (100 IU/ml) between 50 and 90 minutes, and its effect ends in a period of approximately 360 to 420 minutes in a person. The maximum insulin concentration is between 90 and 180 minutes in a person.

<p dir="rtl">20 This is the pretext for memorizing the memory of the person who wants to concentrate this 600 minutes.</p>

Madhdhular (100 and ḍadḥdād and wālidhaḥa / madhdhal) with two 30 and 60 minutes, and it ends with two yawns.

٥٦٣٩

-٤٦-

300-240 minutes per person. The time to reach the maximum insulin concentration in the blood ranges between 50 and 90 minutes in a person.

Related to the sister, i.e_aA method has been used to prepare a human insulin formulation in which the insulin concentration ranges between 240 and 3000 microM (40 to 500 microM), in which the concentration of the individual is minimal by comparison.

<p dir="rtl">5 By the reference formula at this same anionic concentration, the anionic oscillator is solvated by this substitution and the multi-anion oscillator is characterized by its inclusion of (1) x with an addition to the aforementioned formula, the anionic oscillator and determine the smaller one by this substitution, the oscillator includes Mentioned as a carboxyl tail and implemented herein by partial substitution, Two unsubstituted carboxyl groups form a salt, (2) and in addition to the ballistic formula, at least one polyanionic compound.</p>

<p dir="rtl">10 In one form, insulin has a hexagonal shape.</p>

Related to the sister, i.e_aA method has been used to prepare a human insulin formulation in which the insulin concentration ranges between 600 and 1200 microM (100 and 200 IU/ml), in which the individual's plasma concentration is lower compared to the reference formula at the same insulin concentration. I will not replace this The center of the oscillator is dissipated by the anion, and its magnitude is disturbed by this (1). Take an addition to this formula, the center of the oscillator.

<p dir="rtl">15 At least one anionic substituent, the assimilated compound includes a carboxyl group in which there is a substitution, the sum of which is the carboxyl end of the molar which is not so substituted forming the salt, and (2) taking in addition to the assimilate formula at least one anionic compound.</p>

In one form, insulin has a hexagonal shape.

Related to the sister, i.e_aA method used to prepare a human insulin formulation with an insulin concentration of 600 μM (100 IU/ml), and in which the clotting time in an individual is less than 60 minutes, is considered abnormal.

(1) By addition, the aforementioned formula is replaced by a new formula, and the aforementioned formula includes this sum of this tail carboxy and is implemented by this sum by replacing this part, the sum of this tail carboxy and the implementation of the appendix. This is how to replace a component of the file, and (2) take an addition to this The given formula consists of at least one multi-ion oscillator.

٥٦٣٩

-٤٧-

In one form, insulin has a hexagonal shape.

It is a pleasure to take it, i.e_aThe formula for preparing an insulin formula at a maximum concentration of insulin in this sample is 1200 mM (200 mM), which gives the effect of this dose by at least 10% compared to the human insulin formula at this concentration. The same (200 IU/ml) and in L 5

This formula includes a carboxylate assembly and is implemented by this replacement part, a carboxylate assembly. The atomized particle of this substance is thus replaced to form the salt, and (2) x, and in addition to the formula, the ballistic compound is a polyanionic compound, and determine the least .

<p dir="rtl">10 In one form, insulin has a hexagonal shape.</p>

It is a pleasure to take it, i.e_aThe formula for preparing an insulin formula at a maximum concentration of insulin in this sample is 1800 mM (300 mM), which gives the effect of this dose by at least 10% compared to the human insulin formula at this concentration. The same (300 IU/ml) and in L Oh, I am lying to you, please replace me with this multi-animated oscillator, it will be dissatisfied with the deletion of its inclusion in this way (1) Take the addition of this 15 formula. Change, deformation of the centre's oscillation.

The sum of this carboxy tail and this compound is replaced by this part, the sum of this carboxy tail and the compound of this is replaced by the salt, and (2) x and in addition to the formula the ballistic compound is a polyanionic compound and determine at least.

In one form, insulin has a hexagonal shape.

<p dir="rtl">20 It is a pleasure to take it, i.e_aA formula for preparing an insulin formula with an extremity has a concentration of insulin in this form of 2400 mM (400 mcM), which gives the effect of this dose by at least 10% compared to the human insulin formula at this concentration. The same (400 IU/ml) and in L I would like to add this formula to the multi-ion oscillator and replace it with this model. The center's oscillator oscillation deviates as a result of its curvature.</p>

٥٦٣٩

-٤٨-

The sum of this carboxy tail and this compound is replaced by this part, the sum of this carboxy tail and the compound of this is replaced by the salt, and (2) x and in addition to the formula the ballistic compound is a polyanionic compound and determine at least.

In one form, insulin has a hexagonal shape.

<p dir="rtl">5 It is a pleasure to take it, i.e_aThe formula for preparing an insulin formula at a maximum concentration of insulin in this sample is 3,000 mcM (500 mcM), which gives the effect of this dose by at least 10% compared to the human insulin formula at this concentration. The same (500 IU/ml) and in L Yap</p>

The multi-ion oscillator is replaced by this replacement model, and the multiple anion oscillator is replaced by this replacement model. The centre's oscillation and curvature deviate

<p dir="rtl">10 The sum of this carboxy tail and this compound is replaced by this part, the sum of this carboxy tail and the compound of this is replaced by the salt, and (2) x and in addition to the formula the ballistic compound is a polyanionic compound and determine at least.</p>

In one form, insulin has a hexagonal shape.

You disparage the aforementioned formula, so this is a warning formula, and you disdain it with a fragment of a pretext. It is disparaged by the exception of its inclusion of this (1). A carboxyl group that has a molecular substitution, a carboxyl group that has a substitution It does not contain a salt-forming substitution, and (2) x, and in addition to the formula, it is a polyanionic compound, and specify the least.

In one form, insulin has a hexagonal shape.

<p dir="rtl">20 Related to the sister, i.e_aA method has been used to prepare a formulation of human insulin with a concentration of 600 microM (100 IU/ml), in which the individual has a maximum atomization time of 60 minutes, a maximum of 45 minutes, and a maximum of 30 minutes. Enjoy it deliciously (1) Take an addition to the aforementioned formula and add to the previous one. With this substitution, the aforementioned compound includes a total of this carboxylate.</p>

٥٦٣٩

-٤٩-

Hereby substituting a part, the sum of the carboxyl tail of the aliquot is hereby substituting a component of the aliquot, and (2) adding to the formula the at least one polyanionic compound.

In one form, insulin has a hexagonal shape.

Related to the sister, i.e_aA method used to prepare a formula for insulin in which the concentration of insulin ranges between 240 5 and 3000 micromolar (40 and 500 micromolar), in which the concentration of the individual is reduced by comparison.

By the reference formula at this same anionic concentration, the anionic oscillator is solvated by this substitution and the polyanion oscillator is characterized by its inclusion of (1) with an addition to the aforementioned formula of the anionic oscillator and determine the minimum by this substitution, the oscillator includes Mentioned as a carboxyl tail and implemented herein by partial substitution, Two unsubstituted carboxyl groups form the salt, and (2) KH plus L10, the formula is at least one polyanionic compound.

In one form, insulin has a hexagonal shape.

Related to the sister, i.e_aA method has been used to prepare a formula of insulin in which the concentration of insulin ranges between 600 and 1200 micromolar (100 and 200 IU/ml), in which the clotting rate in the individual is reduced compared to

In the reference formula at the same concentration of insulin in the form of an anionic compound with the substitution and of

<p dir="rtl">15 A polyanionic compound, characterized by its inclusion of (1) x and in addition to the ballistic formula an anionic compound.</p>

The center of the oscillator is replaced by the carboxy tail and the carboxy tail is executed by this.

Substituting a part of the carboxyl tail of the molecule that is not thereby substituted constitutes a component of the molecule, and (2) take

In addition to the ballistic formula, there is at least one polyanionic compound.

In one form, insulin has a hexagonal shape.

<p dir="rtl">20 Related to the sister, i.e_aA method is used to prepare a formula for insulin with an insulin concentration of 600 micromol/L (100 IU/mL), and in which clotting time in an individual is less than 30 minutes, and is characterized by including (1) an addition to the aforementioned formula. Add me and add the lowest one with this replacement.</p>

٥٦٣٩

-٥٠-

(2) Add to this formula a component of at least one multi-ion oscillator.

In one form, insulin has a hexagonal shape.

It is a pleasure to take it, i.e_a1200

<p dir="rtl">5 200 micronized atoms (200 liters), the effect of which is 10% on the oscillator, compared to the formula of the two anion oscillators. Therefore, he is dissatisfied with the deviation of his integral according to (1) with the addition of the formula Said compound includes a carboxyl group, including a carboxyl group that has no substitution, forming a salt, and (2) and in addition to</p>

<p dir="rtl">10 The formula is a compound with at least one polyanion.</p>

In one form, insulin has a hexagonal shape.

It is a pleasure to take it, i.e_aThis example is 1800 micrometers (300 million euros), which gives the effect of this person by 10%, compared to the previous one. Why don't you mention me with this?

<p dir="rtl">15 Multiple Anhon, it is characterized by an ostrich of delicacy) 1 (Kh (x) In addition to the formula, at least one polyanionic compound is added to the formula.</p>

In one form, insulin has a hexagonal shape.

<p dir="rtl">20 It is a pleasure to take it, i.e_aThis example is 2,400 micrometers (400 micrometers), which gives the effect of this person by 10%, compared to the previous one. Language The anion is characterized by its inclusion of (1) x with the addition of the aforementioned formula, the annex of anthony and select</p>

According to this substitution, said compound comprises and implements such a carboxylate aggregate.

٥٦٣٩

-٥١-

Molecular carboxyl groups that do not have a salt-forming substitution, and (2) and in addition to the ballistic formula, at least one polyanionic compound.

In one form, insulin has a hexagonal shape.

It is a pleasure to take it, i.e_a3000

<p dir="rtl">5 The effect of this person is 10% on the minimum compared to the formula of the two anionic oscillators, so that the oscillator is dissolved using this oscillator and the polyanion oscillator, It is characterized by the exception of (1) x with the addition of the formula Said compound comprises a carboxylate group and is made hereby partially substituted, a carboxyl group of the unsubstituted molecule forming a salt, and (2) x and in addition to</p>

<p dir="rtl">10 The formula is a compound with at least one polyanion.</p>

In one form, insulin has a hexagonal shape.

You take the excuse, take it as a pretext, so you have to prepare the formula for it, take it as a pretext, take_aThis, which is characterized by including an addition to the above-mentioned formula, is an anatomical compound, and this is defined by this substitution. The annexed compound includes a carboxyl group, the function of which is partially replaced, a carboxyl group, the function of which is

<p dir="rtl">15 It does not contain a salt substitute.</p>

The one who mentions the examples, the warning includes, i.e_aThus, add at least one multi-ion oscillator to the aforementioned formula.

In one form, insulin has a hexagonal shape.

These examples include 20 (Humalog®), 20 (Novolog®, Novorapid®), 20 (Novolog®) and 20 (Novolog®) tablets. These are the ones who are the ones who are the ones

(Apidra®).

In one form, the insulin insulin is insulin lispro (Humalog®).

٥٦٣٩

-٥٢-

Novolog®,

Novorapid®

In one form, the insulin precursor is insulin glulisine (Apidra®).

These examples are described in the European Pharmacopoeia and the US Pharmacopoeia 5.

In one form, an insulin is a combination of insulin selected from the group that you take from these medications (Humalog®), your medication (Novorapid®, Novolog) and insulin glulisine (Apidra®).

Then, this composition warning can be prepared in this way, then this is the solution, this is the solution, then this is the solution of insulin 10 humans or insulin and a solution of any anionic compound that has been replaced in the form of a cell by a polyanionic compound.

Examples include: Preparing this composition with a simple anionic solution: a solution of human insulin or non-insulin, and a solution of any anionic compound with a substituted polyanionic compound in a solution or in dried form.^YLyophilize.

<p dir="rtl">15 So, this is the most important example, and the warning of this structure is similar to the word “Adhaan Rathzak”, “Adhdhan” “Madhdhul”, “Madhdh” in “Madhahn”, “Adhaan”^YIsolation by freezing and ionization in solution or in dried form^YFreezing.</p>

Preferably, the gelled formulation should be in the form of an injectable solution.

In one plant, the concentration of human insulin or nebulin is between 240 and 3000 microM.

20 (40 to 500 IU/ml).

In one plant, the concentration of human insulin or nebulin is between 600 and 3000 microM.

(100 to 500 IU/ml).

٥٦٣٩

-٥٣-

In one plant, the concentration of human insulin or nebulin is between 600 and 2400 microM.

(100 to 400 IU/ml).

In one plant, the concentration of human insulin or nebulin is between 600 and 1800 microM.

(100 to 300 IU/ml).

<p dir="rtl">5 In one model, the concentration of human insulin or nebulin is between 600 and 1200 microM (100 to 200 IU/ml).</p>

In one model, the concentration of human insulin or nebulin is 600 microM (100 IU/ml).

In these models, the concentration of atomized insulin is 1200 mcg (10,200 IU/ml).

In this case, a concentration of 600 mcM atoms (100 IU/ml) can be made by simple dilution, challenge_aThis is the truth about the fulfillment of contentment.

So the one who has the most examples, he yaddhirz insdhulin al-badhdhir or n yaddhir insdhulin 1800 mikddhru mdhullar (300

international units/ml).

<p dir="rtl">15 In the following models, the atomized concentration of Insulin is 2400 mcg (400 IU/ml).</p>

In the following models, the atomized concentration of Insulin is 3,000 mcg (500 IU/ml).

It is a pleasure to take it, i.e_aThis is based on a logical formula_aFor this purpose, you need to obtain this by drying machine 20 and/or freeze-drying.

In one form, it includes i.e_aAdd the composition according to_aThe invention is based on adding zinc salts at a concentration that varies between

Zero and 500 microM.

٥٦٣٩

-٥٤-

In one form, it includes i.e_aAdd the composition according to_aThe invention is based on adding zinc salts at a concentration that varies between

Zero and 300 microM.

In one form, it includes i.e_aAdd the composition according to_aThe invention is based on adding zinc salts at a concentration that varies between

Zero and 200 microM.

<p dir="rtl">5 As I select the models, the composition is deviant accordingly_a100</p>

Millimolar, preferably between 0 and 50 millimolar or between 15 and 50 millimolar.

In one form, the solution of M is an expression of Tris.

In one of the models, the structure is according to_aThe invention includes any_aAdd edge material.

So, if you choose the model, you choose the bound substance from the group that you choose from the m-Crisshol and Finthens,

<p dir="rtl">10 Alone or in groups.</p>

In one growth, the concentration of excipients varies between 10 and 50 mM.

In one growth, the concentration of excipients varies between 10 and 40 mM.

The composition is according to_aA sister, I can say anything_aIt also includes added additives such as strengthening agents, for example

Glycerol, sodium chloride (NaCl), mannitol

<p dir="rtl">15 And glycine.</p>

Installation accordingly_aThis is to take away, ra'a yamkazan, that is_aTherefore, you may add more details accordingly_aThis is for the constitution of Al-Adwidha, for the sake of Sudhabil

A blood pressure reducer, for example, polysorbate.

Installation according to this_aThis is to take away, ra'a yamkazan, that is_aThis means that the information is changed accordingly_aThis is due to the constitution of the medicines, and this is not the case

Two insulin compounds used at working concentrations.

<p dir="rtl">20 In this case, intravenous, subcutaneous, or intradermal or intradermal injection</p>

.intramuscular

٥٦٣٩

-٥٥-

This is done at the same time_aThe ear of the skin, the ear of the oral, the nasal and the vaginal, the ocular, and the pulmonary.

Related to the sister, i.e_aAdd a combination according to_aThe invention of the word “Mhalhul” from the word “Insdholin” with a fragment or a vowel

Insulin with a concentration of 100 IU/ml for use in an implantable insulin pump.

<p dir="rtl">5 Transfer it.</p>

Related to the sister, i.e_aAdd a combination according to_aThe invention of the word “Mhalhul” from the word “Insdholin” with a fragment or a vowel

Insulin with a concentration of 200 IU/ml for use in an implantable insulin pump.

Transfer it.

The invention also relates to a substituted anionic compound, in isolated or cellular forms, selected from

<p dir="rtl">10 Substituent anionic compounds consisting of a main disaccharide chain formed from a discrete number u ranging from 1 to 8 (1 ≥ 8 ≤ u) of identical or different disaccharide units, connected by a glycoside link.</p>

Similar or different, one of the polysaccharides is selected from the two hexose compounds, which have ring radicals or in reduced open forms, characterized by a fold in which they are replaced by:

a) The set of at least one substitution has the general form I:

15 -[m ]AA[-a ]R1 Formula I

<p dir="rtl">• The set of substituted methods is identical or different when there are two roots of the set of substituted methods.</p>

At least, it includes:

<p dir="rtl">• In the part - [AA] is a structural unit for the amino acid,</p>

The slit -R1- is:

20 - Either Arba and M a = zero and the building blocks of the amino acid -]is -]AA are directly connected_a

In the main chain with G and Y,

٥٦٣٩

-٥٦-

<p dir="rtl">- Or this basic sequence, such as a note C2 to this C15, and a note of note 1 = a, hereby replacing a note and/or including a note and specifying that. The most disgusting, the most disgusting, the most shameful, the most shameful, the most disgusting, the most shameful The above-mentioned structure is used for the security certificate - [AA] - and is implemented in this document, and is linked to the main method using a document, and the F tool is the result of 5. Totally delicious I'm sorry</p>

Carried by the material producing the crack -R1-,

<p dir="rtl">• F is an expression chosen from F, Ester and Carbama,</p>

<p dir="rtl">• G represents the word “karbama”,</p>

<p dir="rtl">• m equals 1 or 2,</p>

<p dir="rtl">10 • The degree of replacement and deletion of the two names, j, then this - [m ]AA[-a ]R1, then the next one_a Muthazhan Zudhafar</p>

and less than or equal to 6, zero &gt; 6 ≤ j

b) And, choice_aOh, one or more R sums of substitution -1'R,

<p dir="rtl">• The substituent group -1'R has its base chain as a carbonyl C2 to C15, which is thus substituted.</p>

The aforementioned homogeneous atom, an atomized atom, and a S15 You are lying

It is connected to the main series by the 'F' formula, and the substitution formula is carried out by the two hydroxy compounds.

<p dir="rtl">-</p>

20 1'R, is between 0 and 6-j, 0 &gt; j-6 ≤ i, and

<p dir="rtl">• F and F' are the same or different,</p>

<p dir="rtl">• F and G are the same or different,</p>

٥٦٣٩

-٥٧-

jti 6,

R'l- • is identical to or different from -RI-,

<p dir="rtl">0 The functions of the free acid that forms the salt are carried by the substitution group —1 R in the form of salts of alkali metal cations,</p>

<p dir="rtl">• • The mentioned glycosidic bonds, which may be identical or different, are selected from the group consisting of glycosidic bonds of the type (1,1), (1,2), (1,3), (1,4) or ( 1, 6), in alpha or beta geometric form.</p>

In the above formula, different images have the above values.

Substituent anionic compounds according to the invention can be obtained by grafting

<p dir="rtl">0 1 Random substitution groups on the main polysaccharide chain.</p>

In one embodiment, the substituted anionic compounds selected from the substituted anionic compounds with the substitution groups having the first formula are obtainable by grafting the substitution groups to precise locations on the disaccharide units by a process including the steps of protecting/deprotecting the alcohol or acid groups Carboxyls are naturally carried by the chain

5 1 Home.

This strategy leads to selective grafting, especially region-selective grafting, of substitution groups on the main chain. Protection groups include, but are not limited to, those described in the application:

Wuts, PGM et al., Greene's Protective Groups in Organic Synthesis)

٢٠ 2007).

٥٦٣٩

-٥٨-

This series of traditional memories can be achieved through the method of analyzing this memory and the partial weight of this mental memory. Degradation residues include, but not limited to, chemical degradation and/or enzymatic degradation.

Can any_aIn addition, the main polysaccharide chain is obtained by the formation of glycoside ligands in this part.

<p dir="rtl">5 The mononucleosome or the oligonucleotide is extracted using this strategy, using this chemical or enzyme. You get upset</p>

Smooth, JT et al., Advances in (Carbohydrate Chemistry and Biochemistry 2009, 62, 162-236 Lindhorst, TK, Essentials of Carbohydrate Chemistry and Biochemistry)

(2007, 157-209). Radicals can operate in a solution or in a solid support.

.support 10

Parts of these memories can then be combined, replacing the ones of interest and/or combining them by simply pairing them together, randomly or selectively for the area.

Therefore, according to the same method, this compound can be obtained according to the following principle:

<p dir="rtl">15 ■ Randomization with substitution groups on the main polysaccharide chain</p>

<p dir="rtl">■ And this or that part of this is the treatment with glycosylation in this part of the monosaccharide or oligosaccharide, which includes the total substitution.</p>

<p dir="rtl">■ One or more glycosylations between one or more parts of the monosaccharide 20 or the oligosaccharide of this amount. This polysaccharide or oligosaccharide</p>

٥٦٣٩

-٥٩-

<p dir="rtl">■ One or more entries for the sale of alcohols or alcohol._aThis is based on the official “Memory Card” series, followed by_aThat's it</p>

Replacement kit Finally, remove and remove the two protection assemblies

<p dir="rtl">■ One or more glycosylated cells between one or more monosaccharide molecules</p>

<p dir="rtl">5 Or the Oligoscards that are sold together_aThat's it</p>

By means of the main series of cards, and delete or delete from the authorities of this group the replacement of this main series obtained, and from the point of removing the two sets of protection

<p dir="rtl">■ One or more glycosylated cells between one or more monosaccharide molecules</p>

Or oligosaccharides that provide total protection against alcohols or portable acids_aOh Bwasa

<p dir="rtl">10 The main polysaccharide chain, one or more monosaccharide or oligosaccharide molecules, and one or more</p>

From the replacement group and from the removal of the protection groups.

According to the compound_aThis can be extracted and/or purified using a variety of pure roots, especially_aSa after obtaining it practically described flags.

can be challenged_aThis is a rip-off, especially_a“Preparatory” parchment for:

<p dir="rtl">15 ■ Chromatogia_aSilica silica, and</p>

<p dir="rtl">■ High-quality HPLC</p>

performance liquid chromatography, challenge_aPhase reverse (RP) -

High instrument chromatography (HPLC).

Can any_aAlso use selective sedimentation paper.

<p dir="rtl">20 The invention is explained in the following sentence.</p>

His mother:

٥٦٣٩

-٦٠-

The structures of the anionic compounds having substitution according to the invention are shown in Table 1. Corresponding examples of polysaccharide structures are shown in Table 2.

AA is anionic compounds with substitution

m [1- [RI]- ,R'l,Η = R

<tr><td><p dir="rtl">Replacement set -</p><p>[Rl]a-[AA]m</p></td><td><p dir="rtl">Replacement set</p><p>-R'l</p></td><td><p dir="rtl">Polysaccharide series</p></td><td><p dir="rtl">to</p></td><td><p dir="rtl">a</p></td><td><p dir="rtl">compound</p></td></tr><tr><td></td><td><p dir="rtl">"M 0</p></td><td><p dir="rtl">On him</p></td><td></td><td><p dir="rtl">٦٥</p></td><td><p dir="rtl">١</p></td></tr><tr><td><p dir="rtl">٣</p></td><td><p>/γ5^Ν30</p></td><td><p dir="rtl">Ali Yahya</p></td><td><p dir="rtl">٠,٦</p><p dir="rtl">H</p></td><td></td><td><p dir="rtl">٢</p></td></tr><tr><td></td><td><p dir="rtl">"from</p><p>Ο</p></td><td><p dir="rtl">Hello!</p></td><td><p dir="rtl">١,٢</p></td><td><p dir="rtl">٦٤</p></td><td><p dir="rtl">٣</p></td></tr><tr><td><p dir="rtl">T</p></td><td><p dir="rtl">) ٠٠ 0</p></td><td><p dir="rtl">Gissyyyyyyyyyyyyyyyyyyyyyyy</p></td><td><p dir="rtl">٠,٦</p><p dir="rtl">H</p></td><td><p dir="rtl">٣٥</p></td><td><p dir="rtl">٤</p></td></tr><tr><td><p dir="rtl">٣</p></td><td><p dir="rtl">"M 0</p></td><td><p dir="rtl">style</p></td><td><p dir="rtl">٠,٤</p></td><td><p dir="rtl">٢٥</p></td><td><p dir="rtl">A</p></td></tr><tr><td></td><td><p>0</p></td><td><p dir="rtl">AS</p></td><td><p dir="rtl">٠,٦</p><p dir="rtl">A</p></td><td><p dir="rtl">٨</p></td><td><p dir="rtl">٦</p></td></tr>

٥٦٣٩

-٦١-

<tr><td colspan="2"><p>ΗI</p></td><td colspan="2" rowspan="2"></td><td rowspan="6"><p dir="rtl">Ali shout out</p></td><td rowspan="6"><p dir="rtl">٠,٦</p><p dir="rtl">H</p></td><td rowspan="6"><p dir="rtl">٢</p><p dir="rtl">٦٥</p></td><td rowspan="6"><p dir="rtl">٧</p></td></tr><tr><td rowspan="2"></td><td rowspan="2"><p>0</p></td></tr><tr><td rowspan="2"></td><td rowspan="2"></td></tr><tr><td colspan="2" rowspan="2"><p dir="rtl">because</p></td></tr><tr><td colspan="2" rowspan="2"><p dir="rtl">Yes</p></td></tr><tr><td colspan="2"></td></tr><tr><td></td><td></td><td></td><td><p dir="rtl">"M 0</p></td><td rowspan="2"></td><td rowspan="2"><p dir="rtl">٠,٧</p><p dir="rtl">H</p></td><td rowspan="2"></td><td rowspan="2"><p dir="rtl">٨</p></td></tr><tr><td colspan="2"></td><td colspan="2"></td></tr><tr><td></td><td></td><td colspan="2" rowspan="2"><p>0</p></td><td rowspan="2"></td><td rowspan="2"><p dir="rtl">٠,٦</p><p dir="rtl">H</p></td><td rowspan="2"></td><td rowspan="2"><p>.</p></td></tr><tr><td colspan="2"></td></tr><tr><td colspan="2"><p dir="rtl">Yer</p></td><td><p dir="rtl">a</p></td><td><p dir="rtl">™11.5// No</p><p dir="rtl">0</p></td><td><p dir="rtl">Come</p></td><td></td><td></td><td></td></tr><tr><td colspan="2"><p>0</p></td><td><p dir="rtl">a</p></td><td><p dir="rtl">"M</p><p>O</p></td><td><p dir="rtl">٠</p></td><td><p dir="rtl">٠,٥</p><p dir="rtl">٢</p></td><td><p dir="rtl">١٢</p></td><td><p dir="rtl">١١</p></td></tr>

Table 1

Counterexamples of polysaccharides AB

<tr><td><p dir="rtl">Replacement set</p><p>[Rl]a-</p><p dir="rtl">M[]</p></td><td><p dir="rtl">His group</p><p dir="rtl">Replace 1'R—</p></td><td><p dir="rtl">Average molar mass (kg/mol)</p></td><td><p dir="rtl">series</p><p dir="rtl">Polysaccharide</p></td><td></td><td></td><td><p dir="rtl">Counterexamples</p><p dir="rtl">For polysaccharide</p></td></tr>

Anti-polysaccharides are ΑΒ4 483, ΑΒ2, ΑΒ1 and -RΊ-[Rl]a ΑΒ5: R=H0).

٥٦٣٩

-٦٢-

<tr><td><p>1</p></td><td></td><td><p>)</p></td><td><p dir="rtl">٠,٤٦</p></td><td><p dir="rtl">٠,٦</p></td><td><p>ΑΒ1</p></td></tr><tr><td></td><td><p dir="rtl">٥</p></td><td><p>)</p></td><td><p dir="rtl">٠,٦٤</p></td><td></td><td><p>ΑΒ2</p></td></tr><tr><td><p dir="rtl">Suck on</p></td><td><p dir="rtl">H</p></td><td></td><td><p dir="rtl">٠,٤٥</p></td><td><p dir="rtl">٠,٦٥</p></td><td><p>ΑΒ3</p></td></tr><tr><td><p dir="rtl">with</p></td><td></td><td><p>)</p></td><td><p dir="rtl">٠,٦٤</p></td><td></td><td><p>ΑΒ4</p></td></tr><tr><td><p>5</p></td><td></td><td><p>)</p></td><td><p dir="rtl">٠,٦٥</p></td><td><p dir="rtl">٠,٤٥</p></td><td><p>ΑΒ5</p></td></tr>

Table 2

Sodium 1. Compound: Sodium maltotriosemethylcarboxylate AA phenylalaninate, AA-phenylalaninate, sodium maltotriosemethylcarboxylate

To 8g (143 mmol of hydroxyl functions) of maltotriose (CarboSynth 5) dissolved in water at 65°C, 0.6g (16) is added.

mmol) of sodium borohydride. After stirring for 30 minutes, 28 g (238 mmol) of sodium chloroacetate was added. To the aforementioned solution, 4 ml of NaOH (24 mmol) were added by distillation, and the mixture was then heated at 65 degrees Celsius for 90 minutes. 16.6 g (143 mmol) Then, 1 sodium chloro acetate was added to the reaction medium, in addition to the distillation of 14 ml of

<p dir="rtl">0 titers of sodium hydroxide (NaOH) (4 1 mmol). After</p>

٥٦٣٩

-٦٣-

Heating for 1 hour, the acetic acid was diluted with acetic acid and then purified by fine filtration to obtain 1 kg of 1000 ml. The concentration of this fraction of this solution is determined using the acetone extract, and then taking the root of the meat/seat at the bottom of my mind 50/50 (acetone) to determine the degree of substitution with the following Carboxylate

.methylcarboxylate 5

according to_aFor dry extraction: [compound] = 32.9 mg/g

according to_aFor the acid/base test, the degree of substitution with a carboxyl methylation of 1.65 per disaccharide unit.

Sodium carboxylate sodium

Purolite resin (anionic maltotriosemethylcarboxylate)

<p dir="rtl">10 (anionic) totriosemethylcarboxylic acid, which is then freeze-dried for 18 hours.</p>

A mixture of 10 methylcarboxylic acid functions (63) is obtained from methylcarboxylic acid functions, which is then cooled to 0°C. A mixture of dimethylformamide (DMF) is prepared. Ell Vinyl

15 Ethyl phenylalaninate, hydrochloride salt (8.7 g, 38 mmol) in DMF. 3.8 g of triethylamine (38 mmol) added to

Al-Khalazhi Al-Mazdhatkur. Add a solution of N-methyl maleimide (N-methyl- (6.3) maleimide, 63 mmol) and add it to the acetic acid at zero degrees. M. M. From M

<p dir="rtl">20 The phenylalaninate solution is added and the mixture is stirred at 10 °C. Adding the imidazole solution atomized and then warming the cheek to 30°C. This is the purpose of diluting the medium with the substances and the results of this solution, and then purifying it by means of exceptional filtration.</p>

Polyethersulfone (PES)

0.1 atom ionized sodium hydroxide (0.9%, Sodium Hydroxide (NaOH) chloride)

٥٦٣٩

-٦٤-

Sodium chloride is dead. The molecular concentration of the final solution is determined based on the extracted extract. A sample of this solution is dried by lyophilization and analyzed by 1H NMR using deuterium oxide to determine the degree of substitution with the active carboxymethyl compound using L-phenylalanina sodium. sodium L-phenylalaninate

<p dir="rtl">5 according to_aFor dry extraction: [Compound 1] = 29.4 mg/g</p>

according to_aTo determine the solution/base, the sodium methylcarboxylates are replaced with this compound, which includes 0.65 sodium methylcarboxylates per unit disaccharide.

according to_a1H NMR: The degree of substitution is determined by methylcarboxylates activated with 1.0 sodium L-phenylalanina per saccharide unit.

<p dir="rtl">10 2 AA. Center 2: Sodium carboxylate</p>

Maltotriosemethylcarboxylate activated with L-phenylalanina sodium

In a process similar to that used in the preparation of compound 1, sodium maltotriosecarboxylate functionalized with sodium L-phenylalanina was obtained. according to_aTo delete this name/base, you can replace it with the carboxylate compound below.

15 Sodium 1.0 per unit polysaccharide.

according to_aFor dry extraction: [Compound 2] = 20.2 mg/g

according to_a1H NMR: The degree of substitution is determined by the amylcarboxylate compounds activated using L-phenylalanina sodium 0.65 per disaccharide unit.

<p dir="rtl">3 AA. Compound 3: Sodium malto-methyl carboxylate activated with L-phenyl alanine</p>

20 sodium

In a process similar to that used in the preparation of compound 1, sodium malto-triose carboxylate activated with sodium L-phenylalanina is obtained.

٥٦٣٩

-٦٥-

according to_aFor the acid/base test, the degree of substitution with a sodium carboxylate compound of 0.46 per saccharide unit.

according to_aFor dry extraction: [Compound 3] = 7.2 mg/g

according to_a1H NMR: The degree of substitution is determined by the amylcarboxylate compounds activated with L-phenyl.

5 Sodium alanina 1.2 per unit disaccharide.

<p dir="rtl">4 AA. Compound 4: Sodium malto-methyl carboxylate activated with sodium L-phenylalanine</p>

In a process similar to that used in the preparation of compound 1, sodium malto-triose carboxylate activated with sodium L-phenylalanina is obtained.

10 according to_aTo test the diet/base, the degree of replacement with a sodium carboxylate compound of 0.35 is added.

Each unit has a polysaccharide.

according to_aFor dry extraction: [Compound 4] = 3.1 mg/g

according to_a1H NMR: The degree of substitution is determined by the amylcarboxylate compounds activated using L-phenylalanina sodium 0.65 per disaccharide unit.

15 5 AA. Compound 5: Sodium malto-methyl carboxylate activated with L-phenyl alanine

sodium

Thus, a process similar to that used in Appendix 1 is to be obtained for sodium methyl methylcarboxylases functionalized with L-phenylalanina sodium.

according to_aFor dry extraction: [Compound 5] = 10.9 mg/g

20 according to_a1H NMR: The degree of substitution is determined by the amylcarboxylate compounds activated with L-phenyl.

Alanina sodium 0.40 per unit disaccharide.

٥٦٣٩

-٦٦-

The degree of replacement with sodium methylcarboxylate compounds is 1.25 per disaccharide unit.

<p dir="rtl">6 AA. Compound 6: Sodium malto-methyl carboxylate activated with sodium L-phenylalanine</p>

This is 8

5 (CarboSynth) was stirred at 65 °C after adding 0.6 mol (16 ml) of sodium borohydride. After stirring for 30 minutes, 28 g (237 mmol) of sodium chloroacetate was added to the solution. Sodium NaOH (240 mmol). After heating at 65 degrees Celsius for 90 minutes, reduce 10% of the mixture with the mixture, equalize it by adding the mixture to the mixture and then purify it by filtration.

It has the same value as polyethersulfone (PES), which has the same meaning. It is required to determine the concentration of the solution of the final solution when extracting the mixture, and then it is required to determine the procedures for determining the solution/base, then this is 50/50 (this is 50/50). Acetone to update this These medicines may be replaced with sodium carboxylate.

15 according to_aFor dry extraction: [compound] = 14.5 mg/g

according to_aFor the acid/base test, the degree of substitution with a sodium carboxylate compound of 1.45 per saccharide unit.

This is the most important thing in the world.

(Anionic) Purolite resin (anionic) To obtain a 20 ml carboxylate solution, it is freeze-dried for 18 hours.

Thus, a similar process to that used in the attached preparation 1 is reported to have been obtained using sodium L-phenylalanina.

according to_aFor dry extraction: [compound 6] = 10.8 mg/g

٥٦٣٩

-٦٧-

according to_aFor 1H NMR, the degree of substitution with amylcarboxyl compounds activated with sodium L-phenylalanina is 0.65 per disaccharide unit.

The degree of replacement with sodium methylcarboxylate compounds is 0.8 per disaccharide unit.

<p dir="rtl">7 AA. Compound 7: Sodium malto-methyl carboxylate activated with L-phenyl alanine</p>

<p dir="rtl">5 sodium</p>

In a process similar to that described in the preparation of compound 1, 8 methylene methylene sodium methylene carboxyethyl esters were synthesized and freeze-dried at a substitution temperature of 1.76.

There were 8 liters (58 molasses) of freeze-drying models and 15 10 ml (129 molasses) of molasses, each of those soluble molecules at 65 degrees. This is the most important thing

To form a ball, 13 ml of 10 liters of 130 mmol NaOH were added and the mixture was heated at 65 °C for 90 minutes. Then 9 ml (78 ml of dissolved liquid) were added.

All sodium atoms have a delicious and delicious reaction, so they add 8 soda 10 soda 10 soda (80 millimoles of NaOH). After heating for 1 hour, the solution should be reduced with soda, equating it to:

<p dir="rtl">15 Acety and it were purified by alpha filtration on PES chat, weighing 1 kilodalton for Matt. The concentration of the final solution compound was determined upon dry extraction, and then a daily 50/50 test was performed to determine the concentration of this compound by replacing it with carboxylate. And dium.</p>

according to_aFor dry extraction: [compound] = 11.7 mg/g

<p dir="rtl">20 according to_aTo test the diet/base, the degree of substitution with sodium carboxylate is 3.30.</p>

Each unit has a polysaccharide.

٥٦٣٩

-٦٨-

The conversion of this solution to the formation of a carboxylate solution, which can then be dried by cooling. d 18 hours.

Therefore, a similar process to that used in this compound warning 1 is reported to have occurred in the case of 5-methyl carboxylate sodium activated with L-phenylalanina sodium.

according to_aFor dry extraction: [compound 7] = 14.9 mg/g

according to_a1H NMR: The degree of substitution is determined by the amylcarboxylate compounds activated using L-phenylalanina sodium 0.65 per disaccharide unit.

The degree of replacement with sodium methylcarboxylate compounds is 2.65 per disaccharide unit.

<p dir="rtl">10 8 AA. Compound 8: Sodium maltopentasesylcarboxylase activated with L-phenylalanine.</p>

sodium

So, this is an abnormal process based on the description given to prepare the compound warning 1. Therefore, this lease is obtained using CarboSynth (maltopentaose), 10 g of maltopentaose meat was obtained

Carboxylic methyl alcohol has a carboxylic methyl substitution degree of 1.75 per saccharide unit and methylene.

<p dir="rtl">15 M dried by cooling.</p>

On the basis of a deviant act, with the pleasure of the female employee, in the following warning: 1, it is permissible to obtain the wrongdoings by using them.

Sodium carboxylate activated by L-phenylalanina sodium.

according to_aFor dry extraction: [compound 8] = 7.1 mg/g

according to_a1H NMR: The degree of substitution is determined by the amylcarboxylate compounds activated using L-phenyl 20 sodium alanina 0.75 per saccharide unit.

The degree of replacement with sodium methylcarboxylate is 1.0 per saccharide unit.

٥٦٣٩

-٦٩-

<p dir="rtl">9 .AA. Center 9: This is the result of the use of L-Venethane sodium alanine.</p>

So, this is an abnormal process based on the prescribed method. To prepare the compound warning 1, so this rental can be obtained using CarboSynth (maltooctaose), 10 g of maltooctaose was obtained.

5 The carboxyl substance is maltooctaosemethylcarboxylic, so it can be replaced with a carboxylic substance at a rate of 1.65 per saccharide unit and then freeze-dried.

By means of a process similar to that used in Appendix 1, the following results may be obtained from sodium octahedral carboxylates activated with sodium L-phenylalanina.

according to_aFor dry extraction: [compound 9] = 26.3 mg/g

<p dir="rtl">10 according to_a1H NMR: The degree of substitution is determined by the amylcarboxylate compounds activated with L-phenyl.</p>

Alanina sodium 0.65 per unit disaccharide.

The degree of replacement with sodium methylcarboxylate compounds is 1.0 per saccharide unit.

<p dir="rtl">10 AA. Section 10: Sodium carboxylate methylation of sodium compounds using L-tyrosulfuric acid.</p>

sodium L-tyrosinate Sodium

<p dir="rtl">15 By a process similar to that described for the preparation of compound 1, but carried out using a methyl L-tyrosinate, a Bachem hydrochloride salt, sodium maltomethyl L-tyrosinate is activated, characterized by the degree of sodium methyl L-tyrosinate substitution per TBL polysaccharide limit is 1.64, using L-tyrosina sodium.</p>

according to_aFor dry extraction: [compound 10] = 9.1 mg/g

<p dir="rtl">20 according to_aThis is the most effective 1H NMR: This compound is replaced by a carboxy compound, this effect is replaced by using L-</p>

Tyrocina sodium 0.81 per unit disaccharide.

The degree of replacement with sodium methylcarboxylate compounds is 0.83 per disaccharide unit.

٥٦٣٩

-٧٠-

<p dir="rtl">11 AA. Compound 11: Sodium malto-methyl carboxylate activated with glycithin alpha-</p>

sodium alpha-phenylglycinate Sodium phenylglycinate

By a process similar to that described for the preparation of compound 1, 10 g of maltotriosemethylcarboxylic acid were obtained having a degree of substitution with a carboxylic acidic acid of 1.64 per unit.

<p dir="rtl">5 Polysaccharide and freeze-dried.</p>

Study 8 33 Maladhi Madhuul) and Thadhar i. Yadhuul Ummdin (33 Maladhi Madhuul) so Madhath. Mudhahn Dhim Thadhdh Addition Mahdhuul Mudhahn (4.9 Judham; 49 Maladhi Mazhol (and Mazhan) (ethyl (EtOCOCl).

<p dir="rtl">10 5.3 chloroformete esters (g, 49 mmol) to a solution of maltohydrate</p>

Carboxyl at 0°C. Then a solution of alpha-phenyl sodium glycine was added and the mixture was heated at 30 degrees Celsius. This is the most important thing in the world

Imidazole was dissolved (340 mg/L) after 90 minutes. The liquid was reduced by atoms and the amount of this solution was removed by fine filtration and the amount was 150 mg since $

<p dir="rtl">15 A solution of sodium bicarbonate (NaHCO3) / Sodium carbonate (Na2CO3) (having a pH of 10.4, 0.9% sodium chloride)</p>

Sodium chloride (NaCI) and its side effects. You must determine the concentration of the solution at the time of extraction. A sample of the solution is freeze-dried and analyzed by 1H NMR to determine the degree of solubility of the dicarboxyl compounds activated with α-phenylsodium glycina.

20 according to_aFor dry extraction: [compound 11] = 9.1 mg/g

according to_a1H NMR: The degree of substitution with amylcarboxylate compounds activated using alpha-phenyl sodium glycinate is 0.52 per disaccharide unit.

The degree of replacement with sodium methylcarboxylate compounds is 12.1 per saccharide unit.

Anti-polysaccharide

٥٦٣٩

-٧١-

Sodium dextranmethylcarboxylate activated with L-phenylalanina sodium

The polysaccharide 1 is a sodium dext arnyl carboxylate functionalized with sodium L-phenyl alanide. This is obtained from a sodium dext arnyl carboxylate, which has an average molar weight of 10 kg/mol 5 (Pharmacosmos, 39 = DP) according to_aThe process is described in French Part 02316/07

2 914 305._aIn order to determine this point/base, take this step.

Replacement with sodium methyl carboxylate 0.6 per disaccharide unit.

according to_aSo, 1H NMR: The degree of substitution with the amylcarboxylate compounds activated using L-phenylalanina sodium is 0.46 per disaccharide unit.

10 Granulated polysaccharide, polysaccharide 1 in pulp, French No. 01478/09.

Using L-Venethyl Alanine Sodium

The 2-polysaccharide is a sodium dext arnyl carboxylate activated with L-phenyl.

Now, this is the result of the result, this is the result of this, and this is the average weight of the weight of the person who obtained it, 5 as a person.

<p dir="rtl">15 (DP = 19, Pharmacosmos) according to_aThe process is described in French Part 02316/07</p>

2 914 305._aIn order to determine this point/base, take this step.

Replacement with sodium carboxylate 1.01 per unit disaccharide.

according to_aSo, 1H NMR: The degree of substitution with the amylcarboxylate compounds activated using L-phenylalanina sodium is 0.64 per saccharide unit.

<p dir="rtl">20 Using L-Venethyl Alanine Sodium</p>

Polysaccharide 3 is a sodium dext arnyl carboxylate activated with L-phenylalanine, so the sodium obtained thus has an average molar weight of 5 kg.

٥٦٣٩

-٧٢-

(DP = 19, Pharmacosmos) according to_aAccording to_aTo determine the solution/base, the degree of replacement with a sodium dicarboxylate compound was 0.65 per disaccharide unit.

according to_a1H NMR: The degree of substitution is determined by the amylcarboxylate compounds activated using L-phenyl 5-alanina sodium 0.45 per saccharide unit.

In this case, remember 4: Use L-Vin, then carboxylate, the active substance, using L-Vin, now, this sodium.

The polysaccharide 4 is a form of sodium dextearne methyl carboxylate activated with sodium L-phenylalanine, which is obtained from dextearne so that it has an average molar weight of 10 kg/m10 (Pharmacosmos, 39 = DP) according to_aThe process is described in French Part 02316/07

2 914 305._aIn order to determine this point/base, take this step.

Replacement with sodium carboxylate 1.01 per unit disaccharide.

according to_aSo, 1H NMR: The degree of substitution with the amylcarboxylate compounds activated using L-phenylalanina sodium is 0.64 per saccharide unit.

<p dir="rtl">15 In this case, this is the 5th list: Use L-Vin, this time, Sodium.</p>

The polysaccharide 5 is a sodium dext arnyl carboxylate activated with L-phenyl.

Now, this is the result of the result, this is the result of this, and this is the average weight of the weight of the person who obtained it, 5 as a person.

(DP = 19, Pharmacosmos) according to_aThe process described in the French Protocol 02316/07 20._aTo determine the solution/base, the degree of replacement with a sodium dicarboxylate compound was 0.45 per disaccharide unit.

According to 1H NMR: The degree of substitution of the amylcarboxylate compounds activated with sodium L-phenylalanina is 0.65 per saccharide unit.

٥٦٣٩

-٧٣-

Polyanionic compound

Center 1: Multi-anion: Sodium carboxylate: Sodium

maltotriosemethylcarboxylate

8 g (143 mmol of hydroxyl) of maltotriose 5 (CarboSynth) dissolved at 65 °C after adding 0.6 mol (16 ml of dissolved sodium borohydride). After testing for 30 Minutes, 28 g (238 mmol) of sodium chloroacetate were added. To the spherical solution, 24 ml of 10% NaOH (240 mmol) were added, and horseradish was heated at 65 °C for 90 minutes. .

10 Sodium hydroxide (140 mmol) Sodium hydroxide (NaOH) mmol. After heating for 1 hour, the sodium atom was diluted with sodium atom, neutralized with sodium hydroxide (140 mmol). He was slandered by the exceptional filtering It is necessary to determine the concentration of the final solution at the time of extracting the extract, and then to extract it, then to determine the number of characteristics. /

<p dir="rtl">15 Use acetone to update this level, replace it with carboxylate sodium.</p>

.methylcarboxylate

according to_aFor dry extraction: [compound 1 polyanion] = 32.9 mg/g

according to_aTo test the base/base: the degree of substitution with a sodium carboxylate compound of 1.65 per saccharide unit.

20 B Preparing solutions

B 1. Novolog® effective NIR insulin solution at 100 IU/ml

٥٦٣٩

-٧٤-

The shopkeeper is considered a trader_aThis is why Novo Nordisk is authorized to use aspart insulin using Novolog®. The model is aspart rapid insulin analog.

B2. Valid insulin solution Humalog® at 100 IU/ml

<p dir="rtl">5 The condensed solution is considered a commercial solution_aA solution of lispro insulin from Eli Lilly is sold under the name Humalog®. The product is a fully effective insulin.</p>

B3. Actrapid® regular human insulin solution at 100 IU/ml

The condensed solution is considered a commercial solution_aA solution of human insulin from Novo 10 Nordisk sold under the name Actrapid®. The product is regular human insulin.

B4. Humulin® R human insulin solution at 100 IU/ml

The aforementioned solution is considered a commercial solution_aThe solution of insulin is dispensed with Eli Lilly in a small amount, including Humulin® R. The product is regular human insulin.

<p dir="rtl">B5. Preparing excipient solutions</p>

<p dir="rtl">15 The polyanionic compound should be chosen so that the non-polymeric polyanionic is used to measure it.^،The same as for calcium ions and for their ability to shake</p>

Stability of the hexagonal images of insulin.

Regarding the father of Altaf^،K for calcium ions, is determined as follows.

Solutions were prepared containing 2.5 milliliters of sodium chloride (CaCl2), 150 milliliters of sodium chloride, and the concentration of the compound was increased.

The anonymous is discharged) with the humiliation of the omission and 20 millions of delicious delicacies (.

٥٦٣٩

-٧٥-

etc., using a specific document, Scatchard, to remember to specify and implement this document.^،Such dissociation

constants. This data makes it possible to compare the affinity of carboxylates and phosphates for various forms of the polyanionic compound Calcium.

In relation to its ability to destabilize the hexagonal roots of the center of the oscillator, we measure this property 5 using the duality of the oscillators compared to the two oscillators._aDa) Bdhdun Markdheb Anethoni or Markdheb Mutadid

anions (see the experimental protocols in Experimental Section D.

Prepare sodium citrate solution at 1.188 molar

It is possible to obtain a solution of sodium atomization by means of an atomized solution of 9.0811 solutes of sodium atoms (30.9 solutes) so that 25 solutes of sodium atoms in an atomized flask. It is possible to adjust the hydrogen atoms to 7.4

<p dir="rtl">10 Hydrochloride (H) Cl (Hydrochloric acid. The solution is filtered through a filter and has 0.22 μM.</p>

Prepare 130 mM m-cresol solution

The solution of m-cresdol can be obtained by taking 14.114 mol of m-cresdol (130 mmol) in 986.4 ml of MAT in a 1-liter beaker.

<p dir="rtl">15 Prepare a solution of m-cresol and glycerol (96.6 mM m-cresol and 566 mM glycerol)</p>

Addition of 73.3 ml of 130 ml of glycerol dissolved in 5.26 ml of glycerol and diluting it by adding 22.25 g of mate. The obtained m-cresol and glycerol solutions were homogenized for 30 minutes and then filtered through a 0.22 μM filter.

20 Prepare 32.7 mM Tween 20 solution

٥٦٣٩

-٧٦-

The Tween 20 solution is obtained by taking 2.0079 ml of 20 (1,636 ml) solution, 50 ml of molasses, and 50 ml of molasses in a beaker. The solution is filtered with a particle of 0.22 micrometers.

B6. Prepare a 500 IU/ml human insulin solution

<p dir="rtl">5 Addition 15.</p>

The pH was increased to the acidic pH by adding 5.98 g of 0.1 M HCl. After calculating the complete equation for the solution of this acid, the pH of this solution was 7.2 by adding 8.3 nitrates and 0.1 nitrates of NaOH. The concentration must be adjusted to 500 IU/ml by adding 0.76 g of MAT. Finally, the solution is filtered through a 10 0.22 µM filter.

B7. Prepare 100 IU/ml insulin lispro solution in the presence of compound 1

To obtain a formula with a final volume of 100 ml, with a [compound 1]/[lispro insulin] mass ratio of 2.0, various reagents are added in the specified amount.^YAdd Adnam and in the following order:

Composite 1 dryer^YRefrigerated 730 mg

15 100 IU/ml of Humalog® 100 ml solution

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B8. Prepare 100 IU/ml lispro insulin solution in the presence of compound 1

citrate and citrate

20 To obtain a formula with a final volume of 100 ml, what is a mass ratio of 2.0 and 9.3 milliliters of [compound 1]/[insulin lispro]?^YDD ADDDDDDDDAM

In the following order:

٥٦٣٩

-٧٧-

Composite 1 dryer^YRefrigerated 730 mg

100 IU/ml of solution Humalog® 100 ml

1.188 molar of sodium citrate solution 783 microliter

As for the radicals, you can use the radicals or the radicals, as this is the radical

<p dir="rtl">5 Sodium, potassium salt or other salt compatible with what injectable formula.</p>

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B9. Preparation of 100 IU/ml insulin lispro solution in the presence of compound 1 and polyanionic compound 1

<p dir="rtl">10 To obtain this formula, its volume is 100 atoms, so [concentration 1]/[concentration 1 polyanion]/[lispro insulin] has a mass ratio of 1/2.0/2.0, various reagents are added in the specified quantity.^Ydd adndha m</p>

In the following order:

Composite 1 dryer^YRefrigerated 730 mg

Compound 1 polyanionic dehydrator^YRefrigerated 730 mg 100

15 IU/ml of solution Humalog® 100 ml

Compound 1 is polyanionic in acidic or basic forms as a sodium salt, potassium salt or other compatible salt as an injectable formulation.

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

<p dir="rtl">20 B10. Warning 100</p>

٥٦٣٩

-٧٨-

To obtain this volume formula of 100 atoms, then [concentration 1]/[concentration 1 polyanion]/[lisproinsulin] mass ratio of 1/5.5/2.0, various reagents are added in the specified quantity.^YDd adndam

In the following order:

Composite 1 dryer^YRefrigerated 730 mg

5 Compound 1 polyanionic dehydrator^YFreeze-dried 2000 mg

100 IU/ml of solution Humalog® 100 ml

Compound 1 is polyanionic in acidic or basic forms as a sodium salt, potassium salt or other compatible salt as an injectable formulation.

The final pH is adjusted to 7.4 ± 0.4.

<p dir="rtl">10 The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.</p>

B11. Prepare 100 IU/ml insulin lispro solution in the presence of 2-LucTR

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 2]/[insulin lispro]?

<p dir="rtl">2.0 This document has been added to this document. 9.3 This document has been added to this document.^YDD ADDDDDDDDAM</p>

In the following order:

15 Lyophilized Compound 2 730 mg

100 IU/ml of solution Humalog® 100 ml

1.188 molar of 783 microliter sodium citrate solution

As for the radicals, you can use the radicals or the radicals, as this is the radical

Sodium, potassium salt or other salt compatible with what injectable formula.

20 The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

٥٦٣٩

-٧٩-

B12. Preparation 100

To obtain this example, the formula uses 100 micronized particles, using [concentrator 2]/[concentrator 1 multi-anion]/[lispro insulin] with a mass ratio of 1/2.0/2.0, various images of the reagents have been added.

5 In quantity^YDade Adnam in the following order:

Compound 2 lyophilized 730 mg

Compound 1 polyanionic dehydrator^YRefrigerated 730 mg

100 IU/ml of solution Humalog® 100 ml

Compound 1 polyanionic may be used in acidic or basic forms as sodium salt, potassium salt or other compatible salt as an injectable formulation.

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B13. Warning 100

15 To obtain this formula, the volume of this model is 100 atoms, so that [concentration 2]/[multimeter 1 polyanion]/[lispro insulin] has a mass ratio of 1/5.5/2.0, various reagents are added in the specified quantity.^YDd adndam

In the following order:

Lyophilized Compound 2 730 mg

Compound 1 polyanionic dehydrator^YFreeze-dried 2000 mg

20 100 IU/ml of Humalog® 100 ml solution

٥٦٣٩

-٨٠-

10

15

20

Compound 1 is polyanionic in acidic or basic forms as a sodium salt, potassium salt or other compatible salt as an injectable formulation.

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B14. Prepare 100 IU/ml insulin lispro solution in the presence of compound 1

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 1]/[insulin lispro]?

4, Various reagents are added in equal quantities^YDed Adnam:

Compound 1 in dried images^YCold pack 1460 mg

100 IU/ml of solution Humalog® 100 ml

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B15. Prepare 100 IU/ml insulin lispro solution in the presence of compound 2

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 2]/[insulin lispro]?

<p dir="rtl">4, Various reagents are added in equal quantities^YDed Adnam:</p>

Compound 2 in dried images^YCold pack 1460 mg

100 IU/ml of solution Humalog® 100 ml

The pH is now adjusted to 7.4 ± 0.4. The nacreous solution is filtered with a 0.22 µm atom and stored at 4 °C.

B16. Prepare 100 IU/ml lispro-ner insulin solution in the presence of 1 and 1 titrate solution.

sodium tartrate Sodium

٥٦٣٩

-٨١-

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 1]/[insulin lispro]?

<p dir="rtl">2.0 You can add a variety of detectors to this page with an additional concentration of 80 mm.^Ydd</p>

Adnam:

Compound 1 in dried images^YCold pack 730 mg

<p dir="rtl">5 100 IU/ml of Humalog® 100 ml solution</p>

Sodium tartrate 1.552 g

In addition to atomization, it is possible to use atomized acid radicals or atomized basic radicals, as these are atomized radicals.

Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH is adjusted to 7.4 ± 0.4.

<p dir="rtl">10 The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.</p>

B17. Warning 100

To obtain this formula, the volume of this formula is 100 atoms, so that [concentration 1]/[concentration 1 polyanion]/[lispro insulin] has a mass ratio of 1/4/2, various reagents are added in the specified quantity.^YDed Adnam:

15 Compound 1 in dried images^YCold pack 730 mg

Compound 1 is polyanionic in dried form^YCold pack 1460 mg

100 IU/ml of solution Humalog® 100 ml

Compound 1 is polyanionic in acidic or basic forms as a sodium salt, potassium salt or other compatible salt as an injectable formulation.

<p dir="rtl">20 The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.</p>

٥٦٣٩

-٨٢-

B18. Prepare 100 IU/ml insulin lispro solution in the presence of compound 1 and sodium tar

sodium triphosphate Phospha

To obtain this formula, the size of this model is 100 mm, you can add various indicators to this method.^Ydd

Adnam:

<p dir="rtl">5 Compound 1 in dried images^YCold pack 730 mg</p>

Sodium Tar Phospha 184 mg

100 IU/ml of solution Humalog® 100 ml

For triphosphate, the acidic form or the basic form can be used as a salt

Sodium, potassium salt or other salt compatible with what injectable formula.

<p dir="rtl">10 The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.</p>

B19. Prepare 100 IU/ml lispro-ner insulin solution in the presence of 2-dimer and tetramer.

sodium tartrate Sodium

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 2]/[insulin lispro]?

<p dir="rtl">15 2.0 You can add a variety of detectors to this page with an additional concentration of 80 mm.^Ydd</p>

Adnam:

Compound 2 in dried images^YCold pack 730 mg

100 IU/ml of solution Humalog® 100 ml

Sodium tartrate 1.552 g

<p dir="rtl">20 In addition to atomization, it is possible to use atomized acid radicals or atomized basic radicals, as these are atomized radicals.</p>

Sodium, potassium salt or other salt compatible with what injectable formula.

٥٦٣٩

-٨٣-

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B20. Preparation 100

<p dir="rtl">5 To obtain this formula, its volume is 100 anions, so [concentrate 2]/[concentrate 1 polyanion]/[lispro insulin] has a mass ratio of 1/4/2, various reagents are added in the specified quantity.^YDed Adnam:</p>

Compound 2 in dried images^YCold pack 730 mg

Compound 1 is polyanionic in dried form^YCold pack 1460 mg

100 IU/ml of solution Humalog® 100 ml

<p dir="rtl">10 Compound 1 is polyanionic in acidic or basic forms as a sodium salt, potassium salt or other compatible salt as an injectable formulation.</p>

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B21. Prepare 100 IU/ml insulin lispro solution in the presence of 2-tar phospha

15 sodium

To obtain this formula, the size of this model is 100 mm, you can add various indicators to this method.^Ydd

Adnam:

Compound 2 in dried images^YCold pack 730 mg

Sodium tar phosphate 184 mg

<p dir="rtl">20 100 IU/ml of Humalog® 100 ml solution</p>

٥٦٣٩

-٨٤-

For triphosphate, the acidic form or the basic form can be used as a salt

Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH of the atom must be adjusted to 7.4 ± 0.4. The solution is filtered at 0.22 micrometer atoms and stored at 4 °C.

<p dir="rtl">5 B22. Prepare 200 IU/ml Nir Insulin Solution (Insulin Lispro)</p>

Concentration of the commercial formula for Insulin (Humalog®) using central oscillator tubes.

<p dir="rtl">15-Amicon Ultra If you choose a weight of 3 kilograms, then set the weight. First, he denounced Amicon by using 12 detractors from the time of his death. The commercial formula for 35 minutes at this time is 4000 pounds at 20 degrees this year. Disclaimer of this Retention document</p>

<p dir="rtl">10 The concentration was therefore estimated. The retention yields were also collected and the total concentration (&lt;200 IU/ml) was estimated.</p>

Remember that you can't change the focus of a particular file without mentioning it again.^YThis is also 200 and this document is added internationally by adding this commercial formula to this document (Humalog®).^YLikewise, this means that the same concentration of salt (m-cresol, glycerol, phosphate)

15 In commercial form, at 100 IU/ml.

The final pH of the atom must be adjusted to 7.4 ± 0.4. The solution is filtered at 0.22 micrometer atoms and stored at 4 °C.

B23. Prepare 200 IU/ml insulin lispro solution in the presence of compound 1 and CetR

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 1]/[insulin lispro]?

<p dir="rtl">20 2, The various reagents are mixed in sufficient quantities^YDed Adnam:</p>

200 IU/ml Insulin Lispro 100 ml

The product of T^YLyophilization of compound 1 1460 mg

٥٦٣٩

-٨٥-

1.188 molar of 1566 L sodium citrate solution

The final pH of the atom must be adjusted to 7.4 ± 0.4. The solution is filtered at 0.22 micrometer atoms and stored at 4 °C.

B24. Preparation Warning 200

<p dir="rtl">5 Polyanion 1</p>

To obtain this formula, its volume is 100 ml, so [concentrate 1]/[concentrate 1 polyanion]/[lispro insulin] has a mass ratio of 1/2/2, the various reagents are eluted in the specified quantity.^YDed Adnam:

200 IU/ml Insulin Lispro 100 ml

The product of T^YLyophilization of compound 1 1460 mg

10 The product of T^YLyophilization of compound 1 polyanion 1460 mg

Compound 1 is polyanionic in acidic or basic forms as a sodium salt, potassium salt or other compatible salt as an injectable formulation.

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

<p dir="rtl">15 B25. Warning 200</p>

To obtain this formula, its volume is 100 ml, so that [concentrate 1]/[concentrate 1 polyanion]/[lispro insulin] has a mass ratio of 1/4/2, the various reagents are mixed in the specified quantity.^YDed Adnam:

200 IU/ml Insulin Lispro 100 ml

20 The product of T^YLyophilization of compound 1 1460 mg

The product of T^YLyophilization of compound 1 polyanion 2920 mg

٥٦٣٩

-٨٦-

Compound 1 is polyanionic in acidic or basic forms as a sodium salt, potassium salt or other compatible salt as an injectable formulation.

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

<p dir="rtl">5 B26. Preparation 200</p>

To obtain this formula, its volume is 100 anions, so [concentration 2]/[concentration 1 polyanion]/[lispro insulin] has a mass ratio of 1/4/2, the various reagents are mixed in the specified quantity.^YDed Adnam:

200 IU/ml Insulin Lispro 100 ml

10 The product of T^YLyophilization of compound 2 1460 mg

The product of T^YLyophilization of compound 1 polyanion 2920 mg

Compound 1 is polyanionic in acidic or basic forms as a sodium salt, potassium salt or other compatible salt as an injectable formulation.

The final pH of the atom must be adjusted to 7.4 ± 0.4. It is mentioned that Al-Mahdal Al-Sadafi is nominated as an anomaly

15 It has a thickness of 0.22 micrometers and is stored at 4 °C.

B27. Prepare 100 IU/ml human insulin solution in the presence of compound 1 and TR

For a formula with a final volume of 100 ml, what is the [compound 1]/[insulin fragment] ratio as an exaggerated pleasure?

<p dir="rtl">2 And 80 mM of TTR, the various reagents are mixed in equal quantities^YDed Adnam:</p>

500 International unit/ml human insulin 20 ml

20 36.1 mg/ml solution of compound 1 20.27 ml

Solution 96.6 mM m-cresol/566 mM glycerol 30 ml

٥٦٣٩

-٨٧-

Matte 28.95 ml

Sodium tartrate 1.552 g

In addition to dispensing, you can use an acid radical or a basic radical, such as a sodium radical, a potassium salt, or another compatible salt, such as an injectable formulation.

<p dir="rtl">5 The final pH is 7.4 ± 0.4. The clear solution is filtered through a 0.22 µM filter and maintained at +4°C.</p>

B28. Prepare 100 IU/ml human insulin solution in the presence of 1-tar phospha compound

To obtain this formula, the size of this model is 100 m, the various indicators are given in this example.^YDed Adnam:

10 500 IU/ml human insulin 20 ml

<p dir="rtl">3 6.1 mg/mL solution of compound 1 20.27 mL</p>

Solution 96.6 mM m-cresol/566 mM glycerol 30 ml

Matte 28.95 ml

Sodium Tar Phospha 184 mg

<p dir="rtl">15 For triphosphate, the acidic form or the basic form can be used as a salt</p>

Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH is 7.4 ± 0.4. The clear solution is filtered through a 0.22 µM filter and maintained at +4°C.

B29. Prepare 100 IU/ml human insulin solution in the presence of compound 2 and TR

20 For a formula with a final volume of 100 ml, what is the [compound 2]/[insulin fragment] ratio as an exaggerated pleasure?

<p dir="rtl">2 And 80 mM of TTR, the various reagents are mixed in equal quantities^YDed Adnam:</p>

٥٦٣٩

-٨٨-

500 International unit/ml human insulin 20 ml

<p dir="rtl">36.1 mg/ml solution of compound 2 20.27 ml</p>

Solution 96.6 mM m-cresol/566 mM glycerol 30 ml

Matte 28.95 ml

<p dir="rtl">5 Sodium tartrate 1.552 g</p>

In addition to dispensing, you can use an acid radical or a basic radical, such as a sodium radical, a potassium salt, or another compatible salt, such as an injectable formulation.

The final pH is 7.4 ± 0.4.

The atomized solution is filtered with 0.22 micrometres of atoms at its temperature at +4 10°C.

<p dir="rtl">For 30. Prepare 100 IU/ml human insulin solution in the presence of 2-tar phospha</p>

To obtain this formula, the size of this model is 100 m, the various indicators are given in this example.^YDed Adnam:

500 International unit/ml human insulin 20 ml

15 36.1 mg/ml solution of compound 2 20.27 ml

Solution 96.6 mM m-cresol/566 mM glycerol 30 ml

Matte 28.95 ml

Sodium tar phosphate 184 mg

For triphosphate, the acidic form or the basic form can be used as a salt

<p dir="rtl">20 Sodium, potassium salt or other salt compatible with what injectable formula.</p>

٥٦٣٩

-٨٩-

The final pH is 7.4 ± 0.4. The clear solution is filtered through a 0.22 µM filter and maintained at +4°C.

B31. Prepare 200 IU/ml human insulin solution

The commercial formulation of exuded insulin (Humulin® R) was concentrated using centrifugal tubes.

<p dir="rtl">5 15-Amicon Ultra. Firstly, I complain about the Amicon tubes</p>

Using 12 times since then. Disparagement of the origins of the center of pleasure 12 humiliation of the mother of the word

Commercial at this time 35 minutes at this time 4000 pounds at this time 20 degrees C and this. This retention model was retrieved and thus the concentration was estimated. The retention yields were also collected and the total concentration (&lt;200 IU/ml) was estimated.

<p dir="rtl">10 I remember that it was not possible to change the focus of this particular issue in a bad way.^YThis is 200 and the following is added by adding the formula.</p>

Examples of Insulin formula are bitter (Humulin® R).^YExecute this

Concentration of salt (m-cresol, glycerol) in commercial form at 100 IU/

Ml.

The final pH of the atom must be adjusted to 7.4 ± 0.4. The solution is filtered with 15 particles and has a thickness of 0.22 µm and is stored at 4 °C.

B32. Prepare 200 IU/ml human insulin solution in the presence of compound 1 and CetR

To obtain a formula with a final volume of 100 ml, which is [compound 1]/[insulin fragment] in a ratio such as 2, the various reagents are mixed in the specified quantity.^YDed Adnam:

200 IU/ml human insulin 100 ml

20 The product of T^YLyophilization of compound 1 1460 mg

1.188 molar of 1566 microliter sodium citrate solution

٥٦٣٩

-٩٠-

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B33. Preparation of 200 IU/ml human insulin solution in the presence of compound 1 and polyanionic compound 1

<p dir="rtl">5 To obtain this formula, its volume is 100 anions, so that [concentration 1]/[concentration 1 polyanion]/[human insulin] has a mass ratio of 1/2/2, the various reagents are mixed in the specified quantity.^YDed Adnam:</p>

200 IU/ml human insulin 100 ml

The product of T^YLyophilization of compound 1 1460 mg

The product of T^YLyophilization of compound 1 polyanion 1460 mg

<p dir="rtl">10 The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.</p>

B34. Prepare a 200 IU/ml human insulin solution in the presence of compound 1 and compound 1

Aniona 1

To obtain this formula, its volume is 100 anions, so [concentration 1]/[concentration 1 polyanion then]/15 [human insulin] with a mass ratio of 1/4/2, the various reagents are mixed in the specified quantity.^YDed Adnam:

200 IU/ml human insulin 100 ml

The product of T^YLyophilization of compound 1 1460 mg

The product of T^YLyophilization of compound 1 polyanion 2920 mg

Compound 1 polyanionic may be used in acidic or basic forms as sodium salt, potassium salt or other compatible salt as an injectable formulation.

٥٦٣٩

-٩١-

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B 35. Prepare 200 IU/ml human insulin solution in the presence of 2-LucTR

For a formula with a final volume of 100 ml, what is the [compound 2]/[insulin fragment] ratio as an exaggerated pleasure?

<p dir="rtl">5 2, The various reagents are mixed in sufficient quantities^YDed Adnam:</p>

200 IU/ml human insulin 100 ml

The product of T^YLyophilization of compound 2 1460 mg

1.188 molar of 1566 microliter sodium citrate solution

The final pH of the atom must be adjusted to 7.4 ± 0.4. The solution is filtered with 10 particles and has a density of 0.22 µm and is stored at 4 °C.

<p dir="rtl">B36. Prepare 200 IU/ml human insulin solution in the presence of compound 2 and compound 2</p>

Aniona 1

To obtain this formula, the size of this model is 100 m, so [center 2]/ [center 1 multi-ion]/

[Human insulin] mass ratio of 1/2/2, the various reagents are mixed in equal quantities^YDed Adnam:

15 200 IU/ml human insulin 100 ml

The product of T^YLyophilization of compound 2 1460 mg

The product of T^YLyophilization of compound 1 polyanion 1460 mg

Compound 1 is polyanionic in acidic or basic forms as a sodium salt, potassium salt or other compatible salt as an injectable formulation.

<p dir="rtl">20 The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.</p>

٥٦٣٩

-٩٢-

B37. Preparation of 200 IU/ml human insulin solution in the presence of compound 2 and polyanionic compound 1

To obtain this formula, its volume is 100 anions, so that [concentration 2]/[concentration 1 polyanion]/[human insulin] has a mass ratio of 1/4/2, the various reagents are mixed in the specified quantity.^YDed Adnam:

5 200 IU/ml human insulin 100 ml

The product of T^YLyophilization of compound 2 1460 mg

The product of T^YLyophilization of compound 1 polyanion 2920 mg

Compound 1 is polyanionic in acidic or basic forms as a sodium salt, potassium salt or other compatible salt as an injectable formulation.

<p dir="rtl">10 The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.</p>

B38. Prepare 100 IU/ml human insulin solution in the presence of 2-LucTR

For a formula with a final volume of 100 ml, what is the [compound 2]/[insulin fragment] ratio as an exaggerated pleasure?

<p dir="rtl">2 And 9.3 mM Citrate, the various reagents are mixed in equal quantities^YDed Adnam:</p>

15 500 IU/ml human insulin 20 ml

<p dir="rtl">36.1 mg/ml solution of compound 2 20.27 ml</p>

<p dir="rtl">96.6 mM m-cresol/566 mM glycerol 30 ml solution</p>

Matte 28.95 ml

<p dir="rtl">1.188 molar of 783 microliter sodium citrate solution</p>

<p dir="rtl">20 As for salts, it is possible to use a salt radical or a base radical, such as a sodium salt, a potassium salt, or another compatible salt in an injectable formulation.</p>

٥٦٣٩

-٩٣-

The final pH is 7.4 ± 0.4. The clear solution is filtered through a 0.22 µM filter and maintained at +4°C.

B39. Prepare 100 IU/ml human insulin solution in the presence of compound 1 and CetR

For a formula with a final volume of 100 ml, what is the [compound 1]/[insulin fragment] ratio as an exaggerated pleasure?

<p dir="rtl">5 2 and 9.3 mM of Citrate, the various reagents are eluted in equal quantities^YDed Adnam:</p>

500 International unit/ml human insulin 20 ml

<p dir="rtl">36.1 mg/ml solution of compound 1 27 ml</p>

<p dir="rtl">96.6 mM m-cresol/566 mM glycerol 30 ml solution</p>

Matte 28.95 ml

<p dir="rtl">10 1.188 molar of 783 microliter sodium citrate solution</p>

As for the radicals, you can use the radicals or the radicals, as this is the radical

Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH is 7.4 ± 0.4. The clear solution is filtered through a 0.22 µM filter and maintained at +4°C.

<p dir="rtl">15 B40. Prepare 100 IU/ml insulin aspirin solution in the presence of 1-lucitar compound.</p>

To obtain the formula for the size of this time in 100 mm, with a ratio such as 2.0 and 9.3 mm, you can add various indicators with this extension.^Ydd adnadhdham

In the following order:

Composite 1 dryer^YRefrigerated 730 mg

20 100 IU/ml Solution: 100 ml

1.188 molar of 783 microliter sodium citrate solution

٥٦٣٩

-٩٤-

10

15

As for salts, it is possible to use a salt radical or a base radical, such as a sodium salt, a potassium salt, or another compatible salt in an injectable formulation.

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B41. 100 IU/ml effective non-insulin solution Apidra®

The aforementioned analyte is considered an analyte_a Merchants_aThe Glysedine Glysedine Solution is produced by Aventis-Sanofi and is sold under the name Apidra®. The product is a fully effective insulin.

B42. Prepare 100 IU/ml insulin glulisine solution in the presence of compound 1 and CetR

To obtain the formula for the size of this time, which is 100 mm, with a ratio such as 2.0 mm and 9.3 cm, you can add various indicators with this extension.^Ydd adnadhdham

In the following order:

Compound 1 Lyophilized 730 mg

100 IU/ml Apidra® 100 ml solution

1.188 molar of sodium citrate solution 783 microliter

As for salts, it is possible to use a salt radical or a base radical, such as a sodium salt, a potassium salt, or another compatible salt in an injectable formulation.

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B43. Prepare 100 IU/ml insulin aspirin solution in the presence of 2-lucitar compound.

٥٦٣٩

-٩٥-

To get the formula for the size of this moment in 100 times, what is the [2]/[Asdābār Ārsdālīn] ratio as pleasure?

2.0 Documents and Documents Added to this document, you can add various documents in this section.^Ydd adnadhdham

In the following order:

Composite 2 dryer^YRefrigerated 730 mg/l

5 100 IU/ml Solution Traders Novolog® 100 ml

1.188 molar of 783 microliter sodium citrate solution

As for the radicals, you can use the radicals or the radicals, as this is the radical

Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH is adjusted to 7.4 ± 0.4.

10 The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B44. Prepare 100 IU/ml glulisine insulin solution in the roots of compound 2 and CetR.

To obtain the formula for the size of this time, which is 100 mm, with a ratio such as 2.0 and 9.3 mm, you can add various indicators with this extension.^Ydd adnadhdham

15 In the following order:

Lyophilized Compound 2 730 mg

100 IU/ml Apidra® 100 ml solution

1.188 molar of 783 microliter sodium citrate solution

As for the radicals, you can use the radicals or the radicals, as this is the radical

20 Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH is adjusted to 7.4 ± 0.4.

٥٦٣٩

-٩٦-

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B45. Prepare 100 IU/ml insulin lispro solution in the presence of 5-CitR compound

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 5]/[insulin lispro]?

<p dir="rtl">2.0 This document has been added to this document. 9.3 This document has been added to this document.^YDD ADDDDDDDDAM</p>

<p dir="rtl">5 In the following order:</p>

Lyophilized Compound 5 730 mg

100 IU/ml of solution Humalog® 100 ml

<p dir="rtl">1 188 molar of 783 microliter sodium citrate solution</p>

As for the radicals, you can use the radicals or the radicals, as this is the radical

<p dir="rtl">10 Sodium, potassium salt or other salt compatible with what injectable formula.</p>

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B46. Prepare 100 IU/ml insulin lispro solution in the presence of 6-LucTR

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 6]/[insulin lispro]?

<p dir="rtl">15 2.0 This document has been added to this document. 9.3 This document has been added to this document.^YDD ADDDDDDDDAM</p>

In the following order:

Composite 6 dryer^YRefrigerated 730 mg

100 IU/ml of solution Humalog® 100 ml

1.188 molar of 783 microliter sodium citrate solution

<p dir="rtl">20 As for the radicals, you can use the radicals or the radicals, as this is the radical</p>

Sodium, potassium salt or other salt compatible with what injectable formula.

٥٦٣٩

-٩٧-

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B47. Prepare 100 IU/ml insulin lispro solution in the presence of 7-LucitR compound

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 7]/[insulin lispro]?

<p dir="rtl">5 2.0 This document has been added to this document. 9.3 This document has been added to this document.^YDD ADDDDDDDDAM</p>

In the following order:

Compound 7 730 mg

100 IU/ml of solution Humalog® 100 ml

1.188 molar of 783 microliter sodium citrate solution

<p dir="rtl">10 As for the radicals, you can use the radicals or the radicals, as this is the radical</p>

Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B48. Prepare 100 IU/ml insulin lispro solution in the presence of 8-LucitR

15 For a formula with a final volume of 100 ml, what is the mass ratio of [compound 8]/[insulin lispro]?

<p dir="rtl">2.0 This document has been added to this document. 9.3 This document has been added to this document.^YDD ADDDDDDDDAM</p>

In the following order:

8 dry compound^YRefrigerated 730 mg

100 IU/ml of solution Humalog® 100 ml

20 1.188 molar of 783 microliter sodium citrate solution

٥٦٣٩

-٩٨-

As for the radicals, you can use the radicals or the radicals, as this is the radical

Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

5 B49. Prepare 100 IU/ml insulin lispro solution in the presence of 9-LucitR compound

9 dry compound^YRefrigerated 730 mg

100 IU/ml of solution Humalog® 100 ml

1.188 molar of 783 microliter sodium citrate solution

As for salts, it is possible to use a salt radical or a base radical, such as a sodium salt, a potassium salt, or another compatible salt, such as an injectable formulation.

The final pH is adjusted to 7.4 ± 0.4.

For 50. Prepare 100 IU/ml human insulin solution in the presence of 5-LucTR

For a formula with a final volume of 100 ml, what is the [compound 5]/[insulin fragment] ratio as an exaggerated pleasure?

<p dir="rtl">2.0 This document has been added to this document. 9.3 This document has been added to this document.^YDD ADDDDDDDDAM</p>

15 In the following order:

Lyophilized Compound 5 730 mg

100 IU/ml of solution Traders Humulin® R 100 ml

1.188 molar of 783 microliter sodium citrate solution

As for the radicals, you can use the radicals or the radicals, as this is the radical

20 Sodium, potassium salt or other salt compatible with what injectable formula.

٥٦٣٩

-٩٩-

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B51. Prepare 100 IU/ml human insulin solution in the presence of 6-LucTR

For a formula with a final volume of 100 ml, what is the [compound 6]/[insulin fragment] ratio as an exaggerated pleasure?

5 2.0 This document has been added to this document. 9.3 This document has been added to this document.^YDD ADDDDDDDDAM

In the following order:

Lyophilized Compound 6 730 mg

100 IU/ml of solution Traders Humulin® R 100 ml

1.188 molar of 783 microliter sodium citrate solution

10 As for the radicals, you can use the radicals or the radicals, as this is the radical

Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B52. Prepare 100 IU/ml human insulin solution in the presence of 7-LucTR

15 For a formula with a final volume of 100 ml, what is the [compound 7]/[insulin fragment] ratio as an exaggerated pleasure?

<p dir="rtl">2.0 This document has been added to this document. 9.3 This document has been added to this document.^YDD ADDDDDDDDAM</p>

In the following order:

Compound 7 dryer^YRefrigerated 730 mg

100 IU/ml of solution Traders Humulin® R 100 ml

20 1.188 molar of 783 microliter sodium citrate solution

٥٦٣٩

-١٠٠-

As for the radicals, you can use the radicals or the radicals, as this is the radical

Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

<p dir="rtl">5 B53. Prepare 100 IU/ml human insulin solution in the presence of 8-LucTR</p>

For a formula with a final volume of 100 ml, what is the [compound 8]/[insulin fragment] ratio as an exaggerated pleasure?

<p dir="rtl">2.0 This document has been added to this document. 9.3 This document has been added to this document.^YDD ADDDDDDDDAM</p>

In the following order:

8 dry compound^YRefrigerated 730 mg

10 100 IU/ml of solution Humulin® R 100 ml

1.188 molar of 783 microliter sodium citrate solution

As for the radicals, you can use the radicals or the radicals, as this is the radical

Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH is adjusted to 7.4 ± 0.4.

<p dir="rtl">15 The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.</p>

B54. Preparation of 100 IU/ml human insulin solution in the presence of 9-LucTR

To obtain a formula with a final volume of 100 ml, what is the ratio of [compound 9]/[insulin fragment] as a dose of 2.0 ml and 9.3 ml of this amount, you can add various ingredients in this amount.^YDD ADDDDDDDDAM

In the following order:

20 9 dry compound^YRefrigerated 730 mg

100 IU/ml of solution Traders Humulin® R 100 ml

٥٦٣٩

-١٠١-

1.188 molar of 783 microliter sodium citrate solution

As for salts, it is possible to use a salt radical or a base radical, such as a sodium salt, a potassium salt, or another compatible salt in an injectable formulation.

The final pH is adjusted to 7.4 ± 0.4.

5 The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B55. Prepare 100 IU/ml human insulin solution in the presence of compound 2

For a formula with a final volume of 100 ml, what is the [compound 2]/[insulin fragment] ratio as an exaggerated pleasure?

<p dir="rtl">2.0, various reagents are added in exact quantities^YAdd Adnam and in the following order:</p>

Composite 2 dryer^YRefrigerated 730 mg

10 100 IU/ml of solution Humulin® R 100 ml

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

B56. Prepare 100 IU/ml human insulin solution in the presence of compound 7

For a formula with a final volume of 100 ml, what is the [compound 7]/[insulin fragment] ratio as an exaggerated pleasure?

15 2.0, various reagents are added in exact quantities^YAdd Adnam and in the following order:

Compound 7 dryer^YRefrigerated 730 mg

100 IU/ml of solution Traders Humulin® R 100 ml

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

20 B57. Prepare 100 IU/ml insulin lispro solution in the presence of 10-LucitR compound

٥٦٣٩

-١٠٢-

To obtain a formula for the size of this formula, which is 100 mm, then a ratio such as 2.0 and 9.3 mm is given, you can add various indicators in this manner.^Ydd adnadhdham

In the following order:

Compound 10 dry^YRefrigerated 730 mg

5 100 IU/ml of Humalog® 100 ml solution

1.188 molar of 783 microliter sodium citrate solution

As for the radicals, you can use the radicals or the radicals, as this is the radical

Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH is adjusted to 7.4 ± 0.4.

<p dir="rtl">10 The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C. B58. Prepare 100 IU/ml lispro insulin solution in the presence of compound 11 mL to obtain a volume formula of 100 mol, with [ concentrate 11]/[lispro insulin] a ratio of 2.0 mL with a volume of 9.3 mL, then adding reagents. Delete a variety of things like this The eraser^Ydd adnadhdham</p>

In the following order:

15 Compound 11 dryer^YRefrigerated 730 mg

100 IU/ml of solution Humalog® 100 ml

1.188 molar of 783 microliter sodium citrate solution

As for the radicals, you can use the radicals or the radicals, as this is the radical

Sodium, potassium salt or other salt compatible with what injectable formula.

20 The final pH is adjusted to 7.4 ± 0.4.

B59. Prepare 100 IU/ml human insulin solution in the presence of 10-LucitR compound

٥٦٣٩

-١٠٣-

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 10]/[human insulin]?

<p dir="rtl">2.0 This document has been added to this document. 9.3 This document has been added to this document.^YDD ADDDDDDDDAM</p>

In the following order:

Compound 10 dry^YRefrigerated 730 mg

<p dir="rtl">5 100 IU/ml of solution Humulin® R 100 ml</p>

<p dir="rtl">1 188 molar of 783 microliter sodium citrate solution</p>

As for the radicals, you can use the radicals or the radicals, as this is the radical

Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH is adjusted to 7.4 ± 0.4.

<p dir="rtl">10 The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C. B60. Prepare 100 IU/ml human insulin solution in the presence of compound 11 citrate to obtain a formula with a final volume of 100 ml, giving a mass ratio of 2.0 and 9.3 milliliters of salt. Various reagents are added. So delicious The model^YDD ADDDDDDDDAM</p>

In the following order:

15 Compound 11 dryer^YRefrigerated 730 mg

100 IU/ml of solution Traders Humulin® R 100 ml

1.188 molar of 783 microliter sodium citrate solution

As for the radicals, you can use the radicals or the radicals, as this is the radical

Sodium, potassium salt or other salt compatible with what injectable formula.

20 The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

٥٦٣٩

-١٠٤-

B61. Prepare 200 IU/ml of insulin aspar solution

The commercial formula for automated oscillators (Novolog®) was established using centralized oscillator tubes.

15-Amicon Ultra. Firstly, I complain about the Amicon tubes

Using 12 times since then. Disparagement of the origins of the center of pleasure 12 humiliation of the mother of the word

<p dir="rtl">5 Commercial at this time 35 minutes at this time 4000 pounds at this time 20 degrees C and this. Disclaimer of this Retention document</p>

The concentration was therefore estimated. The retention yields were also collected and the total concentration (&lt;200 IU/ml) was estimated.

I remember that it was not possible to modify the focus of this particular issue.^Y200

The commercial formula for personal data (Novolog®).^YLike this

<p dir="rtl">10 We take the concentration of the base (m-creso, glycerol) in the roots of the commercial formula at 100 and determine</p>

international/ml.

By adjusting the concentrated response time and the final dilution using the commercial formula, the authorizer

Prepare insulin injections in the same manner at 300, 400 or 500 IU/ml.

The final pH of the atom must be adjusted to 7.4 ± 0.4. The solution is filtered with 15 particles and has a thickness of 0.22 µm and is stored at 4 °C.

B62. Prepare 200 IU/ml of insulin glulisine solution

The commercial formulation of Apidra® insulin glulisine was concentrated using Amicon Ultra 15-concentrate tubes to a weight limit of 3 kDa. The Amicon tubes were first filtered using 12 ml of deionized water. Earning a response 20 centers of pleasure 12 times the commercial formula for 35 minutes at 4000 degrees at 20 degrees Celsius.

It is necessary to disparage the retention models and thus to disapprove of the retention documents. These are also reported as aggregation models, and the total concentration (&gt; 200 IU/ml) is reported.

٥٦٣٩

-١٠٥-

It is necessary to adjust the concentration of the bitter insulin glyceride solution^YThis is 200 and the document is added by adding the “Apidra®” commercial formula to the “Apidra” formula.^YWe also implement a Turkish version based on the following: m-cresol, sodium chloride

(TRIS) in commercial form at 100 IU/ml.

<p dir="rtl">5 Then, it is necessary to adjust the concentration and final dilution using the commercial formula, then the authorized person</p>

Prepare insulin gluculidine in the same manner at 300, 400 or 500 IU/ml.

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B63. Prepare 200 IU/ml insulin as a sodium solution and 1 solution at 14.6

10 mg/ml and 18.6 mM CetR

To obtain a formula with a final volume of 100 ml, which is [compound 1]/[insulin fragment] atomized as a mixture of 2.0, various reagents are added in the specified quantity.^YAdd Adnam and in the following order:

Compound 1 Lyophilized 1460 mg

200 IU/ml of aspart insulin 100 ml

15 1.188 molar of 783 microliter sodium citrate solution

The final pH number is 7.4 ± 0.4. The elliptical solution is filtered with atoms of 0.22 µm and stored at 4 °C.

<p dir="rtl">B64. Preparation of human insulin, insulin lispro, insulin aspar or insulin glulisine solution.</p>

At 300, 400 and 500 IU/ml

<p dir="rtl">20 Disclaimer: Preparation of the bitter formula^YThis is the most important thing in the world.</p>

Insulin glulisine at 300 IU/ml, 400 IU/ml or 500 IU/ml (i.e._aAlso, the medium concentration) according to the provisions of Protocol 62B relating to the preparation of 200

٥٦٣٩

-١٠٦-

This is an international document, an authorized representative, a registered representative, and an authorized supervisor. This commercial formula can be used using 15-Amicon Ultra concentrator tubes at a weight limit of 3 kDa. Amicon tubes were first filtered using 12 ml of deionized Mate. The central response was made

This is 12 degrees, and the commercial formula is 4,000 degrees, and this is 20 degrees. Ḍazḍn ḍạdh ạdhdẓ ạdzdạl and filth

<p dir="rtl">5 The extremity of the center, the minaret of the eminent lies in order to modify the typical focus of the two instruments, so this formula. It disparages the retention models and thus disposes of the concentration. The retention results are also mentioned and the maximum concentration (&gt; 300, 400 or 500 IU/ml) is mentioned.</p>

You cannot adjust the concentration of the bitter insulin solution^YThe solute concentration is determined (as shown below: 300, 400, 400, or 500) by adding formula 10 (Humalog®, Novolog®, Humulin® R, or Humulin® A). pidra(. be For the bitter insulin formula^YPoke

The same concentration as the commercial formula is 100 IU/ml.

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B65. Prepare 200 IU/ml insulin glulisine solution in the presence of 1-LucTR compound

<p dir="rtl">15 To obtain the formula for the volume of this moment in 100 mm, then [Mrqd 1]/[Glulisthin Insdol] in a ratio such as 2, the various reagents are mixed in the specified quantity^YAdd Adnam and in the following order:</p>

The product of T^YLyophilization of compound 1 1460 mg

200 IU/ml Insulin glulisine 100 ml

1.188 molar of 1566 microliter sodium citrate solution

<p dir="rtl">20 The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.</p>

B66. Prepare 300 IU/ml insulin aspirin solution in the presence of 1-lucitar compound.

٥٦٣٩

-١٠٧-

10

15

20

To obtain the formula for the volume of this moment in 100 mm, then [Platform 1]/[Instrumental Instruments] in a ratio such as Table 2.0, the various reagents are mixed in the specified quantity^YDed Adnam:

300 IU/ml Aspar Insulin 100 ml

The product of T^YLyophilization of compound 1 2190 mg

Sodium CetR 720 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

67B. Prepare a 300 IU/ml insulin glulisine solution in the presence of compound 1 and CetR

To get the formula for the volume of this moment in 100 Mdhālān, what is [Mrqd 1]/ [Jalāwālīsdīn Insdālīn] as a factor?

Seasoning 2.0, various reagents are mixed in equal quantities^YDed Adnam:

300 IU/ml Insulin glulisine 100 ml

The product of T^YLyophilization of compound 1 2190 mg

Sodium CetR 720 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. It is mentioned that Al-Mahdal Al-Sadafi is nominated as an anomaly

It has a thickness of 0.22 micrometers and is stored at 4 °C.

B68. Prepare 400 IU/ml insulin aspirin solution in the presence of 1-lucitar compound.

To get the formula for the size of this moment in 100 times, what is [Platform 1]/[Asadhir R Insdullin] as a ratio as pleasure?

Seasoning 2, mix the various reagents in sufficient quantity^YDed Adnam:

400 IU/ml Aspar Insulin 100 ml

The product of T^YLyophilization of compound 1 2920 mg

٥٦٣٩

-١٠٨-

Sodium CetR 960 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B69. Prepare a 400 IU/ml insulin glulisine solution in the presence of compound 1 and CetR

5 To obtain the formula for the volume of this moment in 100 mm, with a ratio such as 2.0, the various reagents are mixed in the specified quantity.^YDed Adnam:

400 IU/ml Insulin glulisine 100 ml

The product of T^YLyophilization of compound 1 2920 mg

Sodium CetR 960 mg

10 The final pH number is 7.4 ± 0.4. The elliptical solution is filtered with atoms of 0.22 µm and stored at 4 °C.

B70. Prepare 500 IU/ml insulin aspirin solution in the presence of 1-lucitar compound.

To obtain the formula for the volume of this moment in 100 mm, then [Platform 1]/[Instrumental Instruments] in a ratio such as Table 2.0, the various reagents are mixed in the specified quantity^YDed Adnam:

15 500 IU/ml Aspar Insulin 100 ml

The product of T^YLyophilization of compound 1 3650 mg

Sodium CetR 1200 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

20 B71. Prepare a 500 IU/ml insulin glulisine solution in the presence of compound 1 and CetR

٥٦٣٩

-١٠٩-

To obtain the formula for the volume of this moment in 100 mm, with a ratio such as 2.0, the various reagents are mixed in the specified quantity.^YDed Adnam:

500 IU/ml Insulin glulisine 100 ml

The product of T^YLyophilization of compound 1 3650 mg

5 Sodium CetR 1200 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B72. Prepare 300 IU/ml human insulin solution in the presence of compound 1 and CetR

For a formula with a final volume of 100 ml, what is the [compound 1]/[insulin fragment] ratio as an exaggerated pleasure?

10 2.0, various reagents are mixed in equal quantities^YDed Adnam:

300 IU/ml human insulin 100 ml

The product of T^YLyophilization of compound 1 2190 mg

Sodium CetR 720 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. It is mentioned that Al-Mahdal Al-Sadafi is nominated as an anomaly

15 It has a thickness of 0.22 micrometers and is stored at 4 °C.

B73. Prepare 300 IU/ml insulin lispro solution in the presence of compound 1 and CetR

To obtain the formula for the volume of this moment in 100 mm, with a ratio such as 2.0, the various reagents are mixed in the specified quantity.^YDed Adnam:

500 IU/ml Insulin glulisine 100 ml

20 The product of T^YLyophilization of compound 1 2190 mg

٥٦٣٩

-١١٠-

Sodium Citr

720 mg

The final pH number is 7.4 ± 0.4. The elliptical solution is filtered with atoms of 0.22 µm and stored at 4 °C.

B74. Prepare 400 IU/ml human insulin solution in the presence of compound 1 and CetR

For a formula with a final volume of 100 ml, what is the [compound 1]/[insulin fragment] ratio as an exaggerated pleasure?

<p dir="rtl">2.0, various reagents are mixed in equal quantities^YDed Adnam:</p>

400 IU/ml human insulin 100 ml

The product of T^YLyophilization of compound 1 2920 mg

Sodium CetR 960 mg

10 The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B75. Prepare 400 IU/ml insulin lispro solution in the presence of compound 1 and CetR

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 1]/[insulin lispro]?

<p dir="rtl">2.0, various reagents are mixed in equal quantities^YDed Adnam:</p>

15

400 IU/ml Insulin Lispro 100 ml

The product of T^YLyophilization of compound 1 2920 mg

Sodium CetR 960 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

20 B76. Prepare 500 IU/ml human insulin solution in the presence of compound 1 and CetR

٥٦٣٩

-١١١-

For a formula with a final volume of 100 ml, what is the [compound 1]/[insulin fragment] ratio as an exaggerated pleasure?

<p dir="rtl">2.0, various reagents are mixed in equal quantities^YDed Adnam:</p>

500 IU/ml human insulin 100 ml

The product of T^YLyophilization of compound 1 3650 mg

5 Sodium CetR 1200 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B77. Prepare 500 IU/ml insulin lispro solution in the presence of compound 1 and CetR

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 1]/[insulin lispro]?

10 2.0, various reagents are mixed in equal quantities^YDed Adnam:

500 IU/ml Insulin Lispro 100 ml

The product of T^YLyophilization of compound 1 3650 mg

Sodium CetR 1200 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. It is mentioned that Al-Mahdal Al-Sadafi is nominated as an anomaly

15 It has a thickness of 0.22 micrometers and is stored at 4 °C.

B78. Prepare 200 IU/ml insulin lispro solution in the presence of 2-lucitr compound

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 2]/[insulin lispro]?

<p dir="rtl">2.0, various reagents are mixed in equal quantities^YDed Adnam:</p>

200 IU/ml Insulin Lispro 100 ml

20 The product of T^YLyophilization of compound 2 1460 mg

٥٦٣٩

-١١٢-

1.188 molar of 1566 microliter sodium citrate solution

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B79. Preparation of 200 IU/ml insulin aspirin solution in the presence of 2-lucitar compound.

5 To get the formula for the size of this moment in 100 times, what is the [2]/[Asdābār Ārsdālīn] ratio as pleasure?

Seasoning 2.0, various reagents are mixed in equal quantities^YDed Adnam:

200 IU/ml Aspar Insulin 100 ml

The product of T^YLyophilization of compound 2 1460 mg

1.188 molar of 1566 microliter sodium citrate solution

10 The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B80. Prepare 200 IU/ml insulin glulisine solution in the presence of 2-lucitre compound

To obtain the formula for the volume of this moment in 100 mm, with a ratio such as 2.0, the various reagents are mixed in the specified quantity.^YDed Adnam:

15

200 IU/ml Insulin glulisine 100 ml

The product of T^YLyophilization of compound 2 1460 mg

1.188 molar of 1566 microliter sodium citrate solution

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

20 B81. Prepare 300 IU/ml insulin aspirin solution in the presence of 2-lucitar compound.

٥٦٣٩

-١١٣-

To obtain the formula for the volume of this moment in 100 mm, then [Platform 2]/[Instrumental Instruments] as simple as 2.0, the various reagents are mixed in the specified quantity^YDed Adnam:

300 IU/ml Aspar Insulin 100 ml

The product of T^YLyophilization of compound 2 2190 mg

5 Sodium CetR 720 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B82. Prepare a 300 IU/ml insulin glulisine solution in the presence of 2-lucitre compound

To get the formula for the size of this moment in 100 mdhālān, then [Mrqdāb 2]/[Jlāwālīsdīn Insdulīn] is a factor like pleasure.

10 Seasoning 2.0, various reagents are mixed in equal quantities^YDed Adnam:

300 IU/ml Insulin glulisine 100 ml

The product of T^YLyophilization of compound 2 2190 mg

Sodium CetR 720 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. It is mentioned that Al-Mahdal Al-Sadafi is nominated as an anomaly

15 It has a thickness of 0.22 micrometers and is stored at 4 °C.

B83. Prepare 400 IU/ml insulin aspirin solution in the presence of 2-lucitar compound.

To obtain the formula for the volume of this moment in 100 mm, then [Platform 2]/[Instrumental Instruments] as simple as 2.0, the various reagents are mixed in the specified quantity^YDed Adnam:

400 IU/ml Aspar Insulin 100 ml

20 The product of T^YLyophilization of compound 2 2920 mg

٥٦٣٩

-١١٤-

Sodium CetR 960 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B84. Prepare a 400 IU/ml insulin glulisine solution in the presence of 2-lucitre compound

5 To obtain the formula for the volume of this moment in 100 mm, with a ratio such as 2.0, the various reagents are mixed in the specified quantity.^YDed Adnam:

400 IU/ml Insulin glulisine 100 ml

The product of T^YLyophilization of compound 2 2920 mg

Sodium CetR 960 mg

10 The final pH number is 7.4 ± 0.4. The elliptical solution is filtered with atoms of 0.22 µm and stored at 4 °C.

B85. Prepare 500 IU/ml insulin aspirin solution in the presence of 2-lucitar compound.

To obtain the formula for the volume of this moment in 100 mm, then [Platform 2]/[Instrumental Instruments] as simple as 2.0, the various reagents are mixed in the specified quantity^YDed Adnam:

15 500 IU/ml Aspar Insulin 100 ml

The product of T^YLyophilization of compound 2 3650 mg

Sodium CetR 1200 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

20 B86. Prepare 500 IU/ml insulin glulisine solution in the presence of 2-lucitre compound

٥٦٣٩

-١١٥-

To obtain the formula for the volume of this moment in 100 mm, with a ratio such as 2.0, the various reagents are mixed in the specified quantity.^YDed Adnam:

500 IU/ml Insulin glulisine 100 ml

The product of T^YLyophilization of compound 2 3650 mg

5 Sodium CetR 1200 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B87. Prepare 300 IU/ml human insulin solution in the presence of 2-LucTR

For a formula with a final volume of 100 ml, what is the [compound 2]/[insulin fragment] ratio as an exaggerated pleasure?

10 2, The various reagents are mixed in sufficient quantities^YDed Adnam:

300 IU/ml human insulin 100 ml

The product of T^YLyophilization of compound 2 2190 mg

Sodium CetR 720 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. It is mentioned that Al-Mahdal Al-Sadafi is nominated as an anomaly

15 It has a thickness of 0.22 micrometers and is stored at 4 °C.

B88. Prepare 300 IU/ml insulin lispro solution in the presence of 2-LucTR

300 IU/ml Insulin Lispro 100 ml

The product of T^YLyophilization of compound 2 2190 mg

Sodium CetR 720 mg

٥٦٣٩

-١١٦-

The final pH number is 7.4 ± 0.4. The elliptical solution is filtered with atoms of 0.22 µm and stored at 4 °C.

B89. Prepare 400 IU/ml human insulin solution in the presence of 2-LucTR

For a formula with a final volume of 100 ml, what is the [compound 2]/[insulin fragment] ratio as an exaggerated pleasure?

5 2.0, various reagents are mixed in equal quantities^YDed Adnam:

400 IU/ml human insulin 100 ml

The product of T^YLyophilization of compound 2 2920 mg

Sodium citrate 960

mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. It is mentioned that Al-Mahdal Al-Sadafi is nominated as an anomaly

10 It has a thickness of 0.22 micrometers and is stored at 4 °C.

B90. Prepare a 400 IU/ml insulin lispro solution in the presence of 2-LucTR

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 2]/[insulin lispro]?

<p dir="rtl">2.0, various reagents are mixed in equal quantities^YDed Adnam:</p>

400 IU/ml Insulin Lispro 100 ml

15 The product of T^YLyophilization of compound 2 2920 mg

Sodium CetR 960 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B91. Prepare 500 IU/ml human insulin solution in the presence of 2-LucTR

20 For a formula with a final volume of 100 ml, what is the [compound 2]/[insulin fragment] ratio as an exaggerated pleasure?

<p dir="rtl">2.0, various reagents are mixed in equal quantities^YDed Adnam:</p>

٥٦٣٩

-١١٧-

500 IU/ml human insulin 100 ml

The product of T^YLyophilization of compound 2 3650 mg

Sodium CetR 1200 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. It is mentioned that Al-Mahdal Al-Sadafi is nominated as an anomaly

5 It has a thickness of 0.22 micrometers and is stored at 4 °C.

B92. Prepare 500 IU/ml insulin lispro solution in the presence of 2-LucTR

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 2]/[insulin lispro]?

<p dir="rtl">2.0, various reagents are added in exact quantities^YDed Adnam:</p>

500 IU/ml Insulin Lispro 100 ml

10 The product of T^YLyophilization of compound 2 3650 mg

Sodium CetR 1200 mg

The final pH of the atom must be adjusted to 7.4 ± 0.4. The nacreous solution is filtered with 0.22 µm atoms and stored at 4 °C.

B93. Prepare 100 IU/ml insulin lispro solution in the presence of 3-LucTR

15 For a formula with a final volume of 100 ml, what is the mass ratio of [compound 3]/[insulin lispro]?

<p dir="rtl">2.0 This document has been added to this document. 9.3 This document has been added to this document.^YDD ADDDDDDDDAM</p>

In the following order:

Lyophilized Compound 3 730 mg

<p dir="rtl">100 IU/ml of solution Humalog® 100 ml</p>

20 1.188 molar of 783 microliter sodium citrate solution

٥٦٣٩

-١١٨-

As for salts, it is possible to use a salt radical or a base radical, such as a sodium salt, a potassium salt, or another compatible salt in an injectable formulation.

The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

<p dir="rtl">5 B94. Prepare 100 IU/ml insulin lispro solution in the presence of 4-lucitr compound</p>

For a formula with a final volume of 100 ml, what is the mass ratio of [compound 4]/[insulin lispro]?

<p dir="rtl">2 0. You will be able to add a variety of information in this document. 9.3 of this document.^YDD ADDDDDDDDAM</p>

In the following order:

Composite 4 dryer^YRefrigerated 730 mg

<p dir="rtl">10 100 IU/ml of Humalog® 100 ml solution</p>

1.188 molar of sodium citrate solution

783 Micro liter

As for the radicals, you can use the radicals or the radicals, as this is the radical

Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH is adjusted to 7.4 ± 0.4.

<p dir="rtl">15 The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.</p>

B95. Prepare 100 IU/ml human insulin solution in the presence of 3-LucTR

To obtain a formula with a final volume of 100 ml, what is the ratio of [compound 3]/[insulin fragment] as a dose of 2.0 ml and 9.3 ml of this amount, you can add various amounts in this amount^YDD ADDDDDDDDAM

In the following order:

20 3 dryer compound^YRefrigerated 730 mg

100 IU/ml of solution Traders Humulin® R 100 ml

٥٦٣٩

-١١٩-

1.188 molar of 783 microliter sodium citrate solution

As for the radicals, you can use the radicals or the radicals, as this is the radical

Sodium, potassium salt or other salt compatible with what injectable formula.

The final pH is adjusted to 7.4 ± 0.4.

<p dir="rtl">5 The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C. B96. Prepare 100 IU/ml human insulin solution in the presence of compound 4 and citrate to obtain a formula with a final volume of 100 ml, which is [compound 4]/[insulin fragment] in proportion as an exaggerated pleasure.</p>

<p dir="rtl">2.0 This document has been added to this document. 9.3 This document has been added to this document.^YDD ADDDDDDDDAM</p>

In the following order:

<p dir="rtl">10 Composite 4 dryer^YRefrigerated 730 mg</p>

100 IU/ml of solution Traders Humulin® R 100 ml

1.188 molar of 783 microliter sodium citrate solution

As for the radicals, you can use the radicals or the radicals, as this is the radical

Sodium, potassium salt or other salt compatible with what injectable formula.

15 The final pH is adjusted to 7.4 ± 0.4.

The clear solution was filtered through a 0.22 μM saturator and stored at 4 °C.

Pharmacodynamics and pharmacokinetics

<p dir="rtl">1 : Pharmacodynamic measurement protocol for insulin solutions</p>

12 slaughtered pigs were slaughtered, weighing approximately 50 kg of leprosy, and were vilified and filthy, filthy and disgusting._aI have the jugular vein,

<p dir="rtl">20 For 2.5 minutes, the experience was over. In the previous test for insulin injections, 3 samples of blood were taken in order to determine the basal level of glucose and insulin.</p>

٥٦٣٩

-١٢٠-

Insulin was injected at a dose of 0.09 IU/kg from insulin lispro and a dose of 0.125 IU/kg from insulin lispro.

Animal, using a Novopen insulin pen equipped with a 31 g needle.

Since then, it has been taken for 4 minutes since 20 minutes, and since 10 minutes before, 3 minutes have passed. After 5 tests of each sample, the catheter is instilled with a diluted heparin solution^YF.

Some blood was sampled to determine blood sugar using a glucose meter.

The pharmacodynamic curve for glucose was determined, and the time required to reach it was determined. This report shows the glucose signal at this time, as well as a minute-by-minute report for glucose.

<p dir="rtl">10 The average time per minute for glucose was calculated.</p>

The remaining blood was collected in a centrifuge and centrifuge_aThis is the most beautiful thing. Insulin levels in serum eyes were measured using a competitive immunoassay for each pig.

The pharmacokinetic curve has been determined. The time for the solute to reach the solute was determined as the maximum concentration of insullin in the solute, so that the pigment and takadram in the mouth would be the most effective and necessary for the insullin. 15 Calculate the average maximum values ​​of insulin.

2 : Pharmacodynamic and pharmacokinetic results of insulin solutions for linin B2 and B8.

<tr><td><p dir="rtl">Number of pigs</p></td><td><p dir="rtl">Polyanionic compound</p><p dir="rtl">compound</p></td><td><p dir="rtl">compound</p></td><td><p dir="rtl">Insulin</p></td><td><p dir="rtl">money</p></td></tr><tr><td><p>11</p></td><td></td><td></td><td><p dir="rtl">Yesbro</p></td><td><p dir="rtl">B2</p></td></tr>

٥٦٣٩

-١٢١-

<tr><td><p>10</p></td><td><p dir="rtl">9.3</p><p dir="rtl">Molar</p></td><td><p>1</p></td><td><p dir="rtl">Yesbro</p></td><td><p dir="rtl">B8</p></td></tr>

The pharmacodynamic results obtained using the formula described above for subjects B2 and B8 are shown in Figure 1.

according to_aTo take this example, you can solve this curve by 8, which is the anomaly in the center of 1, and you will have an amount of 9.3 mm that is present at the origins of the anomaly (the curve that you can take from this figure). Using the square of 5 and 8, the maximum value of glucose = 30 ± 11 Minute (minute) from the person who is able to obtain this

Arm response compared to the response obtained using the commercial formula Humalog® MLP2 (curve modeled using MLP2, maximum glucose time = 44 ± 14 minutes).

Extract the excuse for the movement model of this function obtained by using the described formula, so this is the number of these two, B2, 10, and B8 in Figure 2.

according to_aTo take this example, you can solve this curve by 8, which is the anomaly in the center of 1, and you will have an amount of 9.3 mm that is present at the origins of the anomaly (the curve that you can take from this angle). Using the square of this YN R M L B8, the maximum time for insulin = 11 ± 6 minutes s) Absorption of insulin lispro is approximately 15% greater than that of the commercial formula Humalog®, this method is 15 minutes, using the maximum insulin dose = 18 ± 8 minutes.

3 : Pharmacodynamic and pharmacokinetic results of insulin solutions for lamin B2 and B10

<tr><td><p dir="rtl">Number of pigs</p></td><td><p dir="rtl">Polyanionic compound</p><p dir="rtl">compound</p></td><td><p dir="rtl">compound</p></td><td><p dir="rtl">Insulin</p></td><td><p dir="rtl">money</p></td></tr><tr><td><p>11</p></td><td></td><td></td><td><p dir="rtl">Yesbro</p></td><td><p dir="rtl">B2</p></td></tr>

٥٦٣٩

-١٢٢-

<tr><td><p>1 1</p></td><td><p dir="rtl">Compound 1 polyanionic</p></td><td><p>1</p></td><td><p dir="rtl">Yesbro</p></td><td><p dir="rtl">B10</p></td></tr>

The pharmacodynamic results obtained using the formula described above for subjects B2 and B10 are shown in Figure 3. According to_aAccording to the invention, an analysis of the curve shows that the formula of MLP10 containing compound 1 and the polyanionic compound 1 in black forms at 20 mg/m (the curve modeled using a Y-squared MLP10), the maximum time for glucose = 33 ± 13 minutes) cringe

<p dir="rtl">5 This response can be compared to the response obtained using the commercial formula Humalog® (this is shown in B2), the maximum glucose time = 44 ± 1 4 minutes(.</p>

Excuse the medicinal motion model obtained by using the word described in the letter B2 and B10 in Figure 4. According to_aAccording to the invention, analysis of the curve shows that the formula of ML B10 which includes...

<p dir="rtl">10 At the same time, the 1st polygon and the polyanionic centromere have black roots at 20 leprosy/paresthesias (the curve that can be determined using a YR square with 10, the maximum time for insulin = 15 ± 9 minutes). Delicious commercial Humalog® delicious M Y B2 (curve modeled using M L A N R M L B2, maximum insulin time = 18 ± 8 minutes).</p>

15

4 : Pharmacodynamic and pharmacokinetic results of insulin solutions for lamin B2 and B7

<tr><td><p dir="rtl">Number of pigs</p></td><td><p dir="rtl">Polyanionic compound</p><p dir="rtl">compound</p></td><td><p dir="rtl">compound</p></td><td><p dir="rtl">Insulin</p></td><td><p dir="rtl">money</p></td></tr>

٥٦٣٩

-١٢٣-

<tr><td><p>12</p></td><td></td><td></td><td><p dir="rtl">Yesbro</p></td><td><p dir="rtl">B2</p></td></tr><tr><td><p>12</p></td><td></td><td><p>1</p></td><td><p dir="rtl">Yesbro</p></td><td><p dir="rtl">B7</p></td></tr>

The pharmacodynamic results obtained using the matrix described in the following B2 and B7 are presented in Figure 5._aTo take a quick example, by analyzing this curve, we assume that the formula of this curve, which is modeled using the formula 1, which is based on the roots of blackness (the curve that is taken using the square of the model B7, maximum glucose time = 41 ± 16 minutes) includes the effect figure. Faster than the recipient

<p dir="rtl">5 Using the commercial formula Humalog®, this is shown in B2 (this method is taken using the formula B2, maximum glucose time = 50 ± 14 minutes).</p>

Excuse the medical movement model that was obtained by using the described word, which is the reason for this. B2

And B7 in Figure 6. Analysis of this curve shows that the formula that includes the formula 1 has dark roots (the curve was modeled using a square of YNRM B2, maximum for insulin = 10 21 ± 10 min s) that does not give rise to the absorption of insulin. In the form of arms compared to the commercial formula

Humalog®

(Maximum duration of insulin = 20 ± 9 minutes.) Therefore, compound 1 alone is sufficient to provide a sufficient flow rate in the pharmacokinetics of insulin lispro.

5 : Pharmacodynamic and pharmacokinetic results of insulin solutions for lines B1 and B3

<tr><td><p dir="rtl">Number of pigs</p></td><td><p dir="rtl">Polyanionic compound</p><p dir="rtl">compound</p></td><td><p dir="rtl">compound</p></td><td><p dir="rtl">Insulin</p></td><td><p dir="rtl">money</p></td></tr><tr><td><p>11</p></td><td></td><td></td><td><p dir="rtl">Asbar</p></td><td><p dir="rtl">B 1</p></td></tr><tr><td><p>11</p></td><td></td><td></td><td><p dir="rtl">Humans</p></td><td><p dir="rtl">B3</p></td></tr>

٥٦٣٩

-١٢٤-

The pharmacodynamics results obtained using the formula described in Figure 7 are shown in Figure 7. We analyze these curves, so that the insulin formula is the seed for the model B3 (Model B3).

This can be calculated using the square of this method by 3, the maximum time for glucose = 61 ± 31 minutes) It has a significantly greater effect compared to the commercial formula of insulin aspirin for Lactate B1 (the curve

<p dir="rtl">5 (Maximum glucose time = 44 ± 13 minutes).</p>

The excuse of the dynamic motion model obtained by using the formula described by the exemplar is given by B1 and B3. This is the example of Figure 8. They attempt to solve this curve so that the formula of the two exemplars is executed._aTherefore, B3 (the curve was simulated using a Y square for Insulin = 36 ± 33 min) is the maximum absorption rate compared to the commercial formula for insulin absorption (Novolog®) 10 mM B1 (the curve that was calculated Choose it using MLA ENA R MLA B1, the maximum insulin dose

<p dir="rtl">= 28 ± 13 minutes.</p>

Insulin absorption will not see effective insulin for human insulin.

6 : Pharmacodynamic and pharmacokinetic results of insulin solutions for linin B1 and B39.

<tr><td><p dir="rtl">Number of pigs</p></td><td><p dir="rtl">Polyanionic compound</p><p dir="rtl">compound</p></td><td><p dir="rtl">compound</p></td><td><p dir="rtl">Insulin</p></td><td><p dir="rtl">money</p></td></tr><tr><td><p>14</p></td><td></td><td></td><td><p dir="rtl">Asbar</p></td><td><p dir="rtl">B 1</p></td></tr><tr><td><p>5</p></td><td><p dir="rtl">Set R 9.3 mM</p></td><td><p>1</p></td><td><p dir="rtl">Humans</p></td><td><p dir="rtl">B39</p></td></tr>

15 The pharmacodynamic result obtained using the formula described for B1 and B39 is shown in Figure 9. Analysis of this curve shows that the formula is_aTa Alz Insdulin Al-Bashdhar Al-Mazal

٥٦٣٩

-١٢٥-

B39 The exaggeration includes a compound 1 and a 9.3 mm excursion number. This is the root of the increase (the model was chosen using a Y-square for B39, maximum glucose time = 46 ± 9 minutes) that makes it possible to obtain an effect similar to that obtained Using the commercial formula for insulin aspirin (Novolog®) in MLB1 (curve modeled using MLB5B1, maximum glucose time = 53±24 minutes).

The pharmacokinetic model obtained is based on the formula described in Figure 10 and B39. An analysis of the curve shows that the formula of MLA B39 containing compound 1 and citrate has a concentration of 9.3 mM in the black form (the curve was chosen). e using a square

This is 39 min., the maximum amount of insulin = 20 ± 7 min.) The absorption rate of insulin 10 is similar to that obtained using the commercial formulation of insulin aspirin (Novolog®). Take advantage of this using this method The maximum value of insulin = 22 ± 10 min.

Since the timing variables for insulin injections (Novolog®) between lines C5 and C6 are similar, it is

The lecturers indicated that the model B39 radically distorts the absorption of human insulin compared to the commercial formula for human insulin (MLA B3).

<p dir="rtl">7 : Pharmacodynamic and pharmacokinetic results of insulin solutions for lamin B2 and B11</p><table border="1"><tbody><tr><td><p dir="rtl">Number of pigs</p></td><td><p dir="rtl">Polyanionic compound</p><p dir="rtl">compound</p></td><td><p dir="rtl">compound</p></td><td><p dir="rtl">Insulin</p></td><td><p dir="rtl">money</p></td></tr><tr><td><p>26</p></td><td></td><td></td><td><p dir="rtl">Yesbro</p></td><td><p dir="rtl">B2</p></td></tr><tr><td><p>23</p></td><td><p dir="rtl">Set R 9.3 mM</p></td><td><p>2</p></td><td><p dir="rtl">Yesbro</p></td><td><p dir="rtl">B11</p></td></tr></tbody></table>

The pharmacodynamic results obtained using the formula described in Figure 2 and 11 are presented in Figure 13. According to_aTo take this as an example, you can solve this curve by solving this curve. This is the most important thing

٥٦٣٩

-١٢٦-

Figure it out using a Y square with 11, the maximum glucose time = 32 ± 10 minutes (make

It is possible to obtain this response using a comparison with the response obtained using the formula.

Commercial Humalog® Timeline B2 (the recommended time frame for taking this medication is 20 minutes, maximum glucose time = 41 ± 21 minutes).

5 The excuse of an example of the medicinal movement that was obtained by using the described anomaly is censured, so this is the same as B2 and B11, so this is the anomaly of all 14. According to_aTo take this as an example, you can solve this curve by solving this curve. This is the most important thing

Figure it out using a Y square with 11, maximum insulin time = 13 ± 5 minutes)

10 (Curve modeled using mnh2, maximum for insulin = 22 ± 13 min).

<p dir="rtl">8 : Pharmacodynamic and pharmacokinetic results of insulin solutions for linin B1 and B3 8</p><table border="1"><tbody><tr><td><p dir="rtl">Number of pigs</p></td><td><p dir="rtl">Polyanionic compound</p><p dir="rtl">compound</p></td><td><p dir="rtl">compound</p></td><td><p dir="rtl">Insulin</p></td><td><p dir="rtl">money</p></td></tr><tr><td><p>37</p></td><td></td><td></td><td><p dir="rtl">Asbar</p></td><td><p dir="rtl">B 1</p></td></tr><tr><td><p>3 1</p></td><td><p dir="rtl">Set R 9.3 mM</p></td><td><p>2</p></td><td><p dir="rtl">Humans</p></td><td><p dir="rtl">B 3 8</p></td></tr></tbody></table>

The pharmacodynamic results obtained using the formula described for B1 and B3 8 are shown in Figure 15. Analysis of the curve shows that the formula is_aTa Al-Insdulin Al-Bashdhar is this

15 3 8

(The curve was chosen using a square of YNm 102, maximum glucose = 47 ± 30 min)

٥٦٣٩

-١٢٧-

Commercial insulin aspirin (Novolog®) in MLA B1 (the form you wish to take using)

(M L E N R M L B1, maximum glucose time = 47 ± 15 minutes).

The results of the pharmacokinetics obtained are shown using the formula described in Line B1 and B

<p dir="rtl">3 8 in Figure 16. The analysis of the curve shows that the formula of M L B 3 8 which includes the formula</p>

<p dir="rtl">5 2 and a mean of 9.3 mM in dark images (the curve was sampled using a square</p>

The maximum dose of insulin = 22 ± 21 minutes. The maximum absorption of insulin is 30 minutes. The maximum absorption of insulin is based on the pleasure obtained using this commercial formula for this purpose. Novolog® This means that the maximum time for insulin = 19 ± 12 minutes.

<p dir="rtl">10 Since the time variables of insulin spikes (Novolog®) between mothers 5 and 8 are similar, it is</p>

It can be concluded, by means of extrapolation, that the formulation of MAL B3 8 significantly reduces the memory and absorption of human insulin compared to the commercial formulation of human insulin (MAL B3).

9 : Pharmacodynamic and pharmacokinetic results of insulin solutions for linin B1 and B53.

<tr><td><p dir="rtl">Number of pigs</p></td><td><p dir="rtl">Polyanionic compound</p><p dir="rtl">compound</p></td><td><p dir="rtl">compound</p></td><td><p dir="rtl">Insulin</p></td><td><p dir="rtl">money</p></td></tr><tr><td><p>12</p></td><td></td><td></td><td><p dir="rtl">Asbar</p></td><td><p dir="rtl">B 1</p></td></tr><tr><td><p>8</p></td><td><p dir="rtl">Set R 9.3 mM</p></td><td><p dir="rtl">compound 8</p></td><td><p dir="rtl">Humans</p></td><td><p dir="rtl">B53</p></td></tr>

1

15 And B53 in Figure 17. Analysis of the curve shows that the formula is us_aTalk about human insulin

B 53

This is 53, the maximum value of this value is 63 ± 36.

٥٦٣٩

-١٢٨-

This is the exact example of the effect obtained using the commercial formula for insulin aspirin (Novolog®) for Lactate 1 (the curve you are taking using the formula). This means that B1 Maximum maximum temperature = 53 ± 19 minutes s().

<p dir="rtl">5 The pharmacokinetic model obtained is presented using the formula described in Figure 1 and B53 in Figure 18. An analysis of the curve shows that the formula of MLB53 containing compound 8 citrate has a concentration of 9.3 mM in the black form (the curve selected e using a square</p>

The maximum amount of this amount is 53, the maximum amount of this amount = 19 ± 12 minutes) The absorption of this amount is equal to the amount of absorption of the amount obtained by using the commercial formula for this method. Please see this page

<p dir="rtl">10 (Novolog®) for LBP1 (curve modeled using LINAR LBP1, maximum insulin time = 19±6 minutes).</p>

Since the time variables of the two oscillators (Novolog®) with the motherboards 5 and 9 are oscillator,

It can be extrapolated that the MLA B53 formulation is less effective in reducing absorption and absorption of human insulin compared to the commercial formulation of human insulin (MLA B3).

<p dir="rtl">15 D Increase the color</p>

D1: The state of insulin lispro confusion is evaluated by chromatography in the presence of compound 1.

Increased chromaticity makes the pattern of the two structures similar to the two structures. The insulin monomer is arranged in dimer forms and hexagonal compound forms. The hexadecane is the most stable atom in the physical and chemical sense of insulin. There are hexagrams, 6R roots and 6T roots.

<p dir="rtl">20 This is followed by a strong atomistic atomization at 251 nm, which is typical of the 6R radical of the hexagonal oscillator (the most stable form). The disc signal loss at 251 nm is related to the destabilization of the hexagonal compound (and hence the first signal of the hexagonal conversion to a dimer). .</p>

٥٦٣٩

-١٢٩-

Ethylene diamine-acetic acid (EDTA) works to make the diet better.

tetra and EDTA/Citre completely depend on the derivatization of the 6R radicals of lissopro insulin (Figure 11).

Therefore, EDTA expresses an effect on the hexagonal compound.

On the contrary, do not fill the Ctr alone, compound 1 is repulsive_aDa, and A_aDhaa Al-Khaladi Morzad 1/Sathit Ar and Morzad

<p dir="rtl">5 1/Multiplexed 1 is an atomized anion. Therefore, the two compounds do not have an effect on the 6R structure of the hexagonal compound, and everything that is less than that of the hexagonal compound does not affect the structure of the hexagonal compound.</p>

D2: The state of human insulin confusion is evaluated by chromatography in the presence of compound 1

Increase the chromaticity and make the structure of the two structures similar to the two structures. Disparage the arrangement of the Mondum Ar

<p dir="rtl">10 Insulin is in dimer forms and has hexagonal compound radicals. This hexagonal compound has the most atom radicals</p>

The study of the minaret of the minaret provides physics and chemistry for the two men. There was no signal loss at 275 atoms, and a characteristic signal for the hexa radicals of insulin (the hexa compound indicated at about -300°, the dimer indicated between -200° and -250°, and the monomer indicated below -200°). Accordingly, there was no signal loss at 275 atoms. An additive to destabilize the hexa-dimer or monomer compound.

<p dir="rtl">15 Note: EDTA and the EDTA/SSD combination are clear notes._aThis is the same as the hexagonal center for two different types (turn, this is the same for the six-sided center that has always been mentioned, Figure 12).</p>

This device has 1 port, the second oscillator has 1 port, and it has 1 port._aThis is a combination of this center

1/Multi-Anion Oscillator 1/Multi-Anion Oscillator 1/Multi-Anion Oscillator

For the mischievous Insdulin. In contrast to EDTA, do not use insulin as a result of the harmful effects of insulin.

<p dir="rtl">20 Compound 1 Lucitr or Polyanionic Compound 1a Tf^،K is the hexameric compound of human insulin.</p>

D3: Evaluation of the case of insulin lispro isoform chromatography in the presence of compounds 1L11.

Increase the chromaticity and make the structure of the two structures similar to the two structures. The insulin monomer is arranged in dimer forms and in hexagonal compound radicals. This hexa compound is the most physically and chemically stable radical of insulin. There are two images of the hexagonal compound, radical 6R

٥٦٣٩

-١٣٠-

And 6T pictures. Lispro has a strong warning signal at 251, and is characterized by the 6R root of the hexagon (the most dangerous root). This warning occurs when the 251 model is disturbed by the destabilization of this document. The center is a six-month period (and thus the first instance of the transfer of this position to a permanent six-pointer this year). In Figure 19, this figure describes the x-axis:

5 - A: Insulin lispro (100 IU/ml)

<p dir="rtl">B: Insulin lispro + 7.3 mg/ml of compound 2</p>

<p dir="rtl">C: Insulin lispro + 7.3 mg/ml C2 + CetR 9.3 mM</p>

<p dir="rtl">D: Insulin lispro + 7.3 mg/ml of compound 1</p>

<p dir="rtl">E: Insulin lispro + 7.3 mg/ml Compound 1 + CetR 9.3 mM</p>

<p dir="rtl">10 - F: Insulin lispro + 7.3 mg/ml of compound 3</p>

<p dir="rtl">G: Insulin lispro + 7.3 mg/ml C3 + CETR 9.3 mM</p>

<p dir="rtl">H: Insulin lispro + 7.3 mg/ml of compound 4</p>

I: Insulin lispro + 7.3 mg/ml of compound 4 + CetR by 9.3 mM.

J: Insulin lispro + 7.3 mg/ml of compound 5

15 - K: Insulin lispro + 7.3 mg/ml of compound 5 + CetR by 9.3 mM

L: Insulin lispro + 7.3 mg/ml of compound 6

M: Insulin lispro + 7.3 mg/ml of complex 6 + CetR 9.3 mM

N: Insulin lispro + 7.3 mg/ml of compound 7

O: Insulin lispro + 7.3 mg/ml of compound 7 + CetR 9.3 mM

20 - P: Insulin lispro + 7.3 mg/ml of compound 8

٥٦٣٩

-١٣١-

Q: Insulin lispro + 7.3 mg/ml Compound 8 + CetR 9.3 mM

<tr><td><p>9</p></td><td><p dir="rtl">Insulin lispro + 7.3 mg/ml of compound</p></td><td><p>:R -</p></td></tr><tr><td><p dir="rtl">9 + This is what I saw in my mouth 9.3</p></td><td><p dir="rtl">Insulin lispro + 7.3 mg/ml of compound</p></td><td><p>:S -</p><p dir="rtl">mM</p></td></tr><tr><td></td><td><p dir="rtl">Insulin lispro + 7.3 mg/ml of compound 10</p></td><td><p>:T -</p></td></tr><tr><td><p dir="rtl">10 +Shạtạt R Bmqdạddar 9.3</p></td><td><p dir="rtl">Insulin lispro + 7.3 mg/ml of compound</p></td><td><p>:U -</p><p dir="rtl">mM</p></td></tr><tr><td><p>11</p></td><td><p dir="rtl">Insulin lispro + 7.3 mg/ml of compound</p></td><td><p>:V -</p></td></tr><tr><td><p dir="rtl">11 + Szdhitar Bmddhadar 9.3</p></td><td><p dir="rtl">Insulin lispro + 7.3 mg/ml of compound</p></td><td><p>:W-</p></td></tr>

10 mM

On the y axis, the color signal increases at 251 nanometers (degrees.cm2.dmol-1).

Do not fill out compounds 1 to 11 alone and any_aAddition of compounds 1 to 11 will have no effect

Signal at 251 nm for insulin lispro. Therefore, components 1 to 11a do not tend to scatter

6R at this time

15 Insulin.

D4: Evaluation of the confusion of human insulin by chromatography in the presence of compounds 1 to 11.

The chromatic aberration of the compound makes it possible to study the anomeric and tetragonal structures of the two structures. The insulin monomer is arranged in dimer forms and in hexagonal compound radicals. The hexagonal compound provides the most atom roots, the physics and chemistry of the two hexagons. 275

20 The hexagonal oscillator of two males (the eclipse of the hexagonal oscillator then passing by -300°, the eccentricity of the hexagon passing by two males -

(200° and -250°, and the monomer signal is less than -200°). Therefore, there is a signal loss at 275 nm

٥٦٣٩

-١٣٢-

It is characteristic of destabilizing the stability of the hexagonal oscillator at all times. Disclaimer of the excuse for the obtained model

It is depicted in Figure 20. This figure describes the axis

:x

10

15

:A

:B

:C

:D

:E

:F

:G

:H

Human insulin (100 IU/ml)

Human insulin

Human insulin

Human insulin

Human insulin

Human insulin

Human insulin

Human insulin

7.3 mg/ml of compound

7.3 mg/ml of compound

7.3 mg/ml of compound

7.3 mg/ml of compound

7.3 mg/ml of compound

7.3 mg/ml of compound

7.3 mg/ml of compound

set r

set r

+ Set R

By 9.3 mM

By 9.3 mM

By 9.3 mM

I: Human insulin + 7.3 mg/ml of complex IV + CetR 9.3 mM

:J

:K

:L

Human insulin

Human insulin

Human insulin

M: Human insulin

:N

Human insulin

:O

Human insulin

7.3 mg/ml of compound

7.3 mg/ml of compound

7.3 mg/ml of compound

+ Set R

By 9.3 mM

:P

Human insulin

:Q

7.3 mg/ml of compound

7.3 mg/ml of compound

7.3 mg/ml of compound

7.3 mg/ml of compound

Human insulin + 7.3 mg/ml of compound

set r

set r

By 9.3 mM

By 9.3 mM

SetR of 9.3 mM

٥٦٣٩

-١٣٣-

<p dir="rtl">R: Human insulin + 7.3 mg/ml of compound 9</p>

<p dir="rtl">S: human insulin + 7.3 mg/ml of compound 9 + CetR 9.3 mM</p>

<p dir="rtl">T: Human insulin + 7.3 mg/ml of compound 10</p>

<p dir="rtl">U: Human insulin + 7.3 mg/ml of Compound 10 + CetR 9.3 mM</p>

<p dir="rtl">5 V: Human insulin + 7.3 mg/ml of compound 11</p>

W: Insaddhulin Bazdhadhar + 7.3 Majzdhim/ Mazdhim Mazdhan Markazdhi 11 + Sdzdhit Ar Bmqddhadhar 9.3 Mlzdhi Mazdhilar and Alaaz

The y axis is the color signal at 275 nm (degrees.cm2.dmol-1).

Do not flatter the compound, that 1, that 11 outlet, and any_aThis compound is 1, so 11, what did you say, what did you say?

On Ishar Atad 275 Nadhanu Mutathar for Al-Ansadulin Al-Bashdhar. Therefore, the compound 1 does not have a trace of 10 on the structure of the hexagonal compound of human insulin.

<p dir="rtl">1 this. Decomposition of human insulin and insulin at the isoelectric point</p>

Decomposition of human insulin and insulin at the isoelectric point

Human insulin has an isoelectric point of 5.3. At agglutinated pH of 5.3, insedolin precipitates out. You have taken the root of this exaggeration, and you have done so^YThis is the most important thing, using the roots of 15 different compounds, then this method is used to explain this method and electricity. So, this is the word "Hadhadha" and "Jadhdhud Tafa'dhadha", they are like "Mudhadhdhan Al-Mumdhazan", "Itabdhadhadha"

Insulin is at its isoelectric point.

200 units/mL of seed insulin solution are prepared. Solutions of this compound are prepared at different concentrations (8.30 or 100 mg/ml) in a solution. An equal volume (50/50) mixture is prepared.

With these two solutions, they are called the anomaly and the solution of the center is modeled by this model, which is modeled after 100.

20 Io/ml of human insulin and the desired concentration of the compound (4.15 or 50 mg/ml). The pH of the various solutions is adjusted to pH 5.3 by adding 200 ml of acetic acid.

٥٦٣٩

-١٣٤-

The clarity of the solution was verified. The solution is also cloudy, as the solution at the concentration used in the test does not allow human insulin to break down. If the solution is semi-transparent, the compound allows human insulin to be administered at the concentration used in the test. With care, the concentration of the compound required to replenish human insulin can be determined at this electroporation point. The more vulgar these two approaches are, the more exquisite they become

<p dir="rtl">5 Compound for human insulin.</p>

The results obtained are presented in Table 3. The results show that the compound and the two polysaccharide compounds do not have the same properties with regard to human insulin production.

<tr><td><p dir="rtl">The solution should be discontinued at 50 mg/ml.</p></td><td><p dir="rtl">The solution should be taken at 100 mg/ml.</p></td><td><p dir="rtl">Tablets: 4 mg/ml.</p></td><td><p dir="rtl">Compound (mother of this) or Compound This is the case</p></td></tr><tr><td></td><td></td><td></td><td><p dir="rtl">A) The most beautiful thing ever</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">Yes</p></td><td><p dir="rtl">paternal uncle</p></td><td><p dir="rtl">^aB^toAnd^Mfor me^AntiMin⁽I want 1</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">Yes</p></td><td><p dir="rtl">paternal uncle</p></td><td><p dir="rtl">Polysaccharide 4</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">Yes</p></td><td><p dir="rtl">paternal uncle</p></td><td><p dir="rtl">Polysaccharide 3</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">Yes</p></td><td><p dir="rtl">paternal uncle</p></td><td><p dir="rtl">Polysaccharide 2</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">Yes</p></td><td><p dir="rtl">paternal uncle</p></td><td><p dir="rtl">Polysaccharide 5</p></td></tr><tr><td></td><td></td><td></td><td><p dir="rtl">The mother has him</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">Composite 1</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">compound 2</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">compound 3</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">compound 4</p></td></tr>

٥٦٣٩

-١٣٥-

<tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">compound 6</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">compound 8</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">compound 9</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">Compound 10</p></td></tr>

Table 3

This is 2. Topan lispro insulin at its isoelectric point

Insulin lispro has an isoelectric point of 5.3. At this pH, insulin lispro precipitates. This test is being performed without delay^YThey say that they pronounce Insdullin using various roots.

<p dir="rtl">5 This compound is based on this method of electrical conduction. This is the case with the microelectronics that dispense insulin at its isoelectric point.</p>

The commercial formula for insulin lispro (Humalog®) is based on dietary liberation, with a concentration of 1 mM of PO4 solution (pH 7). After lispro insulin concentration, the concentration of insulin lispro is approximately 90 IU/ml. .

10 The dried compound is weighed^YRefrigerated and dissolved in a solution of insulin lispro, an insulin solution containing 90% insulin, and this mixture is concentrated at this concentration (4.15 or 50%).

mg/ml). The pH of various radicals in the solution is adjusted to a pH of 5.3 by adding 200 mM acetic acid.

The solution is scheduled to be ready. If the solution is cloudy, the compound is at the concentration used in the test

<p dir="rtl">15 Melting of non-soluble liquids is not allowed. If the solution is omitted, the concentrator will allow the dissolution of insulin lysate at the concentration used in the test. With care, the concentration of the compound required to form insulin lispro can be determined at its isoelectric point. The lower this concentration, the greater the affinity of the compound for insulin lispro.</p>

٥٦٣٩

-١٣٦-

The results obtained are presented in Table 4. The results show that the compound and the polysaccharide compounds do not have the same properties with regard to insulin lispro topan.

<tr><td><p dir="rtl">Determine the compound at 50 mg/ml.</p></td><td><p dir="rtl">Determine the compound at 15 mg/ml.</p></td><td><p dir="rtl">This is not the case at 90 and the solution is determined at 4 mg/ml.</p></td><td><p dir="rtl">This compound (the mother is this) or</p><p dir="rtl">This compound is called the opposite word.</p></td></tr><tr><td></td><td></td><td></td><td><p dir="rtl">The mother has the opposite</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">Yes</p></td><td><p dir="rtl">paternal uncle</p></td><td><p dir="rtl">Polysaccharide 1</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">Yes</p></td><td><p dir="rtl">paternal uncle</p></td><td><p dir="rtl">Polysaccharide 3</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">Yes</p></td><td><p dir="rtl">paternal uncle</p></td><td><p dir="rtl">Polysaccharide 2</p></td></tr><tr><td></td><td></td><td></td><td><p dir="rtl">The mother has him</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">Composite 1</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">compound 2</p></td></tr><tr><td><p dir="rtl">Yes</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">no</p></td><td><p dir="rtl">compound 3</p></td></tr>

Table 4

What is the interaction with albumin?

5 1: In order to determine the interaction between the various forms of this compound, or 10 of this compound, and a typical protein called albumin, a Centricon test was performed (a test with a maximum limit of 50 kilograms). / Tightly unpleasant paresthesias in a solution of bovine serum albumin (BSA) at 20 mg/ml

٥٦٣٩

-١٣٧-

Sodhi (concentration: Sozkarid: 2.43 leprosy/leprous sulphur, 13.3 leprosy/sulphurous sulphur, two albums and about 100 millimolar salts).

A centered unit has been installed for this unit, so that the centerpiece will be installed next to it.

Take the humiliation of cheaters. Disclaimer of the abhorrence of the people, so this is the origin of such anomalies, such as this, such anomalies as this will be created. This polysaccharide compound is a 5-saccharide and the compounds analyzed individually pass in large quantities through the membranes (for the 5-saccharide compound that has the largest molar masses, about 20% of the polysaccharide is retained).

After the concentrated reaction, the polysaccharide or compound is screened with UV light in the filtrate. The ordered percentage of polysaccharide or albumin is calculated by the following equation:

(1- [Polysaccharide or compound in the filtrate in the presence of albumin]/ [Polysaccharide or compound in 10 filtrate in the presence of albumin])*100

Excuse the result obtained for this in Table 5. It is made very clear that this body of mind is a memory that is like a child's pleasure that takes pleasure in the mind 5-15. Alternatively, the compound must be separated accordingly_aThis is to take care of the filthiest, for this is the purest pleasure with the roots of the filthiest

Significantly due to albumin in this test.

15 Table 5.

<tr><td><p dir="rtl">%polysaccharide or % compound arranged with BSA</p></td><td><p dir="rtl">Polysaccharide or compound</p></td></tr><tr><td></td><td><p dir="rtl">The mother has the opposite</p></td></tr><tr><td><p>%97</p></td><td><p dir="rtl">Polysaccharide 4</p></td></tr><tr><td><p>%95</p></td><td><p dir="rtl">Polysaccharide 1</p></td></tr><tr><td><p>%77</p></td><td><p dir="rtl">Polysaccharide 3</p></td></tr>

٥٦٣٩

-١٣٨-

<tr><td><p>%86</p></td><td><p dir="rtl">Polysaccharide 5</p></td></tr><tr><td><p>%82</p></td><td><p dir="rtl">Polysaccharide 2</p></td></tr><tr><td></td><td><p dir="rtl">The mother has him</p></td></tr><tr><td><p>%21</p></td><td><p dir="rtl">compound 2</p></td></tr><tr><td><p>%20</p></td><td><p dir="rtl">Composite 1</p></td></tr><tr><td><p>%27</p></td><td><p dir="rtl">compound 3</p></td></tr><tr><td><p>%24</p></td><td><p dir="rtl">compound 4</p></td></tr><tr><td><p>%24</p></td><td><p dir="rtl">compound 5</p></td></tr><tr><td><p>%26</p></td><td><p dir="rtl">compound 6</p></td></tr><tr><td><p>%27</p></td><td><p dir="rtl">compound 7</p></td></tr><tr><td><p>%27</p></td><td><p dir="rtl">compound 8</p></td></tr><tr><td><p>%43</p></td><td><p dir="rtl">compound 9</p></td></tr><tr><td><p>%35</p></td><td><p dir="rtl">Compound 11</p></td></tr>

٥٦٣٩

-١٣٩-